Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Feb. 04, 2022 | Jun. 30, 2021 | |
Entity Information [Line Items] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2021 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 1-5823 | ||
Entity Registrant Name | CNA FINANCIAL CORPORATION | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 36-6169860 | ||
Entity Address, Address Line One | 151 N. Franklin | ||
Entity Address, Postal Zip Code | 60606 | ||
Entity Address, City or Town | Chicago, | ||
Entity Address, State or Province | IL | ||
City Area Code | 312 | ||
Local Phone Number | 822-5000 | ||
Title of 12(b) Security | Common Stock, Par value $2.50 | ||
Trading Symbol | "CNA" | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Common Stock, Shares Outstanding (in shares) | 271,365,221 | ||
Entity Public Float | $ 1,255 | ||
Documents Incorporated by Reference | Portions of the CNA Financial Corporation Proxy Statement prepared for the 2022 annual meeting of shareholders, pursuant to Regulation 14A, are incorporated by reference into Part III of this report. | ||
Entity Central Index Key | 0000021175 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false | ||
New York Stock Exchange | |||
Entity Information [Line Items] | |||
Security Exchange Name | NYSE | ||
Chicago Stock Exchange | |||
Entity Information [Line Items] | |||
Security Exchange Name | CHX |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2021 | |
Audit Information [Abstract] | |
Auditor Name | DELOITTE & TOUCHE LLP |
Auditor Location | Chicago, Illinois |
Auditor Firm ID | 34 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Revenues | |||
Net earned premiums | $ 8,175 | $ 7,649 | $ 7,428 |
Net investment income | 2,159 | 1,935 | 2,118 |
Net investment gains (losses) | 120 | (54) | 29 |
Non-insurance warranty revenue | 1,430 | 1,252 | 1,161 |
Other revenues | 24 | 26 | 31 |
Total revenues | 11,908 | 10,808 | 10,767 |
Claims, Benefits and Expenses | |||
Insurance claims and policyholders’ benefits | 6,349 | 6,170 | 5,806 |
Amortization of deferred acquisition costs | 1,443 | 1,410 | 1,383 |
Non-insurance warranty expense | 1,328 | 1,159 | 1,082 |
Other operating expenses | 1,191 | 1,126 | 1,142 |
Interest | 113 | 122 | 131 |
Total claims, benefits and expenses | 10,424 | 9,987 | 9,544 |
Income before income tax | 1,484 | 821 | 1,223 |
Income tax expense | (282) | (131) | (223) |
Net income | $ 1,202 | $ 690 | $ 1,000 |
Basic earnings per share | |||
Basic earnings per share (in usd per share) | $ 4.42 | $ 2.54 | $ 3.68 |
Diluted earnings per share | |||
Diluted earnings per share (in usd per share) | $ 4.41 | $ 2.53 | $ 3.67 |
Weighted Average Outstanding Common Stock and Common Stock Equivalents | |||
Basic (in shares) | 271.8 | 271.6 | 271.6 |
Diluted (in shares) | 272.8 | 272.4 | 272.5 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Net income | $ 1,202 | $ 690 | $ 1,000 |
Other Comprehensive Income (Loss), net of tax | |||
Net unrealized gains and losses on investments | (708) | 720 | 948 |
Foreign currency translation adjustment | (19) | 47 | 39 |
Pension and postretirement benefits | 244 | (15) | (58) |
Other comprehensive (loss) income, net of tax | (483) | 752 | 929 |
Total comprehensive income | 719 | 1,442 | 1,929 |
Investments | |||
Other Comprehensive Income (Loss), net of tax | |||
Net unrealized gains and losses on investments | (2) | 0 | 0 |
Net unrealized gains and losses on other investments | |||
Other Comprehensive Income (Loss), net of tax | |||
Net unrealized gains and losses on investments | $ (706) | $ 720 | $ 948 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Investments: | ||
Fixed maturity securities at fair value (amortized cost of $39,952 and $38,953, less allowance for credit loss of $18 and $40) | $ 44,380 | $ 44,631 |
Equity securities at fair value (cost of $964 and $941) | 1,035 | 992 |
Limited partnership investments | 1,859 | 1,619 |
Other invested assets | 91 | 76 |
Mortgage loans (less allowance for uncollectible receivables of $16 and $26) | 973 | 1,068 |
Short term investments | 1,990 | 1,907 |
Total investments | 50,328 | 50,293 |
Cash | 536 | 419 |
Reinsurance receivables (less allowance for uncollectible receivables of $21 and $21) | 5,463 | 4,457 |
Insurance receivables (less allowance for uncollectible receivables of $29 and $33) | 2,945 | 2,607 |
Accrued investment income | 377 | 380 |
Deferred acquisition costs | 737 | 708 |
Deferred income taxes | 142 | 66 |
Property and equipment at cost (less accumulated depreciation of $255 and $231) | 226 | 252 |
Goodwill | 148 | 148 |
Deferred non-insurance warranty acquisition expense | 3,476 | 3,068 |
Other assets | 2,261 | 1,628 |
Total assets | 66,639 | 64,026 |
Insurance reserves: | ||
Claim and claim adjustment expenses | 24,174 | 22,706 |
Unearned premiums | 5,761 | 5,119 |
Future policy benefits | 13,236 | 13,318 |
Long term debt | 2,779 | 2,776 |
Deferred non-insurance warranty revenue | 4,503 | 4,023 |
Other liabilities (includes $56 and $89 due to Loews Corporation) | 3,377 | 3,377 |
Total liabilities | 53,830 | 51,319 |
Commitments and contingencies (Notes B and F) | ||
Stockholders' Equity | ||
Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 271,363,999 and 271,391,603 shares outstanding) | 683 | 683 |
Additional paid-in capital | 2,215 | 2,211 |
Retained earnings | 9,663 | 9,081 |
Accumulated other comprehensive income | 320 | 803 |
Treasury stock (1,676,244 and 1,648,640 shares), at cost | (72) | (71) |
Total stockholders’ equity | 12,809 | 12,707 |
Total liabilities and stockholders' equity | $ 66,639 | $ 64,026 |
Consolidated Balance Sheets - (
Consolidated Balance Sheets - (Parenthetical) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Fixed maturities securities at amortized cost | $ 39,952 | $ 38,953 |
Marketable securities fixed maturities allowance for credit loss | 18 | 40 |
Equity securities at cost | 964 | 941 |
Mortgage loans on real estate commercial and consumer allowance for credit loss | 16 | 26 |
Allowance for uncollectible reinsurance | 21 | 21 |
Allowance for uncollectible insurance receivables | 29 | 33 |
Accumulated depreciation on property and equipment | 255 | 231 |
Due to related parties | $ 56 | $ 89 |
Common stock, par value (in usd per share) | $ 2.50 | $ 2.50 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 273,040,243 | 273,040,243 |
Common stock, shares outstanding (in shares) | 271,363,999 | 271,391,603 |
Treasury stock, shares (in shares) | 1,676,244 | 1,648,640 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Cash Flows from Operating Activities | |||
Net income | $ 1,202 | $ 690 | $ 1,000 |
Adjustments to reconcile net income to net cash flows provided by operating activities: | |||
Deferred income tax expense (benefit) | 47 | (49) | (46) |
Trading portfolio activity | 20 | (5) | (16) |
Net investment (gains) losses | (120) | 54 | (29) |
Equity method investees | (127) | (8) | 11 |
Net amortization of investments | (81) | (67) | (89) |
Depreciation and amortization | 54 | 60 | 68 |
Changes in: | |||
Receivables, net | (1,358) | (409) | 137 |
Accrued investment income | 3 | 16 | (3) |
Deferred acquisition costs | (30) | (43) | (26) |
Insurance reserves | 2,463 | 1,681 | 358 |
Other, net | (76) | (145) | (225) |
Net cash flows provided by operating activities | 1,997 | 1,775 | 1,140 |
Dispositions: | |||
Fixed maturity securities - sales | 3,816 | 5,904 | 5,842 |
Fixed maturity securities - maturities, calls and redemptions | 4,464 | 3,760 | 2,997 |
Equity securities | 316 | 355 | 214 |
Limited partnerships | 246 | 373 | 479 |
Mortgage loans | 190 | 74 | 143 |
Purchases: | |||
Fixed maturity securities | (9,307) | (10,269) | (8,661) |
Equity securities | (304) | (452) | (186) |
Limited partnerships | (440) | (224) | (198) |
Mortgage loans | (95) | (172) | (298) |
Change in other investments | (6) | (8) | (11) |
Change in short term investments | (83) | (39) | (535) |
Purchases of property and equipment | (26) | (23) | (26) |
Other, net | 1 | 16 | 15 |
Net cash flows used by investing activities | (1,228) | (705) | (225) |
Cash Flows from Financing Activities | |||
Dividends paid to common stockholders | (621) | (950) | (929) |
Proceeds from the issuance of debt | 0 | 495 | 496 |
Repayment of debt | 0 | (419) | (520) |
Purchase of treasury stock | (18) | (18) | (23) |
Other, net | (9) | (10) | (12) |
Net cash flows used by financing activities | (648) | (902) | (988) |
Effect of foreign exchange rate changes on cash | (4) | 9 | 5 |
Net change in cash | 117 | 177 | (68) |
Cash, beginning of year | 419 | 242 | 310 |
Cash, end of period | $ 536 | $ 419 | $ 242 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Retained EarningsCumulative effect adjustments from changes in accounting guidance, net of tax | Retained EarningsBalance, beginning of year, as adjusted | Accumulated Other Comprehensive Income (Loss) | Treasury Stock |
Total stockholder's equity at beginning of period at Dec. 31, 2018 | $ 683 | $ 2,192 | $ 9,277 | $ 9,277 | $ (878) | $ (57) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Stock-based compensation | 11 | 10 | ||||||
Dividends to common stockholders ($2.27, $3.48, and $3.40 per share) | (929) | |||||||
Net income | $ 1,000 | 1,000 | ||||||
Other comprehensive (loss) income | 929 | 929 | ||||||
Purchase of treasury stock | (23) | |||||||
Total stockholder's equity at end of period at Dec. 31, 2019 | 12,215 | 683 | 2,203 | 9,348 | $ (5) | 9,343 | 51 | (70) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Stock-based compensation | 8 | 17 | ||||||
Dividends to common stockholders ($2.27, $3.48, and $3.40 per share) | (952) | |||||||
Net income | 690 | 690 | ||||||
Other comprehensive (loss) income | 752 | 752 | ||||||
Purchase of treasury stock | (18) | |||||||
Total stockholder's equity at end of period at Dec. 31, 2020 | 12,707 | 683 | 2,211 | 9,081 | $ 9,081 | 803 | (71) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Stock-based compensation | 4 | 17 | ||||||
Dividends to common stockholders ($2.27, $3.48, and $3.40 per share) | (620) | |||||||
Net income | 1,202 | 1,202 | ||||||
Other comprehensive (loss) income | (483) | (483) | ||||||
Purchase of treasury stock | (18) | |||||||
Total stockholder's equity at end of period at Dec. 31, 2021 | $ 12,809 | $ 683 | $ 2,215 | $ 9,663 | $ 320 | $ (72) |
Consolidated Statements of St_2
Consolidated Statements of Stockholders' Equity - (Parenthetical) - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statement of Stockholders' Equity [Abstract] | |||
Dividends declared per share (usd per share) | $ 2.27 | $ 3.48 | $ 3.40 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation The Consolidated Financial Statements include the accounts of CNA Financial Corporation (CNAF) and its subsidiaries. Collectively, CNAF and its subsidiaries are referred to as CNA or the Company. Loews Corporation (Loews) owned approximately 89.6% of the outstanding common stock of CNAF as of December 31, 2021. The accompanying Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). Intercompany amounts have been eliminated. The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. Recently Adopted Accounting Standards Updates (ASU) ASU 2016-13: In June 2016 the Financial Accounting Standards Board (FASB) issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . The updated accounting guidance required changes to the recognition of credit losses on financial instruments not accounted for at fair value through the Company’s results of operations. For financial assets measured at cost, the expected credit loss model requires immediate recognition of estimated credit losses over the life of the asset and presentation of the asset at the net amount expected to be collected. This updated guidance applies to mortgage loan investments, reinsurance and insurance receivables and other financing receivables. For available-for-sale fixed maturity securities carried at fair value, estimated credit losses will continue to be measured at the present value of expected cash flows, however, the other than temporary impairment (OTTI) concept has been eliminated. Under the previous guidance, estimated credit impairments resulted in a write-down of amortized cost. Under the updated guidance, estimated credit losses are recognized through an allowance and reversals of the allowance are permitted if the estimate of credit losses declines. For available-for-sale fixed maturity securities where the Company has an intent to sell, impairment will continue to result in a write-down of amortized cost. On January 1, 2020, the Company adopted the updated guidance using a modified retrospective method with a cumulative effect adjustment recorded to beginning Retained earnings. Prior period amounts have not been adjusted and continue to be reported in accordance with the previous accounting guidance. A prospective transition approach is required for available-for-sale fixed maturity securities that were purchased with credit deterioration (PCD assets) or have recognized an OTTI write-down prior to the effective date. The cumulative effect of the accounting change resulted in a $5 million decrease in Retained earnings, with a corresponding $7 million allowance for credit losses recorded for Mortgage loans partially offset by a $2 million tax impact. The allowance for uncollectible reinsurance and insurance receivables was unchanged as a result of adopting the updated guidance. At adoption, an allowance for credit losses of $6 million was established for available-for-sale fixed maturity securities that were PCD assets, with a corresponding increase to amortized cost, resulting in no adjustment to the carrying value of the securities. See the accounting policy discussion within this Note, as well as Notes B and G to the Consolidated Financial Statements for additional information regarding credit losses. Accounting Standards Pending Adoption In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts. The updated accounting guidance requires changes to the measurement and disclosure of long-duration contracts. Entities will be required to update cash flow assumptions (including morbidity and persistency) at least annually, and to update discount rate assumptions quarterly using an upper-medium grade fixed-income instrument yield. The effect of changes in cash flow assumptions will be recorded in the Company's results of operations and the effect of changes in discount rate assumptions will be recorded in Other comprehensive income. The guidance is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted, and may be applied using either a modified retrospective transition method or a full retrospective transition method. Restatement of prior periods presented is required. The Company will adopt the new guidance effective January 1, 2023, using the modified retrospective method applied as of the transition date of January 1, 2021. The most significant impact at the transition date will be the effect of updating the discount rate assumption to reflect an upper-medium grade fixed-income instrument yield, which will be partially offset by the de-recognition of shadow adjustments associated with long duration contracts. The Company expects the net impact of these changes will be a material decrease in Accumulated other comprehensive income as of the transition date. The requirement to update cash flow assumptions at least annually is expected to change the pattern of earnings emergence being recognized. Adoption will also significantly expand the Company’s disclosures, and will impact systems, processes, and controls. While the requirements of the new guidance represent a material change from existing GAAP, the new guidance will not impact capital and surplus under statutory accounting practices, related cash flows, or the underlying economics of the business. The Company continues to make progress in connection with these matters and is in process of refining key accounting policy decisions, technology solutions and updates to internal controls associated with adoption of the new guidance. These in-progress activities include modifications of actuarial valuation systems, data sourcing, analytical procedures and reporting processes. Insurance Operations Premiums: Insurance premiums on property and casualty insurance contracts are recognized in proportion to the underlying risk insured and are principally earned ratably over the term of the policies. Premiums on long term care contracts are earned ratably over the policy year in which they are due. The reserve for unearned premiums represents the portion of premiums written relating to the unexpired terms of coverage. Property and casualty contracts that are retrospectively rated or subject to audit premiums contain provisions that result in an adjustment to the initial policy premium depending on the contract provisions. These provisions stipulate the adjustment due to loss experience of the insured during the coverage period, or changes in the level of exposure to insurance risk. For such contracts, the Company estimates the amount of ultimate premiums that the Company may earn upon completion of the coverage period and recognizes either an asset or a liability for the difference between the initial policy premium and the estimated ultimate premium. The Company either adjusts such estimated ultimate premium amounts during the course of the coverage period based on actual results to date, or by conducting premium audits after the policy has expired to determine the final exposure to insured risks. The resulting adjustment is recorded as either a reduction of or an increase to the earned premiums for the period. Insurance receivables include balances due currently or in the future, including amounts due from insureds related to paid losses under high deductible policies, and are presented at unpaid balances, net of an allowance for uncollectible receivables. A loss rate methodology is used to determine expected credit losses for premium receivables. This methodology uses the Company’s historical annual credit losses relative to gross premium written to develop a range of credit loss rates for each dollar of gross written premium underwritten. Additionally, an expected credit loss for amounts due from insureds under high deductible and retrospectively rated policies is calculated on a pool basis, informed by historical default rate data obtained from major rating agencies. Changes in the allowance are presented as a component of Other operating expenses on the Consolidated Statements of Operations. Amounts are considered past due based on policy payment terms. Insurance receivables and any related allowance are written off after collection efforts are exhausted or a negotiated settlement is reached. See the Credit Losses section of this note for additional information on the Company’s allowances for expected credit losses. Claim and claim adjustment expense reserves: Claim and claim adjustment expense reserves, except reserves for structured settlements not associated with asbestos and environmental pollution (A&EP), workers' compensation lifetime claims and long term care claims, are not discounted and are based on i) case basis estimates for losses reported on direct business, adjusted in the aggregate for ultimate loss expectations; ii) estimates of incurred but not reported (IBNR) losses; iii) estimates of losses on assumed reinsurance; iv) estimates of future expenses to be incurred in the settlement of claims; v) estimates of salvage and subrogation recoveries and vi) estimates of amounts due from insureds related to losses under high deductible policies. Management considers current conditions and trends as well as past Company and industry experience in establishing these estimates. The effects of inflation, which can be significant, are implicitly considered in the reserving process and are part of the recorded reserve balance. Ceded claim and claim adjustment expense reserves are reported as a component of Reinsurance receivables on the Consolidated Balance Sheets. Claim and claim adjustment expense reserves are presented net of anticipated amounts due from insureds related to losses under deductible policies of $1.1 billion and $1.2 billion as of December 31, 2021 and 2020. A significant portion of these amounts are supported by collateral. The Company has an allowance for uncollectible deductible amounts, which is presented as a component of the allowance for doubtful accounts included in Insurance receivables on the Consolidated Balance Sheets. Structured settlements have been negotiated for certain property and casualty insurance claims. Structured settlements are agreements to provide fixed periodic payments to claimants. The Company's obligations for structured settlements not funded by annuities are included in claim and claim adjustment expense reserves and are discounted at a weighted average interest rate of 6.4% and 6.5% as of December 31, 2021 and 2020. As of December 31, 2021 and 2020, the discounted reserves for unfunded structured settlements were $503 million and $520 million, net of discount of $621 million and $657 million. For the years ended December 31, 2021, 2020 and 2019, the amount of interest recognized on the discounted reserves of unfunded structured settlements was $36 million, $35 million and $36 million, respectively. This interest accretion is presented as a component of Insurance claims and policyholders’ benefits on the Consolidated Statements of Operations, but is excluded from the Company’s disclosure of prior year loss reserve development. Workers' compensation lifetime claim reserves are calculated using mortality assumptions determined through statutory regulation and economic factors. As of December 31, 2021 and 2020, workers' compensation lifetime claim reserves are discounted at a 3.5% interest rate. As of December 31, 2021 and 2020, the discounted reserves for workers’ compensation lifetime claim reserves were $228 million and $258 million, net of discount of $97 million and $113 million. For the years ended December 31, 2021, 2020 and 2019, the amount of interest accretion recognized on the discounted reserves of workers’ compensation lifetime claim reserves was $12 million, $15 million and $21 million, respectively. This interest accretion is presented as a component of Insurance claims and policyholders' benefits on the Consolidated Statements of Operations, but is excluded from the Company's disclosure of prior year loss reserve development. Long term care claim reserves for policyholders that are currently receiving benefits are calculated using mortality and morbidity assumptions based on Company and industry experience. These long term care claim reserves are discounted at a weighted average interest rate of 5.8% as of December 31, 2021 and 2020. As of December 31, 2021 and 2020, such discounted reserves totaled $2.7 billion, net of discount of $428 million and $439 million. Future policy benefit reserves: Future policy benefit reserves represent the active life reserves related to the Company's long term care policies for policyholders that are not currently receiving benefits and are computed using the net level premium method, which incorporates actuarial assumptions as to morbidity, persistency, inclusive of mortality, discount rate, future premium rate adjustments and expenses. Expense assumptions primarily relate to claim adjudication. These assumptions are locked in over the life of the policy; however if a premium deficiency emerges, the assumptions are unlocked and the future policy benefit reserves are increased. The September 30, 2021 gross premium valuation (GPV) indicated that recorded reserves included a margin of approximately $72 million. Long term care active life reserves for policy holders not currently receiving benefits are discounted at a weighted average interest rate of 5.3% and 5.4% as of December 31, 2021 and 2020. In circumstances where the cash flow projections supporting future policy benefit reserves are expected to result in profits being recognized in early future years followed by losses in later future years, the future policy benefit reserves are increased by an amount necessary to offset losses that are projected to be recognized in later future years. The Company has not recorded additional future policy benefit reserves for profits followed by losses. Insurance-related assessments: Liabilities for insurance-related assessments are accrued when an assessment is probable, when it can be reasonably estimated and when the event obligating the entity to pay an imposed or probable assessment has occurred. Liabilities for insurance-related assessments are not discounted and are included as part of Other liabilities on the Consolidated Balance Sheets. As of December 31, 2021 and 2020, the liability balances were $79 million and $82 million. Reinsurance: Reinsurance accounting allows for contractual cash flows to be reflected as premiums and losses. To qualify for reinsurance accounting, reinsurance agreements must include risk transfer. To meet risk transfer requirements, a reinsurance contract must include both insurance risk, consisting of underwriting and timing risk, and a reasonable possibility of a significant loss for the assuming entity. Reinsurance receivables related to paid losses are presented at unpaid balances. Reinsurance receivables related to unpaid losses are estimated in a manner consistent with claim and claim adjustment expense reserves or future policy benefit reserves. Reinsurance receivables are reported net of an allowance for uncollectible amounts on the Consolidated Balance Sheets. The cost of reinsurance is primarily accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies or over the reinsurance contract period. The ceding of insurance does not discharge the primary liability of the Company. The Company has established an allowance for uncollectible reinsurance receivables which relates to both amounts already billed on ceded paid losses as well as ceded reserves that will be billed when losses are paid in the future. For assessing expected credit losses, the Company separates reinsurance receivables into two pools: voluntary reinsurance receivables and involuntary receivables related to mandatory pools. The Company has not recorded an allowance for involuntary pools as there is no perceived credit risk. The principal credit quality indicator used in the valuation of the allowance on voluntary reinsurance receivables is the financial strength rating of the reinsurer sourced from major rating agencies. If the reinsurer is unrated, an internal financial strength rating is assigned based on the Company’s historical loss experience and the Company’s assessment of reinsurance counterparty risk profile, which generally corresponds with a B rating. Reinsurer financial strength ratings are updated and reviewed on an annual basis or sooner if the Company becomes aware of significant changes related to a reinsurer. The allowance for uncollectible reinsurance receivables is estimated on the basis of periodic evaluations of balances due from reinsurers, reinsurer financial strength rating and solvency, industry experience and current and forecast economic conditions. Because billed receivables generally approximate 5% or less of total reinsurance receivables, the age of the reinsurance receivables related to paid losses is not a significant input into the allowance analysis. Changes in the allowance for uncollectible reinsurance receivables are presented as a component of Insurance claims and policyholders' benefits on the Consolidated Statements of Operations. See the Credit Losses section of this note for additional information on the Company's allowances for expected credit losses. Amounts are considered past due based on the reinsurance contract terms. Reinsurance receivables related to paid losses and any related allowance are written off after collection efforts have been exhausted or a negotiated settlement is reached with the reinsurer. Reinsurance receivables from insolvent insurers related to paid losses are written off when the settlement due from the estate can be reasonably estimated. At the time reinsurance receivables related to paid losses are written off, any required adjustment to reinsurance receivables related to unpaid losses is recorded as a component of Insurance claims and policyholders' benefits on the Consolidated Statements of Operations. A loss portfolio transfer is a retroactive reinsurance contract. If the cumulative claim and allocated claim adjustment expenses ceded under a loss portfolio transfer exceed the consideration paid, the resulting gain from such excess is deferred and amortized into earnings in future periods in proportion to actual recoveries under the loss portfolio transfer. In any period in which there is a revised estimate of claim and allocated claim adjustment expenses and the loss portfolio transfer is in a gain position, the deferred gain is recalculated as if the revised estimate was available at the inception date of the loss portfolio transfer and the change in the deferred gain is recognized in earnings. Deferred acquisition costs: Deferrable acquisition costs include commissions, premium taxes and certain underwriting and policy issuance costs which are incremental direct costs of successful contract acquisitions. Acquisition costs related to property and casualty business are deferred and amortized ratably over the period the related premiums are earned. Deferred acquisition costs are presented net of ceding commissions and other ceded acquisition costs. The Company evaluates deferred acquisition costs for recoverability. Anticipated investment income is considered in the determination of the recoverability of deferred acquisition costs. Adjustments, if necessary, are recorded in current period results of operations. Policyholder dividends: Policyholder dividends are paid to participating policyholders within the workers' compensation and surety lines of business. Net written premiums for participating dividend policies were approximately 1% of total net written premiums for each of the years ended December 31, 2021, 2020 and 2019. Dividends to policyholders are accrued according to the Company's best estimate of the amount to be paid in accordance with contractual provisions and applicable state laws. Dividends to policyholders are presented as a component of Insurance claims & policyholders' benefits on the Consolidated Statements of Operations and Other liabilities on the Consolidated Balance Sheets. Investments The Company classifies its fixed maturity securities as either available-for-sale or trading, and as such, they are carried at fair value. Changes in fair value of trading securities are reported within Net investment income on the Consolidated Statements of Operations. Changes in fair value related to available-for-sale securities are reported as a component of Other comprehensive income. The cost of fixed maturity securities classified as available-for-sale is adjusted for amortization of premiums and accretion of discounts, which are included in Net investment income on the Consolidated Statements of Operations. The amortization of premium and accretion of discount for fixed maturity securities takes into consideration call and maturity dates that produce the lowest yield. For asset-backed securities included in fixed maturity securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments predominantly using the retrospective method. To the extent that unrealized gains on fixed maturity securities supporting structured settlements not funded by annuities were realized, or that unrealized gains on fixed maturity securities supporting long term care products would result in a premium deficiency if realized, a related increase in Insurance reserves is recorded, net of tax, as a reduction of net unrealized gains through Other comprehensive income (Shadow Adjustments). Shadow Adjustments, net of tax, decreased $296 million and increased $575 million for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, net unrealized gains on investments included in Accumulated other comprehensive income (AOCI) were correspondingly reduced by Shadow Adjustments of $2,477 million and $2,773 million, respectively. Equity securities are carried at fair value. The Company's non-redeemable preferred stock contain characteristics of debt securities, are priced similarly to bonds and are held primarily for income generation through periodic dividends. While recognition of gains and losses on these securities is not discretionary, management does not consider the changes in fair value of non-redeemable preferred stock to be reflective of our primary operations. As such, the changes in the fair value of these securities are recorded through Net investment gains (losses) on the Consolidated Statements of Operations. The Company owns certain common stock with the intention of holding the securities primarily for market appreciation and as such, the changes in the fair value of these securities are recorded through Net investment income. The Company's carrying value of investments in limited partnerships is its share of the net asset value of each partnership, as determined by the general partner. Certain partnerships for which results are not available on a timely basis are reported on a lag, primarily three months or less. Changes in net asset values are accounted for under the equity method and recorded within Net investment income on the Consolidated Statements of Operations. Mortgage loans are commercial in nature, are carried at unpaid principal balance, net of unamortized fees and an allowance for expected credit losses, and are recorded once funded. The allowance for expected credit losses is developed by assessing the credit quality of pools of mortgage loans in good standing using debt service coverage ratios (DSCR) and loan-to-value ratios (LTV). The DSCR compares a property’s net operating income to its debt service payments, including principal and interest. The LTV ratio compares the current unpaid principal balance of the loan to the estimated fair value of the underlying property collateralizing the loan. The pools developed to measure the credit loss allowance use increments of DSCR and LTV to draw distinctions between risk levels. The Company applies expected credit loss rates by pool to the outstanding receivable balances. Changes in the allowance for mortgage loans are presented as a component of Net investment gains (losses) on the Consolidated Statements of Operations. Prior to 2020, mortgage loans were evaluated on an individual loan basis considering the collection experience of each loan and other credit quality indicators such as DSCR and the credit-worthiness of the borrower or tenants of credit tenant loan properties. Mortgage loans were considered to be impaired loans and a loss incurred when it was probable that contractual principal and interest payments would not be collected and any impairment losses were recognized as a direct write-down of amortized cost. See the Credit Losses section of this note for additional information on the Company’s allowances for expected credit losses. Interest income from mortgage loans is recognized on an accrual basis using the effective yield method. Other invested assets include overseas deposits. Overseas deposits are valued using the net asset value per share (or equivalent) practical expedient. They are primarily short-term government securities, agency securities and corporate bonds held in trusts that are managed by Lloyd's of London. These funds are required of Lloyd's syndicates to protect policyholders in overseas markets and may be denominated in local currency. Short term investments are carried at fair value, with the exception of cash accounts earning interest, which are carried at cost and approximate fair value. Changes in fair value are reported as a component of Other comprehensive income. Purchases and sales of all securities are recorded on the trade date, except for private placement securities, including bank loan participations, which are recorded once funded. Net investment gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold. In the normal course of investing activities, the Company enters into relationships with variable interest entities (VIEs), as both an investor in limited partnerships and asset-backed securities issued by third-party VIEs. The Company is not the primary beneficiary of these VIEs, and therefore does not consolidate them. The Company determines whether it is the primary beneficiary of a VIE based on a qualitative assessment of the relative power and benefits of the Company and the other participants in the VIE. The Company’s maximum exposure to loss with respect to these investments is limited to the investment carrying values included in the Company’s Consolidated Balance Sheets and any unfunded commitments. An available-for-sale security is impaired if the fair value of the security is less than its cost adjusted for accretion, amortization and allowance for credit losses. When a security is impaired, it is evaluated to determine whether the Company intends to sell the security before recovery of amortized cost or whether a credit loss exists. Losses on securities that the Company intends to sell are recognized as impairment losses within Net investment gains (losses) on the Consolidated Statements of Operations. If a credit loss exists, an allowance is established and the corresponding amount is recognized as an impairment loss within Net investment gains (losses) on the Consolidated Statements of Operations. The allowance for credit losses related to available-for-sale fixed maturity securities is the difference between the present value of cash flows expected to be collected and the amortized cost basis, limited by the amount that the fair value is less than the amortized cost basis. In subsequent periods, the allowance is reviewed, with any changes in the allowance presented as a component of Net investment gains (losses) on the Consolidated Statements of Operations. Changes in the difference between the amortized cost basis, net of the allowance, and the fair value, are recognized in Other comprehensive income. Significant judgment is required in the determination of whether an impairment loss has occurred for a security. The Company follows a consistent and systematic process for determining and recording an impairment loss, including the evaluation of securities in an unrealized loss position and securities with an allowance for credit losses on at least a quarterly basis. The Company’s assessment of whether an impairment loss has occurred incorporates both quantitative and qualitative information. A credit loss exists if the present value of cash flows expected to be collected is less than the amortized cost basis. Significant assumptions enter into these cash flow projections including delinquency rates, probable risk of default, loss severity upon a default, over collateralization and interest coverage triggers and credit support from lower level tranches. The Company considers all available evidence when determining whether an investment requires a credit loss write-down or allowance to be recorded. Examples of such evidence may include the financial condition and near-term and long-term prospects of the issuer, whether the issuer is current with interest and principal payments, credit ratings on the security or changes in ratings over time, general market conditions and industry, sector or other specific factors and whether it is likely that the Company will recover its amortized cost through the collection of cash flows. See the Credit Losses section of this note for additional information on the Company’s allowances for expected credit losses. Prior to 2020, the Company’s assessment of whether an impairment loss occurred also incorporated both quantitative and qualitative information. Fixed maturity securities in an unrealized loss position that the Company intended to sell, or it more likely than not would be required to sell before recovery of amortized cost, were considered to be impaired and the entire difference between the amortized cost basis and fair value of the security was recognized as an impairment loss in earnings as a direct write-down of amortized cost. The remaining fixed maturity securities in an unrealized loss position were evaluated to determine if a credit loss existed. If a credit loss was determined to exist, the credit loss was recognized in earnings as a direct write-down of amortized cost. Credit Losses The allowances for credit losses on fixed maturity securities, mortgage loans, reinsurance receivables and insurance receivables are valuation accounts that are reported as a reduction of a financial asset’s cost basis and are measured on a pool basis when similar risk characteristics exist. Management estimates the allowance using relevant available information from both internal and external sources. Historical credit loss experience provides the basis for the estimation of expected credit losses and adjustments may be made to reflect current conditions and reasonable and supportable forecasts. Adjustments to historical loss information are made for any additional factors that come to the Company’s attention. This could include significant shifts in counterparty financial strength ratings, aging of past due receivables, amounts sent to collection agencies, or other underlying portfolio changes. Amounts are considered past due when payments have not been received according to contractual terms. The Company also considers current and forecast economic conditions, using a variety of economic metrics and forecast indices. The sensitivity of expected credit losses relative to changes to these forecast economic conditions can vary by financial asset class. The Company considers a reasonable and supportable forecast period to be up to 24 months from the balance sheet date. After the forecast per |
Investments
Investments | 12 Months Ended |
Dec. 31, 2021 | |
Investments [Abstract] | |
Investments | Investments The significant components of Net investment income are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Fixed maturity securities $ 1,707 $ 1,728 $ 1,817 Equity securities 83 65 85 Limited partnership investments 362 121 180 Mortgage loans 61 57 51 Short term investments 1 9 34 Trading portfolio 9 18 9 Other — 1 5 Gross investment income 2,223 1,999 2,181 Investment expense (64) (64) (63) Net investment income $ 2,159 $ 1,935 $ 2,118 For the years ended December 31, 2021 and 2020 , $28 million and $34 million of Net i nvestment income was recognized due to the change in fair value of common stock still held as of December 31, 2021 and 2020 . As of December 31, 2021 and 2020 , the Company held less than $1 million of non-income producing fixed maturity securities. As of December 31, 2021 and 2020, the Company held $7 million and $0 of non-income producing mortgage loans. As of December 31, 2021 and 2020, no investments in a single issuer exceeded 10% of stockholders' equity, other than investments in securities issued by the U.S. Treasury and obligations of government-sponsored enterprises. Net investment gains (losses) are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Net investment gains (losses): Fixed maturity securities: Gross gains $ 186 $ 220 $ 125 Gross losses (90) (220) (131) Net investment gains (losses) on fixed maturity securities 96 — (6) Equity securities 4 (3) 66 Derivatives 6 (10) (11) Mortgage loans 10 (21) — Short term investments and other 4 (20) (20) Net investment gains (losses) $ 120 $ (54) $ 29 For the ye ars ended December 31, 2021 and 2020 , $2 million of gains and $3 million of losses were recognized in Net investment gains (losses) due to the change in fair value of non-redeemable preferred stock stil l held as of December 31, 2021 and 2020, respectively. Short term investments and other included a $20 million loss for the year ended December 31, 2020 related to the redemption of the Company's $400 million senior notes due August 2021 and a $21 million loss for the year ended December 31, 2019 related to the redemption of the Company's $500 million senior notes due August 2020. The following tables present the activity related to the allowance on available-for-sale securities with credit impairments and purchased credit-deteriorated (PCD) assets. Accrued interest receivable on available-for-sale fixed maturity securities totaled $369 million and $371 million as of December 31, 2021 and 2020 and is excluded from the estimate of expected credit losses and the amortized cost basis in the table included within this Note. (In millions) Corporate and other bonds Asset-backed Total Allowance for credit losses: Balance as of January 1, 2021 $ 23 $ 17 $ 40 Additions to the allowance for credit losses: Securities for which credit losses were not previously recorded 14 — 14 Available-for-sale securities accounted for as PCD assets 5 6 11 Reductions to the allowance for credit losses: Securities sold during the period (realized) 7 17 24 Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis — — — Write-offs charged against the allowance 16 — 16 Recoveries of amounts previously written off — — — Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period (8) 1 (7) Balance as of December 31, 2021 $ 11 $ 7 $ 18 (In millions) Corporate and other bonds Asset-backed Total Allowance for credit losses: Balance as of January 1, 2020 $ — $ — $ — Additions to the allowance for credit losses: Impact of adopting ASC 326 6 — 6 Securities for which credit losses were not previously recorded 67 12 79 Available-for-sale securities accounted for as PCD assets 5 — 5 Reductions to the allowance for credit losses: Securities sold during the period (realized) 22 — 22 Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis 1 — 1 Write-offs charged against the allowance — — — Recoveries of amounts previously written off — — — Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period (32) 5 (27) Balance as of December 31, 2020 $ 23 $ 17 $ 40 The components of available-for-sale impairment losses recognized in earnings by asset type are presented in the following table. The table includes losses on securities with an intention to sell and changes in the allowance for credit losses on securities since acquisition date. Years ended December 31 (In millions) 2021 2020 2019 Fixed maturity securities available-for-sale: Corporate and other bonds $ 11 $ 87 $ 33 Asset-backed 20 24 11 Impairment (gains) losses recognized in earnings $ 31 $ 111 $ 44 For the ye ars ended December 31, 2021 and 2020, the Company also recognized $10 million of gains and $21 million of losses related to mortgage loans primarily due to changes in expected credit losses. The net change in unrealized gains on investments, which consists solely of the change in unrealized gains on fixed maturity securities, was $(1,272) million, $1,637 million and $2,620 million for the years ended December 31, 2021, 2020 and 2019. The following tables present a summary of fixed maturity securities. December 31, 2021 Cost or Gross Gross Allowance for Credit Losses Estimated (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 21,444 $ 2,755 $ 56 $ 11 $ 24,132 States, municipalities and political subdivisions 10,358 1,599 14 — 11,943 Asset-backed: Residential mortgage-backed 2,893 71 8 — 2,956 Commercial mortgage-backed 1,987 63 19 — 2,031 Other asset-backed 2,561 54 10 7 2,598 Total asset-backed 7,441 188 37 7 7,585 U.S. Treasury and obligations of government-sponsored enterprises 132 1 3 — 130 Foreign government 570 15 2 — 583 Total fixed maturity securities available-for-sale 39,945 4,558 112 18 44,373 Total fixed maturity securities trading 7 — — — 7 Total fixed maturity securities $ 39,952 $ 4,558 $ 112 $ 18 $ 44,380 December 31, 2020 Cost or Gross Gross Allowance for Credit Losses Estimated (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 20,792 $ 3,578 $ 22 $ 23 $ 24,325 States, municipalities and political subdivisions 9,729 1,863 — — 11,592 Asset-backed: Residential mortgage-backed 3,442 146 1 — 3,587 Commercial mortgage-backed 1,933 93 42 17 1,967 Other asset-backed 2,179 81 9 — 2,251 Total asset-backed 7,554 320 52 17 7,805 U.S. Treasury and obligations of government-sponsored enterprises 339 2 3 — 338 Foreign government 512 32 — — 544 Total fixed maturity securities available-for-sale 38,926 5,795 77 40 44,604 Total fixed maturity securities trading 27 — — — 27 Total fixed maturity securities $ 38,953 $ 5,795 $ 77 $ 40 $ 44,631 The following tables present the estimated fair value and gross unrealized losses of fixed maturity securities in a gross unrealized loss position for which an allowance for credit loss has not been recorded, by the length of time in which the securities have continuously been in that position. Less than 12 Months 12 Months or Longer Total December 31, 2021 Estimated Gross Estimated Gross Estimated Gross (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 2,389 $ 48 $ 136 $ 8 $ 2,525 $ 56 States, municipalities and political subdivisions 730 14 — — 730 14 Asset-backed: Residential mortgage-backed 1,043 8 — — 1,043 8 Commercial mortgage-backed 527 7 167 12 694 19 Other asset-backed 840 10 62 — 902 10 Total asset-backed 2,410 25 229 12 2,639 37 U.S. Treasury and obligations of government-sponsored enterprises 69 3 5 — 74 3 Foreign government 97 2 — — 97 2 Total $ 5,695 $ 92 $ 370 $ 20 $ 6,065 $ 112 Less than 12 Months 12 Months or Longer Total December 31, 2020 Estimated Gross Estimated Gross Estimated Gross (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 609 $ 21 $ 12 $ 1 $ 621 $ 22 States, municipalities and political subdivisions 33 — — — 33 — Asset-backed: Residential mortgage-backed 71 1 11 — 82 1 Commercial mortgage-backed 533 40 28 2 561 42 Other asset-backed 344 9 13 — 357 9 Total asset-backed 948 50 52 2 1,000 52 U.S. Treasury and obligations of government-sponsored enterprises 63 3 — — 63 3 Foreign government 13 — — — 13 — Total $ 1,666 $ 74 $ 64 $ 3 $ 1,730 $ 77 Based on current facts and circumstances, the Company believes the unrealized losses presented in the December 31, 2021 securities in a gross unrealized loss position table above are not indicative of the ultimate collectibility of the current amortized cost of the securities, but rather are attributable to changes in interest rates, credit spreads and other factors. The Company has no current intent to sell securities with unrealized losses, nor is it more likely than not that it will be required to sell prior to recovery of amortized cost; accordingly, the Company has determined that there are no additional impairment losses to be recorded as of December 31, 2021. Contractual Maturity The following table presents available-for-sale fixed maturity securities by contractual maturity. December 31 2021 2020 (In millions) Cost or Estimated Cost or Estimated Due in one year or less $ 1,603 $ 1,624 $ 1,456 $ 1,458 Due after one year through five years 10,637 11,229 12,304 13,098 Due after five years through ten years 13,294 14,338 12,319 13,878 Due after ten years 14,411 17,182 12,847 16,170 Total $ 39,945 $ 44,373 $ 38,926 $ 44,604 Actual maturities may differ from contractual maturities because certain securities may be called or prepaid. Securities not due at a single date are allocated based on weighted average life. Limited Partnerships The carrying value of limited partnerships as of December 31, 2021 and 2020 was $1,859 million and $1,619 million, which includes net undistributed earnings of $266 million and $235 million. Limited partnerships comprising 32% of the total carrying value are reported on a current basis through December 31, 2021 with no reporting lag, 6% are reported on a one month lag and the remainder are reported on more than a one month lag. The number of limited partnerships held and the strategies employed provide diversification to the limited partnership portfolio and the overall invested asset portfolio. Limited partnerships comprising 68% and 49% of the carrying value as of December 31, 2021 and 2020 were invested in private debt and equity. Limited partnerships comprising 32% and 51% of the carrying value as of December 31, 2021 and 2020 employ hedge fund strategies. Private debt and equity funds cover a broad range of investment strategies including buyout, co-investment, private credit, growth capital, distressed investing and real estate. Hedge fund strategies include both long and short positions in fixed income, equity and derivative instruments. The ten largest limited partnership positions held totaled $665 million and $775 million as of December 31, 2021 and 2020. Based on the most recent information available regarding the Company’s percentage ownership of the individual limited partnerships, the carrying value reflected on the Consolidated Balance Sheets represents approximately 1% and 2% of the aggregate partnership equity as of December 31, 2021 and 2020, and the related income reflected on the Consolidated Statements of Operations represents approximately 2%, 2% and 2% of the changes in aggregate partnership equity for the years ended December 31, 2021, 2020 and 2019. There are risks inherent in limited partnership investments which may result in losses due to short-selling, derivatives or other speculative investment practices. The use of leverage increases volatility generated by the underlying investment strategies. The Company’s private debt, private equity and other non-hedge fund limited partnership investments generally do not permit voluntary withdrawals. The Company’s hedge fund limited partnership investments contain withdrawal provisions that generally limit liquidity for a period of thirty days up to one year or longer. Typically, hedge fund withdrawals require advance written notice of up to 90 days. Derivative Financial Instruments The Company may use derivatives in the normal course of business, primarily in an attempt to reduce its exposure to market risk (principally interest rate risk and foreign currency risk) stemming from various assets and liabilities. The Company's principal objective under such strategies is to achieve the desired reduction in economic risk, even if the position does not receive hedge accounting treatment. The Company may enter into interest rate swaps, futures and forward commitments to purchase securities to manage interest rate risk. The Company may use foreign currency forward contracts to manage foreign currency risk. Credit exposure associated with non-performance by the counterparties to derivative instruments is generally limited to the uncollateralized fair value of the asset related to the instruments recognized on the Consolidated Balance Sheets. The Company generally requires that all over-the-counter derivative contracts be governed by an International Swaps and Derivatives Association Master Agreement, and exchanges collateral under the terms of these agreements with its derivative investment counterparties depending on the amount of the exposure and the credit rating of the counterparty. Gross estimated fair values of derivative positions are presented in Other invested assets and Other liabilities on the Consolidated Balance Sheets. The Company does not offset derivative positions against the fair value of collateral provided or positions subject to netting arrangements. There would be no significant difference in the balance included in such accounts if the estimated fair values were presented net as of December 31, 2021 and 2020. There was no cash collateral provided by the Company or cash collateral received from counterparties as of December 31, 2021 or 2020. The Company holds an embedded derivative on a funds withheld liability with a notional value of $270 million and $190 million and a fair value of $(12) million and $(19) million as of December 31, 2021 and 2020. The embedded derivative on the funds withheld liability is accounted for separately and reported with the funds withheld liability in Other liabilities on the Consolidated Balance Sheets. Investment Commitments As part of its overall investment strategy, the Company invests in various assets which require future purchase, sale or funding commitments. These investments are recorded once funded, and the related commitments may include future capital calls from various third-party limited partnerships, signed and accepted mortgage loan applications, and obligations related to private placement securities. As of December 31, 2021, the Company had commitments to purchase or fund approximately $1,230 million and sell approximately $90 million under the terms of these investments. Investments on Deposit Securities with carrying values of approximately $3.0 billion were deposited by the Company’s insurance subsidiaries under requirements of regulatory authorities and others as of December 31, 2021 and 2020. Cash and securities with carrying values of approximately $1.2 billion and $1.1 billion were deposited with financial institutions in trust accounts or as collateral for letters of credit to secure obligations with various third parties as of December 31, 2021 and 2020. Mortgage Loans The following table presents the amortized cost basis of mortgage loans for each credit quality indicator by year of origination. December 31, 2021 Mortgage Loans Amortized Cost Basis by Origination Year (1) (In millions) 2021 2020 2019 2018 2017 Prior Total DSCR ≥1.6x LTV less than 55% $ 2 $ 75 $ 6 $ 38 $ 99 $ 181 $ 401 LTV 55% to 65% 5 38 15 17 — 24 99 LTV greater than 65% 17 — 8 — — — 25 DSCR 1.2x - 1.6x LTV less than 55% 14 14 95 — 5 42 170 LTV 55% to 65% 36 — — 24 10 — 70 LTV greater than 65% — 24 — — 8 — 32 DSCR ≤1.2 LTV less than 55% — — 35 — 30 — 65 LTV 55% to 65% — — 28 — — — 28 LTV greater than 65% 21 9 62 — — 7 99 Total $ 95 $ 160 $ 249 $ 79 $ 152 $ 254 $ 989 (1) The values in the table above reflect DSCR on a standardized amortization period and LTV based on the most recent appraised values trended forward using changes in a commercial real estate price index. As of December 31, 2021, accrued interest receivable on mortgage loans totaled $3 million and is excluded from the amortized cost basis disclosed in the table above and the estimate of expected credit losses. |
Fair Value
Fair Value | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Fair Value Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable. Level 1 - Quoted prices for identical instruments in active markets. Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level 3 - Valuations derived from valuation techniques in which one or more significant inputs are not observable. Prices may fall within Level 1, 2 or 3 depending upon the methodology and inputs used to estimate fair value for each specific security. In general, the Company seeks to price securities using third-party pricing services. Securities not priced by pricing services are submitted to independent brokers for valuation and, if those are not available, internally developed pricing models are used to value assets using a methodology and inputs the Company believes market participants would use to value the assets. Prices obtained from third-party pricing services or brokers are not adjusted by the Company. The Company performs control procedures over information obtained from pricing services and brokers to ensure prices received represent a reasonable estimate of fair value and to confirm representations regarding whether inputs are observable or unobservable. Procedures may include i) the review of pricing service methodologies or broker pricing qualifications, ii) back-testing, where past fair value estimates are compared to actual transactions executed in the market on similar dates, iii) exception reporting, where period-over-period changes in price are reviewed and challenged with the pricing service or broker based on exception criteria, and iv) deep dives, where the Company performs an independent analysis of the inputs and assumptions used to price individual securities. Assets and Liabilities Measured at Fair Value Assets and liabilities measured at fair value on a recurring basis are presented in the following tables. Corporate bonds and other includes obligations of the U.S. Treasury, government-sponsored enterprises, foreign governments and redeemable preferred stock. December 31, 2021 Total (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate bonds and other $ 140 $ 23,775 $ 937 $ 24,852 States, municipalities and political subdivisions — 11,887 56 11,943 Asset-backed — 7,029 556 7,585 Total fixed maturity securities 140 42,691 1,549 44,380 Equity securities: Common stock 220 — 13 233 Non-redeemable preferred stock 65 721 16 802 Total equity securities 285 721 29 1,035 Short term and other 1,798 74 — 1,872 Total assets $ 2,223 $ 43,486 $ 1,578 $ 47,287 Liabilities Other liabilities $ — $ 12 $ — $ 12 Total liabilities $ — $ 12 $ — $ 12 December 31, 2020 Total (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate bonds and other $ 355 $ 24,109 $ 770 $ 25,234 States, municipalities and political subdivisions — 11,546 46 11,592 Asset-backed — 7,497 308 7,805 Total fixed maturity securities 355 43,152 1,124 44,631 Equity securities: Common stock 175 — 20 195 Non-redeemable preferred stock 68 722 7 797 Total equity securities 243 722 27 992 Short term and other 1,761 28 — 1,789 Total assets $ 2,359 $ 43,902 $ 1,151 $ 47,412 Liabilities Other liabilities $ — $ 19 $ — $ 19 Total liabilities $ — $ 19 $ — $ 19 The tables below present a reconciliation for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3). Level 3 (In millions) Corporate bonds and other States, municipalities and political subdivisions Asset-backed Equity securities Total Balance as of January 1, 2021 $ 770 $ 46 $ 308 $ 27 $ 1,151 Total realized and unrealized investment gains (losses): Reported in Net investment gains (losses) (10) — — (2) (12) Reported in Net investment income — — 7 2 9 Reported in Other comprehensive income (loss) (32) (1) (10) — (43) Total realized and unrealized investment gains (losses) (42) (1) (3) — (46) Purchases 312 12 287 1 612 Sales (3) — (9) (20) (32) Settlements (68) (1) (61) — (130) Transfers into Level 3 20 — 109 21 150 Transfers out of Level 3 (52) — (75) — (127) Balance as of December 31, 2021 $ 937 $ 56 $ 556 $ 29 $ 1,578 Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2021 recognized in Net income (loss) in the period $ — $ — $ — $ (2) $ (2) Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2021 recognized in Other comprehensive income (loss) in the period (32) (1) (11) — (44) Level 3 (In millions) Corporate bonds and other States, municipalities and political subdivisions Asset-backed Equity securities Total Balance as of January 1, 2020 $ 468 $ — $ 165 $ 18 $ 651 Total realized and unrealized investment gains (losses): Reported in Net investment gains (losses) 1 — (1) (4) (4) Reported in Net investment income — — 2 (2) — Reported in Other comprehensive income (loss) 43 1 16 — 60 Total realized and unrealized investment gains (losses) 44 1 17 (6) 56 Purchases 264 45 154 15 478 Sales (3) — (9) — (12) Settlements (13) — (32) — (45) Transfers into Level 3 10 — 30 — 40 Transfers out of Level 3 — — (17) — (17) Balance as of December 31, 2020 $ 770 $ 46 $ 308 $ 27 $ 1,151 Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2020 recognized in Net income (loss) in the period $ — $ — $ — $ (6) $ (6) Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2020 recognized in Other comprehensive income (loss) in the period 43 1 18 — 62 Valuation Methodologies and Inputs The following section describes the valuation methodologies and relevant inputs used to measure different financial instruments at fair value, including an indication of the level in the fair value hierarchy in which the instruments are generally classified. Fixed Maturity Securities Level 1 securities include highly liquid government securities and exchange traded bonds, valued using quoted market prices. Level 2 securities include most other fixed maturity securities as the significant inputs are observable in the marketplace. All classes of Level 2 fixed maturity securities are valued using a methodology based on information generated by market transactions involving identical or comparable assets, a discounted cash flow methodology, or a combination of both when necessary. Common inputs for all classes of fixed maturity securities include prices from recently executed transactions of similar securities, marketplace quotes, benchmark yields, spreads off benchmark yields, interest rates and U.S. Treasury or swap curves. Specifically for asset-backed securities, key inputs include prepayment and default projections based on past performance of the underlying collateral and current market data. Fixed maturity securities are primarily assigned to Level 3 in cases where broker/dealer quotes are significant inputs to the valuation and there is a lack of transparency as to whether these quotes are based on information that is observable in the marketplace. Level 3 securities also include private placement debt securities whose fair value is determined using internal models with some inputs that are not market observable. Equity Securities Level 1 equity securities include publicly traded securities valued using quoted market prices. Level 2 securities are primarily valued using pricing for similar securities, recently executed transactions and other pricing models utilizing market observable inputs. Level 3 securities are primarily priced using broker/dealer quotes and internal models with some inputs that are not market observable. Short Term and Other Invested Assets Securities that are actively traded or have quoted prices are classified as Level 1. These securities include money market funds and treasury bills. Level 2 primarily includes non-U.S. government securities and commercial paper, for which all inputs are market observable. Fixed maturity securities purchased within one year of maturity are classified consistent with fixed maturity securities discussed above. Short term investments as presented in the tables above differ from the amounts presented on the Consolidated Balance Sheets because certain short term investments, such as time deposits, are not measured at fair value. As of December 31, 2021 and December 31, 2020, there were $74 million and $71 million of overseas deposits within Other invested assets, which can be redeemed at net asset value in 90 days or less. Overseas deposits are excluded from the fair value hierarchy because their fair value is recorded using the net asset value per share (or equivalent) practical expedient. Derivative Financial Investments The embedded derivative on funds withheld liability is valued using the change in fair value of the assets supporting the funds withheld liability, which are fixed maturity securities primarily valued with observable inputs. Significant Unobservable Inputs The following tables present quantitative information about the significant unobservable inputs utilized by the Company in the fair value measurements of Level 3 assets. Valuations for assets and liabilities not presented in the tables below are primarily based on broker/dealer quotes for which there is a lack of transparency as to inputs used to develop the valuations. The quantitative detail of these unobservable inputs is neither provided nor reasonably available to the Company. The weighted average rate is calculated based on fair value. December 31, 2021 Estimated Fair Value Valuation Technique(s) Unobservable Input(s) Range Fixed maturity securities $ 1,225 Discounted cash flow Credit spread 1% - 7% (2%) December 31, 2020 Estimated Fair Value Valuation Technique(s) Unobservable Input(s) Range Fixed maturity securities $ 966 Discounted cash flow Credit spread 1% - 8% (3%) For fixed maturity securities, an increase to the credit spread assumptions would result in a lower fair value measurement. Financial Assets and Liabilities Not Measured at Fair Value The carrying amount and estimated fair value of the Company's financial assets and liabilities which are not measured at fair value on the Consolidated Balance Sheets are presented in the following tables. December 31, 2021 Carrying Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 973 $ — $ — $ 1,018 $ 1,018 Liabilities Long term debt $ 2,779 $ — $ 2,978 $ — $ 2,978 December 31, 2020 Carrying Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 1,068 $ — $ — $ 1,151 $ 1,151 Liabilities Long term debt $ 2,776 $ — $ 3,148 $ — $ 3,148 The carrying amounts reported on the Consolidated Balance Sheets for Cash, Short term investments not carried at fair value, Accrued investment income and certain Other assets and Other liabilities approximate fair value due to the short term nature of these items. These assets and liabilities are not listed in the tables above. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The CNA Tax Group is included in the consolidated federal income tax return of Loews and its eligible subsidiaries. Loews and the Company have agreed that for each taxable year, the Company will 1) be paid by Loews the amount, if any, by which the Loews consolidated federal income tax liability is reduced by virtue of the inclusion of the CNA Tax Group in the Loews consolidated federal income tax return, or 2) pay to Loews an amount, if any, equal to the federal income tax that would have been payable by the CNA Tax Group filing a separate consolidated tax return. In the event that Loews should have a net operating loss in the future computed on the basis of filing a separate consolidated tax return without the CNA Tax Group, the Company may be required to repay tax recoveries previously received from Loews. This agreement may be canceled by either party upon 30 days written notice. For the years ended December 31, 2021, 2020 and 2019, the Company paid $238 million, $65 million and $239 million to Loews related to federal income taxes. For 2019 through 2021, Loews and the Company participated in the Internal Revenue Service (IRS) Compliance Assurance Process (CAP), which is a voluntary program for large corporations. Under CAP, the IRS conducted a real-time audit and worked contemporaneously with the Company to resolve any issues prior to the filing of the 2019 tax return. The 2019 examination has been completed. For 2020 and 2021, the Company was selected to participate in the phase of CAP reserved for taxpayers whose risk of noncompliance does not warrant use of IRS resources. The Company believes that participation in CAP should reduce tax-related uncertainties, if any. As of December 31, 2021 and 2020, there were no unrecognized tax benefits. The Company recognizes interest accrued related to unrecognized tax benefits and tax refund claims in Income tax (expense) benefit on the Consolidated Statements of Operations. The Company recognizes penalties (if any) in Income tax (expense) benefit on the Consolidated Statements of Operations. During 2021, 2020 and 2019 the Company recognized no interest and no penalties. There were no amounts accrued for interest or penalties as of December 31, 2021 or 2020. The following table presents a reconciliation between the Company's income tax expense at statutory rates and the recorded income tax expense. Years ended December 31 (In millions) 2021 2020 2019 Income tax expense at statutory rates $ (312) $ (172) $ (257) Tax benefit from tax exempt income 51 52 53 Foreign taxes and credits (3) 2 (1) State income tax expense (13) (6) (14) Other tax expense (5) (7) (4) Income tax expense $ (282) $ (131) $ (223) As of December 31, 2021, no deferred taxes are required on the undistributed earnings of subsidiaries subject to tax. The following table presents the current and deferred components of the Company's income tax expense. Years ended December 31 (In millions) 2021 2020 2019 Current tax expense $ (235) $ (180) $ (269) Deferred tax (expense) benefit (47) 49 46 Total income tax expense $ (282) $ (131) $ (223) Total income tax presented above includes foreign tax expense of approximately $18 million, $16 million and $19 million related to pretax income from foreign operations of approximately $124 million, $45 million and $43 million for the years ended December 31, 2021, 2020 and 2019. The deferred tax effects of the significant components of the Company's deferred tax assets and liabilities are presented in the following table. December 31 (In millions) 2021 2020 Deferred Tax Assets: Insurance reserves: Property and casualty claim and claim adjustment expense reserves $ 173 $ 157 Unearned premium reserves 193 174 Deferred Revenue 64 62 Employee benefits 46 122 Deferred retroactive reinsurance benefit 90 83 Other assets 88 92 Gross deferred tax assets 654 690 Deferred Tax Liabilities: Investment valuation differences 93 28 Deferred acquisition costs 99 93 Net unrealized gains 272 453 Software and hardware 27 31 Other liabilities 21 19 Gross deferred tax liabilities 512 624 Net deferred tax asset $ 142 $ 66 As of December 31, 2021, the CNA Tax Group had no loss carryforwards and no tax credit carryforward. The foreign operations had loss carryforwards of $138 million, of which $1 million expires in 2035 and $137 million has no expiration. The foreign operations had a tax credit carryforward of $4 million, which has no expiration. Although realization of deferred tax assets is not assured, management believes it is more likely than not that the recognized net deferred tax asset will be realized through recoupment of ordinary and capital taxes paid in prior carryback years and through future earnings, reversal of existing temporary differences and available tax planning strategies. As a result, no valuation allowance was recorded as of December 31, 2021 or 2020. |
Claim, Claim Adjustment Expense
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves | 12 Months Ended |
Dec. 31, 2021 | |
Liability for Claims and Claims Adjustment Expense [Abstract] | |
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves | Claim, Claim Adjustment Expense and Future Policy Benefit Reserves Property and casualty insurance claim and claim adjustment expense reserves represent the estimated amounts necessary to resolve all outstanding claims, including IBNR claims as of the reporting date. The Company's reserve projections are based primarily on detailed analysis of the facts in each case, the Company's experience with similar cases and various historical development patterns. Consideration is given to historical patterns such as claim reserving trends and settlement practices, loss payments, pending levels of unpaid claims and product mix, as well as court decisions and economic conditions, including inflation, and public attitudes. All of these factors can affect the estimation of claim and claim adjustment expense reserves. Establishing claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves for catastrophic events that have occurred, is an estimation process. Many factors can ultimately affect the final settlement of a claim and, therefore, the necessary reserve. Changes in the law, results of litigation, medical costs, the cost of repair materials and labor rates can affect ultimate claim costs. In addition, time can be a critical part of reserving determinations since the longer the span between the incidence of a loss and the payment or settlement of the claim, the more variable the ultimate settlement amount can be. Accordingly, short-tail claims, such as property damage claims, tend to be more reasonably estimable than long-tail claims, such as workers' compensation, general liability and professional liability claims. Adjustments to prior year reserve estimates, if necessary, are reflected in the results of operations in the period that the need for such adjustments is determined. There can be no assurance that the Company's ultimate cost for insurance losses will not exceed current estimates. Liability for Unpaid Claim and Claim Adjustment Expenses The table below reconciles the net liability for unpaid claim and claim adjustment expenses to the amount presented on the Consolidated Balance Sheets. As of December 31 (In millions) 2021 Net liability for unpaid claim and claim adjustment expenses: Specialty $ 5,265 Commercial 8,065 International 1,940 Life & Group (1) 3,641 Corporate & Other 294 Total net claim and claim adjustment expenses 19,205 Reinsurance receivables: (2) Specialty 1,168 Commercial 825 International 340 Life & Group 113 Corporate & Other (3) 2,523 Total reinsurance receivables 4,969 Total gross liability for unpaid claim and claim adjustment expenses $ 24,174 (1) The Life & Group segment amounts are primarily related to long term care claim reserves, but also include amounts related to unfunded structured settlements arising from short-duration contracts. Long term care policies are long-duration contracts. (2) Reinsurance receivables presented are gross of the allowance for uncollectible reinsurance and do not include reinsurance receivables related to paid losses. (3) The Corporate & Other Reinsurance receivables are primarily related to A&EP claims covered under the Loss Portfolio Transfer (LPT). The following table presents a reconciliation between beginning and ending claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves of the Life & Group segment. As of or for the years ended December 31 (In millions) 2021 2020 2019 Reserves, beginning of year: Gross $ 22,706 $ 21,720 $ 21,984 Ceded 4,005 3,835 4,019 Net reserves, beginning of year 18,701 17,885 17,965 Reduction of net reserves due to Excess Workers' Compensation Loss Portfolio Transfer (632) — — Net incurred claim and claim adjustment expenses: Provision for insured events of current year 5,970 5,793 5,356 Increase (decrease) in provision for insured events of prior years (104) (119) (127) Amortization of discount 174 183 184 Total net incurred (1) 6,040 5,857 5,413 Net payments attributable to: Current year events (1,014) (948) (992) Prior year events (3,830) (4,216) (4,584) Total net payments (4,844) (5,164) (5,576) Foreign currency translation adjustment and other (60) 123 83 Net reserves, end of year 19,205 18,701 17,885 Ceded reserves, end of year 4,969 4,005 3,835 Gross reserves, end of year $ 24,174 $ 22,706 $ 21,720 (1) Total net incurred above does not agree to Insurance claims and policyholders' benefits as reflected on the Consolidated Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting, the loss on the Excess Workers' Compensation LPT, uncollectible reinsurance and benefit expenses related to future policy benefits, which are not reflected in the table above. Reserving Methodology In developing claim and claim adjustment expense (loss or losses) reserve estimates, the Company's actuaries perform detailed reserve analyses that are staggered throughout the year. The data is organized at a reserve group level. Every reserve group is reviewed at least once during the year, but most are reviewed more frequently. The analyses generally review losses gross of ceded reinsurance and apply the ceded reinsurance terms to the gross estimates to establish estimates net of reinsurance. Factors considered include, but are not limited to, the historical pattern and volatility of the actuarial indications, the sensitivity of the actuarial indications to changes in paid and incurred loss patterns, the consistency of claims handling processes, the consistency of case reserving practices, changes in the Company's pricing and underwriting, pricing and underwriting trends in the insurance market and legal, judicial, social and economic trends. In addition to the detailed analyses, the Company reviews actual loss emergence for all products each quarter. In developing the loss reserve estimates for property and casualty contracts, the Company generally projects ultimate losses using several common actuarial methods as listed below. The Company reviews the various indications from the various methods and applies judgment to select an actuarial point estimate. The carried reserve may differ from the actuarial point estimate as a result of the Company's consideration of the factors noted above as well as the potential volatility of the projections associated with the specific product being analyzed and other factors affecting claims costs that may not be quantifiable through traditional actuarial analysis. The indicated required reserve is the difference between the selected ultimate loss and the inception-to-date paid losses. The difference between the selected ultimate loss and the case incurred or reported loss is IBNR. IBNR includes a provision for development on known cases as well as a provision for late reported incurred claims. The most frequently utilized methods to project ultimate losses include the following: • Paid development: The paid development method estimates ultimate losses by reviewing paid loss patterns and applying them to accident years with further expected changes in paid loss. • Incurred development: The incurred development method is similar to the paid development method, but it uses case incurred losses instead of paid losses. • Loss ratio: The loss ratio method multiplies premiums by an expected loss ratio to produce ultimate loss estimates for each accident year. • Bornhuetter-Ferguson paid loss: The Bornhuetter-Ferguson paid loss method is a combination of the paid development approach and the loss ratio approach. This method normally determines expected loss ratios similar to the approach used to estimate the expected loss ratio for the loss ratio method. • Bornhuetter-Ferguson incurred loss: The Bornhuetter-Ferguson incurred loss method is similar to the Bornhuetter-Ferguson using premiums and paid loss method except that it uses case incurred losses. • Frequency times severity: The frequency times severity method multiplies a projected number of ultimate claims by an estimated ultimate average loss for each accident year to produce ultimate loss estimates. • Stochastic modeling: The stochastic modeling produces a range of possible outcomes based on varying assumptions related to the particular product being modeled. For many exposures, especially those that can be considered long-tail, a particular accident or policy year may not have a sufficient volume of paid losses to produce a statistically reliable estimate of ultimate losses. In such a case, the Company's actuaries typically assign more weight to the incurred development method than to the paid development method. As claims continue to settle and the volume of paid loss increases, the actuaries may assign additional weight to the paid development method. For most of the Company's products, even the incurred losses for accident or policy years that are early in the claim settlement process will not be of sufficient volume to produce a reliable estimate of ultimate losses. In these cases, the Company may not assign much, if any weight to the paid and incurred development methods. The Company may use the loss ratio, Bornhuetter-Ferguson and/or frequency times severity methods. For short-tail exposures, the paid and incurred development methods can often be relied on sooner, primarily because the Company's history includes a sufficient number of years to cover the entire period over which paid and incurred losses are expected to change. However, the Company may also use the loss ratio, Bornhuetter-Ferguson and/or frequency times severity methods for short-tail exposures. For other more complex reserve groups where the above methods may not produce reliable indications, the Company uses additional methods tailored to the characteristics of the specific situation. The Company's reserving methodologies for mass tort and A&EP are similar as both are based on detailed reviews of large accounts with estimates of ultimate payments based on the facts in each case and the Company's view of applicable law and coverage litigation. Gross and Net Carried Reserves The following tables present the gross and net carried reserves. December 31, 2021 Specialty Commercial International Life & Group Corporate & Other Total (In millions) Gross Case Reserves $ 1,578 $ 3,184 $ 859 $ 3,383 $ 1,551 $ 10,555 Gross IBNR Reserves 4,855 5,706 1,421 371 1,266 13,619 Total Gross Carried Claim and Claim Adjustment Expense Reserves $ 6,433 $ 8,890 $ 2,280 $ 3,754 $ 2,817 $ 24,174 Net Case Reserves $ 1,338 $ 2,850 $ 744 $ 3,291 $ 146 $ 8,369 Net IBNR Reserves 3,927 5,215 1,196 350 148 10,836 Total Net Carried Claim and Claim Adjustment Expense Reserves $ 5,265 $ 8,065 $ 1,940 $ 3,641 $ 294 $ 19,205 December 31, 2020 Specialty Commercial International Life & Group Corporate & Other Total (In millions) Gross Case Reserves $ 1,567 $ 3,215 $ 892 $ 3,406 $ 1,614 $ 10,694 Gross IBNR Reserves 4,181 5,035 1,199 337 1,260 12,012 Total Gross Carried Claim and Claim Adjustment Expense Reserves $ 5,748 $ 8,250 $ 2,091 $ 3,743 $ 2,874 $ 22,706 Net Case Reserves $ 1,410 $ 2,885 $ 777 $ 3,298 $ 560 $ 8,930 Net IBNR Reserves 3,488 4,590 1,045 317 331 9,771 Total Net Carried Claim and Claim Adjustment Expense Reserves $ 4,898 $ 7,475 $ 1,822 $ 3,615 $ 891 $ 18,701 Net Prior Year Development Changes in estimates of claim and claim adjustment expense reserves, net of reinsurance, for prior years are defined as net prior year loss reserve development (development). These changes can be favorable or unfavorable. The following table presents development recorded for the Specialty, Commercial, International and Corporate & Other segments. Years ended December 31 (In millions) 2021 2020 2019 Pretax (favorable) unfavorable development: Specialty $ (45) $ (61) $ (92) Commercial (6) (7) (40) International 2 (2) 21 Corporate & Other 60 50 38 Total pretax (favorable) unfavorable development $ 11 $ (20) $ (73) Unfavorable development of $60 million and $50 million was recorded within the Corporate & Other segment for the years ended 2021 and 2020 due to higher than expected emergence in mass tort exposures in older accident years primarily related to abuse. Unfavorable development of $38 million was recorded within the Corporate & Other segment for the year ended 2019 primarily due to higher than expected emergence in environmental mass tort exposures in older accident years. Segment Development Tables For the Specialty, Commercial and International segments, the following tables present further detail and commentary on the development reflected in the financial statements for each of the periods presented. Also presented are loss reserve development tables that illustrate the change over time of reserves established for claim and allocated claim adjustment expenses arising from short-duration insurance contracts for certain lines of business within each of these segments. Not all lines of business or segments are presented based on their context to the Company's overall loss reserves, calendar year reserve development, or calendar year net earned premiums. Insurance contracts are considered to be short-duration contracts when the contracts are not expected to remain in force for an extended period of time. The Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses tables, reading across, show the cumulative net incurred claim and allocated claim adjustment expenses relating to each accident year at the end of the stated calendar year. Changes in the cumulative amount across time are the result of the Company's expanded awareness of additional facts and circumstances that pertain to the unsettled claims. The Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses tables, reading across, show the cumulative amount paid for claims in each accident year as of the end of the stated calendar year. The Net Strengthening or (Releases) of Prior Accident Year Reserves tables, reading across, show the net increase or decrease in the cumulative net incurred accident year claim and allocated claim adjustment expenses during each stated calendar year and indicates whether the reserves for that accident year were strengthened or released. The information in the tables is reported on a net basis after reinsurance and does not include the effects of discounting. The information contained in calendar years 2020 and prior is unaudited. Information contained in the tables pertaining to the Company's International segment has been presented at the year-end 2021 foreign currency exchange rates for all periods presented to remove the effects of foreign currency exchange rate changes between calendar years. The Company has presented development information for the Hardy business prospectively from the date of acquisition and is presented as a separate table within the Company's International segment. To the extent the Company enters into a commutation, the transaction is reported on a prospective basis. To the extent that the Company enters into a disposition, the effects of the disposition are reported on a retrospective basis by removing the balances associated with the disposed of business. The amounts reported for the cumulative number of reported claims include direct and assumed open and closed claims by accident year at the claimant level. The number excludes claim counts for claims within a policy deductible where the insured is responsible for payment of losses in the deductible layer. Claim count data for certain assumed reinsurance contracts is unavailable. IBNR includes reserves for incurred but not reported losses and expected development on case reserves. The Company does not establish case reserves for allocated loss adjusted expenses (ALAE), therefore ALAE reserves are also included in the estimate of IBNR. The following table presents further detail of the development recorded for the Specialty segment. Years ended December 31 (In millions) 2021 2020 2019 Pretax (favorable) unfavorable development: Medical Professional Liability $ 23 $ 35 $ 75 Other Professional Liability and Management Liability 24 (15) (69) Surety (73) (69) (92) Warranty (14) (7) (15) Other (5) (5) 9 Total pretax (favorable) unfavorable development $ (45) $ (61) $ (92) 2021 Unfavorable development in medical professional liability was due to higher than expected large loss activity in recent accident years. Unfavorable development in other professional liability and management liability was due to higher than expected frequency of large losses in multiple accident years, and higher than expected claim severity and frequency in the Company’s cyber business in recent accident years. Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in recent accident years. Favorable development in warranty was due to lower than expected loss emergence in a recent accident year. 2020 Unfavorable development in medical professional liability was primarily due to higher than expected frequency of large losses in recent accident years and unfavorable outcomes on specific claims in older accident years. Favorable development in other professional liability and management liability was primarily due to lower than expected loss emergence in accident year 2017 and accident years prior to 2010. Favorable development in surety was due to lower than expected frequency and lack of systemic loss activity for accident years 2019 and prior. 2019 Unfavorable development in medical professional liability was primarily due to higher than expected severity in accident years 2016 through 2018 in the Company's aging services business, higher than expected severity in accident year 2013 in the Company's allied healthcare business, unfavorable outcomes on individual claims and higher than expected severity in accident year 2017 in the Company's dentists business. Favorable development in other professional liability and management liability was primarily due to lower than expected claim frequency and favorable outcomes on individual claims in accident years 2017 and prior related to financial institutions, lower than expected large claim losses in recent accident years in the Company's public company directors and officers liability (D&O) business and lower than expected loss adjustment expenses across accident years 2010 through 2018. Favorable development in surety was due to lower than expected frequency for accident years 2018 and prior. Favorable development in warranty was due to lower than expected paid loss emergence on vehicle products. Specialty - Line of Business Composition The table below provides the line of business composition of the net liability for unpaid claim and claim adjustment expenses for the Specialty segment. As of December 31 (In millions) 2021 Net liability for unpaid claim and claim adjustment expenses: Medical Professional Liability $ 1,556 Other Professional Liability and Management Liability 3,159 Surety 406 Warranty 44 Other 100 Total net liability for unpaid claim and claim adjustment expenses $ 5,265 Specialty - Medical Professional Liability Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 464 $ 469 $ 508 $ 498 $ 493 $ 484 $ 493 $ 499 $ 497 $ 497 $ 4 17,755 2013 462 479 500 513 525 535 545 531 530 11 19,565 2014 450 489 537 530 535 529 527 524 8 19,800 2015 433 499 510 494 488 510 501 28 18,170 2016 427 487 485 499 508 510 24 16,085 2017 412 449 458 460 455 41 15,197 2018 404 429 431 448 60 14,997 2019 430 445 458 156 13,804 2020 477 476 347 9,935 2021 377 337 6,761 Total $ 4,776 $ 1,016 Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 14 $ 117 $ 221 $ 323 $ 388 $ 427 $ 457 $ 479 $ 482 $ 487 2013 17 119 255 355 414 462 495 508 512 2014 23 136 258 359 417 472 489 497 2015 22 101 230 313 384 420 444 2016 18 121 246 339 401 436 2017 19 107 235 308 355 2018 21 115 211 290 2019 17 91 183 2020 11 61 2021 11 Total $ 3,276 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 1,500 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 28 Liability for unallocated claim adjustment expenses for accident years presented 28 Total net liability for unpaid claim and claim adjustment expenses $ 1,556 Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 5 $ 39 $ (10) $ (5) $ (9) $ 9 $ 6 $ (2) $ — $ 33 2013 17 21 13 12 10 10 (14) (1) 68 2014 39 48 (7) 5 (6) (2) (3) 74 2015 66 11 (16) (6) 22 (9) 68 2016 60 (2) 14 9 2 83 2017 37 9 2 (5) 43 2018 25 2 17 44 2019 15 13 28 2020 (1) (1) Total net development for the accident years presented above 52 32 13 Total net development for accident years prior to 2012 21 3 3 Total unallocated claim adjustment expense development 2 — 7 Total $ 75 $ 35 $ 23 (1) Data presented for these calendar years is required supplemental information, which is unaudited. Specialty - Other Professional Liability and Management Liability Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 923 $ 909 $ 887 $ 878 $ 840 $ 846 $ 833 $ 831 $ 850 $ 848 $ 18 18,506 2013 884 894 926 885 866 863 850 846 833 30 17,950 2014 878 898 885 831 835 854 845 841 37 17,577 2015 888 892 877 832 807 813 836 41 17,436 2016 901 900 900 904 907 891 84 17,968 2017 847 845 813 791 775 152 18,159 2018 850 864 869 906 202 19,926 2019 837 845 856 283 19,357 2020 930 944 568 19,095 2021 1,037 911 15,487 Total $ 8,767 $ 2,326 Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 56 $ 248 $ 400 $ 573 $ 651 $ 711 $ 755 $ 792 $ 812 $ 816 2013 54 249 447 618 702 754 771 779 787 2014 51 223 392 515 647 707 743 787 2015 60 234 404 542 612 677 725 2016 64 248 466 625 701 736 2017 57 222 394 498 557 2018 54 282 473 599 2019 64 263 422 2020 67 248 2021 58 Total $ 5,735 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 3,032 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 74 Liability for unallocated claim adjustment expenses for accident years presented 53 Total net liability for unpaid claim and claim adjustment expenses $ 3,159 Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ (14) $ (22) $ (9) $ (38) $ 6 $ (13) $ (2) $ 19 $ (2) $ (75) 2013 10 32 (41) (19) (3) (13) (4) (13) (51) 2014 20 (13) (54) 4 19 (9) (4) (37) 2015 4 (15) (45) (25) 6 23 (52) 2016 (1) — 4 3 (16) (10) 2017 (2) (32) (22) (16) (72) 2018 14 5 37 56 2019 8 11 19 2020 14 14 Total net development for the accident years presented above (35) 6 34 Total net development for accident years prior to 2012 (20) (21) (12) Total unallocated claim adjustment expense development (14) — 2 Total $ (69) $ (15) $ 24 (1) Data presented for these calendar years is required supplemental information, which is unaudited. Specialty - Surety Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 120 $ 122 $ 98 $ 70 $ 52 $ 45 $ 39 $ 38 $ 37 $ 36 $ 1 5,586 2013 120 121 115 106 91 87 83 82 82 2 5,088 2014 123 124 94 69 60 45 45 43 1 5,118 2015 131 131 104 79 63 58 53 9 5,055 2016 124 124 109 84 67 64 10 5,521 2017 120 115 103 84 71 9 5,795 2018 114 108 91 62 19 6,097 2019 119 112 98 44 5,816 2020 128 119 104 4,006 2021 137 129 2,592 Total $ 765 $ 328 Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 5 $ 32 $ 34 $ 35 $ 35 $ 36 $ 37 $ 37 $ 36 $ 36 2013 16 40 69 78 78 78 77 78 79 2014 7 30 38 36 38 38 39 39 2015 7 26 38 40 42 44 42 2016 5 37 45 45 43 43 2017 23 37 41 46 49 2018 5 25 34 39 2019 12 34 44 2020 4 20 2021 5 Total $ 396 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 369 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 17 Liability for unallocated claim adjustment expenses for accident years presented 20 Total net liability for unpaid claim and claim adjustment expenses $ 406 Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 2 $ (24) $ (28) $ (18) $ (7) $ (6) $ (1) $ (1) $ (1) $ (84) 2013 1 (6) (9) (15) (4) (4) (1) — (38) 2014 1 (30) (25) (9) (15) — (2) (80) 2015 — (27) (25) (16) (5) (5) (78) 2016 — (15) (25) (17) (3) (60) 2017 (5) (12) (19) (13) (49) 2018 (6) (17) (29) (52) 2019 (7) (14) (21) 2020 (9) (9) Total net development for the accident years presented above (79) (67) (76) Total net development for accident years prior to 2012 (3) (2) 3 Total unallocated claim adjustment expense development (10) — — Total $ (92) $ (69) $ (73) (1) Data presented for these calendar years is required supplemental information, which is unaudited. The following table presents further detail of the development recorded for the Commercial segment. Years ended December 31 (In millions) 2021 2020 2019 Pretax (favorable) unfavorable development: Commercial Auto $ 53 $ 33 $ (25) General Liability 15 15 16 Workers' Compensation (82) (96) (13) Property and Other 8 41 (18) Total pretax (favorable) unfavorable development $ (6) $ (7) $ (40) 2021 Unfavorable development in commercial auto was due to higher than expected claim severity in the Company’s middle market and construction businesses in multiple accident years. Unfavorable development in general liability was due to higher than expected claim severity in the Company’s construction and umbrella businesses in multiple accident years. Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity in multiple accident years. 2020 Unfavorable development in commercial auto was due to higher than expected claim severity in the Company's middle market and construction business in recent accident years. Unfavorable development in general liability was driven by increased bodily injury severities in accident years 2012 through 2016 and higher than expected frequency and severity in the Company’s umbrella business in accident years 2015 through 2019. Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity in multiple accident years. Unfavorable development in property and other was primarily due to higher than expected large loss activity in accident year 2019 in the Company's middle market, national accounts and marine business units. 2019 Favorable development in commercial auto was primarily due to continued lower than expected severity across accident years 2015 and prior and a decline in bodily injury frequency in accident year 2018. Unfavorable development in general liability was driven by higher than expected large loss emergence in the Company's umbrella business in multiple accident years. Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity in accident years 2012 through 2018. Favorable development in property and other was primarily driven by lower than expected claim severity related to catastrophe events in accident years 2017 and 2018. Commercial - Line of Business Composition The table below provides the line of business composition of the net liability for unpaid claim and claim adjustment expenses for the Commercial segment. As of December 31 (In millions) 2021 Net Claim and claim adjustment expenses: Commercial Auto $ 673 General Liability 2,911 Workers' Compensation 3,850 Property and Other 631 Total net liability for claim and claim adjustment expenses $ 8,065 Commercial - Commercial Auto Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 275 $ 289 $ 299 $ 303 $ 307 $ 299 $ 299 $ 297 $ 296 $ 295 $ 1 46,288 2013 246 265 265 249 245 245 241 241 241 2 39,430 2014 234 223 212 205 205 201 201 202 2 33,628 2015 201 199 190 190 183 181 183 3 30,427 2016 198 186 186 186 190 195 3 30,449 2017 199 198 200 221 232 5 30,940 2018 229 227 227 245 8 34,292 2019 257 266 289 31 37,142 2020 310 303 107 28,837 2021 397 271 27,182 Total $ 2,582 $ 433 Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 78 $ 160 $ 220 $ 259 $ 282 $ 285 $ 290 $ 291 $ 291 $ 292 2013 74 135 168 200 225 234 238 239 239 2014 64 102 137 166 187 196 198 199 2015 52 96 130 153 172 175 178 2016 52 93 126 154 175 185 2017 58 107 150 178 203 2018 66 128 175 212 2019 77 147 203 2020 71 134 2021 83 Total $ 1,928 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 654 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 5 Liability for unallocated claim adjustment expenses for accident years presented 14 Total net liability for unpaid claim and claim adjustment expenses $ 673 Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 14 $ 10 $ 4 $ 4 $ (8) $ — $ (2) $ (1) $ (1) $ 20 2013 19 — (16) (4) — (4) — — (5) 2014 (11) (11) (7) — (4) — 1 (32) 2015 (2) (9) — (7) (2) 2 (18) 2016 (12) — — 4 5 (3) 2017 (1) 2 21 11 33 2018 (2) — 18 16 2019 9 23 32 2020 (7) (7) Total net development for the accident years presented above (17) 31 52 Total net development for accident years prior to 2012 (7) 2 1 Total unallocated claim adjustment expense development (1) — — Total $ (25) $ 33 $ 53 (1) Data presented for these calendar years is required supplemental information, which is unaudited. Commercial - General Liability Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 587 $ 611 $ 639 $ 636 $ 619 $ 635 $ 635 $ 630 $ 632 $ 632 $ 20 35,313 2013 650 655 650 655 613 623 620 623 624 24 33,706 2014 653 658 654 631 635 658 659 659 28 28,064 2015 581 576 574 589 600 602 617 42 24,118 2016 623 659 667 671 673 683 68 24,511 2017 632 632 632 634 630 67 22,195 2018 653 644 646 639 205 19,917 2019 680 682 682 330 18,602 2020 723 722 516 13,028 2021 782 7 |
Legal Proceedings, Contingencie
Legal Proceedings, Contingencies and Guarantees | 12 Months Ended |
Dec. 31, 2021 | |
Legal Proceedings, Commitments and Contingencies, and Guarantees [Abstract] | |
Legal Proceedings, Contingencies and Guarantees | Legal Proceedings, Contingencies and Guarantees The Company is a party to various claims and litigation incidental to its business, which, based on the facts and circumstances currently known, are not material to the Company's results of operations or financial position. Data Breach-related Contingency As previously disclosed, the Company sustained a sophisticated cybersecurity attack in March 2021 involving ransomware. The Company’s investigation revealed that an unauthorized third party copied some personal information relating to certain current and former employees, contractor workers and their dependents and certain other persons, including some policyholders. In July 2021, we provided notifications to the impacted individuals and to regulators, in accordance with applicable law. The Company may be subject to subsequent investigations, fines or penalties, as well as other legal claims and actions, related to the foregoing. The likelihood is reasonably possible, but the amount of such fines, penalties or costs, if any, cannot be estimated at this time. Based on the information currently known, we do not believe that the March 2021 cybersecurity attack will have a material impact on our business, results of operations or financial condition, but no assurances can be given as we continue to assess the full impact from the incident, including costs, expenses and insurance coverage. Guarantees The Company has provided guarantees, if the primary obligor fails to perform, to holders of structured settlement annuities issued by a previously owned subsidiary. As of December 31, 2021, the potential amount of future payments the Company could be required to pay under these guarantees was approximately $1.6 billion, which will be paid over the lifetime of the annuitants. The Company does not believe any payment is likely under these guarantees, as the Company is the beneficiary of a trust that must be maintained at a level that approximates the discounted reserves for these annuities. |
Reinsurance
Reinsurance | 12 Months Ended |
Dec. 31, 2021 | |
Reinsurance Disclosures [Abstract] | |
Reinsurance | Reinsurance The Company cedes insurance to reinsurers to limit its maximum loss, provide greater diversification of risk, minimize exposures on larger risks and to exit certain lines of business. The ceding of insurance does not discharge the primary liability of the Company. A credit exposure exists with respect to reinsurance ceded to the extent that any reinsurer is unable to meet its obligations. A collectibility exposure also exists to the extent that the reinsurer disputes the liabilities assumed under reinsurance agreements. Property and casualty reinsurance coverages are tailored to the specific risk characteristics of each product line and the Company's retained amount varies by type of coverage. Reinsurance contracts are purchased to protect specific lines of business such as property and workers' compensation. Corporate catastrophe reinsurance is also purchased for property and workers' compensation exposure. The Company also utilizes facultative reinsurance in certain lines. In addition, the Company assumes reinsurance primarily through Hardy and as a member of various reinsurance pools and associations. The following table presents the amounts receivable from reinsurers. December 31 (In millions) 2021 2020 Reinsurance receivables related to insurance reserves: Ceded claim and claim adjustment expenses $ 4,969 $ 4,005 Ceded future policy benefits 288 263 Reinsurance receivables related to paid losses 227 210 Reinsurance receivables 5,484 4,478 Allowance for uncollectible reinsurance (21) (21) Reinsurance receivables, net of allowance for uncollectible reinsurance $ 5,463 $ 4,457 The Company has established an allowance for uncollectible voluntary reinsurance receivables which relates to both amounts already billed on ceded paid losses as well as ceded reserves that will be billed when losses are paid in the future. The following table summarizes the outstanding amount of voluntary reinsurance receivables, gross of any collateral arrangements, by financial strength rating. (In millions) December 31, 2021 A- to A++ 3,812 B- to B++ 987 Insolvent 3 Total voluntary reinsurance outstanding balance (1) $ 4,802 (1) Expected credit losses for legacy A&EP receivables are ceded to NICO and the reinsurance limit on the LPT has not been exhausted, therefore no allowance is recorded for these receivables and they are excluded from the table above. Refer to Note E to the Consolidated Financial Statements for information regarding the LPT. The Company has also excluded receivables from involuntary pools. The Company attempts to mitigate its credit risk related to reinsurance by entering into reinsurance arrangements with reinsurers that have credit ratings above certain levels and by obtaining collateral. On a limited basis, the Company may enter into reinsurance agreements with reinsurers that are not rated, primarily captive reinsurers. Receivables from captive reinsurers are backed by collateral arrangements and comprise the majority of the voluntary reinsurance receivables within the B- to B++ rating distribution in the table above. The primary methods of obtaining collateral are through reinsurance trusts, letters of credit and funds withheld balances. Such collateral, limited by the balance of open recoverables, was approximately $4.0 billion and $3.3 billion as of December 31, 2021 and 2020. The Company's largest recoverables from a single reinsurer as of December 31, 2021, including ceded unearned premium reserves, were approximately $1.8 billion from subsidiaries of the Berkshire Hathaway Insurance Group, $612 million from Cavello Bay Reinsurance Limited and $425 million from the Gateway Rivers Insurance Company. These amounts are substantially collateralized or otherwise secured. The recoverable from subsidiaries of the Berkshire Hathaway Insurance Group includes amounts related to third-party reinsurance for which NICO has assumed the credit risk under the terms of the LPT as discussed in Note E to the Consolidated Financial Statements. The effects of reinsurance on earned premiums and written premiums are presented in the following tables. (In millions) Direct Assumed Ceded Net Assumed/ 2021 Earned Premiums Property and casualty $ 12,554 $ 240 $ 5,110 $ 7,684 3.1 % Long term care 443 48 — 491 9.8 % Total earned premiums $ 12,997 $ 288 $ 5,110 $ 8,175 3.5 % 2020 Earned Premiums Property and casualty $ 11,547 $ 238 $ 4,640 $ 7,145 3.3 % Long term care 454 50 — 504 9.9 % Total earned premiums $ 12,001 $ 288 $ 4,640 $ 7,649 3.8 % 2019 Earned Premiums Property and casualty $ 11,021 $ 288 $ 4,401 $ 6,908 4.2 % Long term care 470 50 — 520 9.6 % Total earned premiums $ 11,491 $ 338 $ 4,401 $ 7,428 4.6 % (In millions) Direct Assumed Ceded Net Assumed/ 2021 Written Premiums Property and casualty $ 13,150 $ 255 $ 5,485 $ 7,920 3.2 % Long term care 437 48 — 485 9.9 % Total written premiums $ 13,587 $ 303 $ 5,485 $ 8,405 3.6 % 2020 Written Premiums Property and casualty $ 12,168 $ 229 $ 4,832 $ 7,565 3.0 % Long term care 444 50 — 494 10.1 % Total written premiums $ 12,612 $ 279 $ 4,832 $ 8,059 3.5 % 2019 Written Premiums Property and casualty $ 11,421 $ 281 $ 4,569 $ 7,133 3.9 % Long term care 473 50 — 523 9.6 % Total written premiums $ 11,894 $ 331 $ 4,569 $ 7,656 4.3 % Included in the direct and ceded earned premiums for the years ended December 31, 2021, 2020 and 2019 are $3,638 million, $3,543 million and $3,578 million related to property business that is 100% reinsured under a significant third-party captive program. The third-party captives that participate in this program are affiliated with the non-insurance company policyholders, therefore this program provides a means for the policyholders to self-insure this property risk. The Company receives and retains a ceding commission. Long term care premiums are from long-duration contracts; property and casualty premiums are from short-duration contracts. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt | Debt Debt is composed of the following long term obligations. December 31 (In millions) 2021 2020 Senior notes of CNAF: 3.950%, face amount of $550, due May 15, 2024 549 548 4.500%, face amount of $500, due March 1, 2026 499 499 3.450%, face amount of $500, due August 15, 2027 497 496 3.900%, face amount of $500, due May 1, 2029 496 496 2.050%, face amount of $500, due August 15, 2030 495 495 Debenture of CNAF, 7.250%, face amount of $243, due November 15, 2023 243 242 Total $ 2,779 $ 2,776 CCC is a member of the Federal Home Loan Bank of Chicago (FHLBC). FHLBC membership provides participants with access to additional sources of liquidity through various programs and services. As a requirement of membership in the FHLBC, CCC held $5 million of FHLBC stock as of December 31, 2021 giving it immediate access to approximately $106 million of additional liquidity. As of December 31, 2021 and 2020, CCC had no outstanding borrowings from the FHLBC. During 2019, the Company amended and restated its existing credit agreement with a syndicate of banks. The agreement provides a five-year $250 million senior unsecured revolving credit facility which is intended to be used for general corporate purposes. At the Company's election, the commitments under the agreement may be increased from time to time up to an additional aggregate amount of $100 million, and two one-year extensions are available prior to any anniversary of the closing date, each subject to applicable consents. Under the agreement, the Company is required to pay a facility fee which will adjust automatically in the event of a change in the Company's financial ratings. The agreement includes several covenants, including maintenance of a minimum consolidated net worth and a specified ratio of consolidated indebtedness to consolidated total capitalization. The minimum consolidated net worth, as defined, at December 31, 2021, was $8.7 billion. As of December 31, 2021 and 2020, the Company had no outstanding borrowings under the credit agreement. The Company's debt obligations contain customary covenants for investment grade issuers. The Company was in compliance with all covenants as of and for the years ended December 31, 2021 and 2020. The combined aggregate maturities for debt as of December 31, 2021 are presented in the following table. (In millions) 2022 $ — 2023 243 2024 550 2025 — 2026 500 Thereafter 1,500 Less: discount (14) Total $ 2,779 |
Benefit Plans
Benefit Plans | 12 Months Ended |
Dec. 31, 2021 | |
Retirement Benefits [Abstract] | |
Benefit Plans | Benefit Plans Pension and Postretirement Health Care Benefit Plans CNA sponsors noncontributory defined benefit pension plans, primarily through the CNA Retirement Plan, covering certain eligible employees. These plans are closed to new entrants. CNA's funding policy for defined benefit pension plans is to make contributions in accordance with applicable governmental regulatory requirements with consideration of the funded status of the plans. Effective January 1, 2000, the CNA Retirement Plan was closed to new participants. Existing participants at that time were given a choice to either continue to accrue benefits under the CNA Retirement Plan or to cease accruals effective December 31, 1999. Employees who chose to continue to accrue benefits under the plan received benefits in accordance with plan provisions through June 30, 2015 as discussed further below. Participants who elected to cease accruals effective December 31, 1999 received the present value of their accrued benefit in an accrued pension account that is credited with interest based on the annual rate of interest on 30-year Treasury securities. These employees also receive certain enhanced employer contributions in the CNA 401k Plan. Effective June 30, 2015, the Company eliminated future benefit accruals associated with the CNA Retirement Plan. Participants continuing to accrue benefits under the CNA Retirement Plan up until that date are entitled to an accrued benefit payable based on their eligible compensation and accrued service through June 30, 2015. These affected participants now also receive enhanced employer contributions in the CNA 401k Plan similar to participants who elected to cease accruals effective December 31, 1999. Employees who elected to cease accruals effective December 31, 1999 were not affected by this curtailment. CNA provides certain postretirement health care benefits to eligible retired employees, their covered dependents and their beneficiaries primarily through the CNA Health and Group Benefits Program. These postretirement benefits have largely been eliminated for active employees. The following table presents a reconciliation of benefit obligations and plan assets. Pension Benefits Postretirement Benefits (In millions) 2021 2020 2021 2020 Benefit obligation as of January 1 $ 2,769 $ 2,661 $ 7 $ 8 Changes in benefit obligation: Interest cost 62 80 — — Participants' contributions — — 3 2 Actuarial (gain) loss (84) 205 1 2 Benefits paid (182) (173) (5) (5) Foreign currency translation and other (2) 3 — — Settlements (2) (7) — — Benefit obligation as of December 31 2,561 2,769 6 7 Fair value of plan assets as of January 1 2,420 2,285 — — Change in plan assets: Actual return on plan assets 332 295 — — Company contributions 10 16 2 3 Participants' contributions — — 3 2 Benefits paid (182) (173) (5) (5) Foreign currency translation and other (1) 4 — — Settlements (2) (7) — — Fair value of plan assets as of December 31 2,577 2,420 — — Funded status $ 16 $ (349) $ (6) $ (7) Amounts recognized on the Consolidated Balance Sheets as of December 31: Other assets $ 77 $ 2 $ — $ — Other liabilities (61) (351) (6) (7) Net amount recognized $ 16 $ (349) $ (6) $ (7) Amounts recognized in Accumulated other comprehensive income, not yet recognized in net periodic cost (benefit): Net actuarial (gain) loss $ 763 $ 1,073 $ 1 $ — Net amount recognized $ 763 $ 1,073 $ 1 $ — The accumulated benefit obligation for all defined benefit pension plans was $2,561 million and $2,769 million as of December 31, 2021 and 2020. Changes for the year ended December 31, 2021 include actuarial gains of $(84) million driven by investment returns and changes in the discount rate used to determine the defined benefit pension obligations. Changes for the year ended December 31, 2020 include actuarial losses of $205 million primarily driven by changes in the discount rate used to determine defined benefit pension obligations. For pension plans with a benefit obligation in excess of plan assets, the benefit obligation was $61 million and the aggregate plan assets were $0 at December 31, 2021. The components of net periodic pension cost (benefit) are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Net periodic pension cost (benefit) Interest cost on projected benefit obligation $ 62 $ 80 $ 100 Expected return on plan assets (154) (155) (142) Amortization of net actuarial (gain) loss 46 45 39 Settlement loss 1 3 — Total net periodic pension cost (benefit) $ (45) $ (27) $ (3) The following table indicates the line items in which the non-service cost (benefit) is presented in the Consolidated Statements of Operations. Years ended December 31 (In millions) 2021 2020 2019 Non-Service Cost (benefit): Insurance claims and policyholder's benefits $ (13) $ (8) $ (1) Other operating expenses (32) (19) (2) Total net periodic pension cost (benefit) $ (45) $ (27) $ (3) The amounts recognized in Other comprehensive income are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Pension and postretirement benefits Amounts arising during the period $ 262 $ (67) $ (112) Settlement 1 3 — Reclassification adjustment relating to prior service credit — — — Reclassification adjustment relating to actuarial loss 46 45 39 Total increase (decrease) in Other comprehensive income $ 309 $ (19) $ (73) Actuarial assumptions used for the CNA Retirement Plan and CNA Health and Group Benefits Program to determine benefit obligations are presented in the following table. The interest crediting rate is the weighted average interest rate applied to the individual pension balances for employees who elected to cease accruals effective December 31, 1999. December 31 2021 2020 Pension benefits Discount rate 2.750 % 2.350 % Interest crediting rate 3.000 3.000 Postretirement benefits Discount rate 2.250 % 1.600 % Actuarial assumptions used for the CNA Retirement Plan and CNA Health and Group Benefits Program to determine net cost or benefit are presented in the following table. Years ended December 31 2021 2020 2019 Pension benefits Discount rate 2.350 % 3.150 % 4.250 % Expected long term rate of return 6.750 7.250 7.500 Interest crediting rate 3.000 5.000 5.000 Postretirement benefits Discount rate 1.600 % 2.300 % 3.550 % To determine the discount rate assumption as of the year-end measurement date for the CNA Retirement Plan and CNA Health and Group Benefits Program, the Company considered the estimated timing of plan benefit payments and available yields on high quality fixed income debt securities. For this purpose, high quality is considered a rating of Aa or better by Moody's Investors Service, Inc. (Moody's) or a rating of AA or better from Standard & Poor's (S&P). The Company reviewed several yield curves constructed using the cash flow characteristics of the plans as well as bond indices as of the measurement date. The trend of those data points was also considered. In determining the expected long term rate of return on plan assets assumption for the CNA Retirement Plan, CNA considered the historical performance of the benefit plan investment portfolio as well as long term market return expectations based on the investment mix of the portfolio and the expected investment horizon. The CNA Health and Group Benefits Program has limited its share of the health care trend rate to a cost-of-living adjustment of 4% per year. For all participants, the employer subsidy on health care costs will not increase by more than 4% per year. As a result, the assumed health care cost trend rate used in measuring the accumulated postretirement benefit obligation for the CNA Health and Group Benefits Program was 4% per year in 2021, 2020 and 2019. CNA employs a total return approach whereby a mix of equity, limited partnerships and fixed maturity securities are used to maximize the long term return of retirement plan assets for a prudent level of risk and to manage cash flows according to plan requirements. The target allocation of plan assets is 40% to 60% invested in equity securities and limited partnerships, with the remainder primarily invested in fixed maturity securities. Alternative investments, including limited partnerships, are used to enhance risk adjusted long term returns while improving portfolio diversification. The intent of this strategy is to minimize the Company's expense related to funding the plan by generating investment returns that exceed the growth of the plan liabilities over the long run. Risk tolerance is established after careful consideration of the plan liabilities, plan funded status and corporate financial conditions. As of December 31, 2021, the Plan had committed approximately $160 million to future capital calls from various third-party limited partnership investments in exchange for an ownership interest in the related partnerships. Derivatives may be used to gain market exposure in an efficient and timely manner. Investment risk is measured and monitored on an ongoing basis through annual liability measurements, periodic asset/liability studies and quarterly investment portfolio reviews. Pension plan assets measured at fair value on a recurring basis as well as cash are presented in the following tables. December 31, 2021 (In millions) Level 1 Level 2 Level 3 Total Assets Fixed maturity securities: Corporate bonds and other $ — $ 645 $ 8 $ 653 States, municipalities and political subdivisions — 30 — 30 Asset-backed — 110 — 110 Total fixed maturity securities — 785 8 793 Equity securities 732 141 — 873 Short term investments 45 — — 45 Other assets — 8 — 8 Cash — — — — Total assets measured at fair value $ 777 $ 934 $ 8 1,719 Total equity securities measured at net asset value (1) 20 Total limited partnerships measured at net asset value (1) 838 Total $ 2,577 December 31, 2020 (In millions) Level 1 Level 2 Level 3 Total Assets Fixed maturity securities: Corporate bonds and other $ — $ 643 $ 9 $ 652 States, municipalities and political subdivisions — 32 — 32 Asset-backed — 98 — 98 Total fixed maturity securities — 773 9 782 Equity securities 666 137 — 803 Short term investments 20 38 — 58 Other assets — 8 — 8 Cash 13 — — 13 Total assets measured at fair value $ 699 $ 956 $ 9 1,664 Total limited partnerships measured at net asset value (1) 756 Total $ 2,420 (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table for these investments are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Plan's Statement of Financial Position. The limited partnership investments held within the plan are recorded at fair value, which represents the plan's share of net asset value of each partnership, as determined by each limited partnership's general partner. Limited partnerships comprising 65% and 75% of the carrying value as of December 31, 2021 and 2020 employ hedge fund strategies that generate returns through investing in marketable securities in the public fixed income and equity markets and the remainder were primarily invested in private debt and equity. Within hedge fund strategies, approximately 76% were equity related, 19% pursued a multi-strategy approach and 5% were focused on distressed investments as of December 31, 2021. For a discussion of the fair value levels and the valuation methodologies used to measure fixed maturity securities, equities, derivatives and short term investments, see Note C to the Consolidated Financial Statements. The table below presents the estimated future minimum benefit payments to participants as of December 31, 2021. (In millions) Pension Benefits Postretirement Benefits 2022 $ 182 $ 1 2023 179 1 2024 177 1 2025 175 — 2026 173 — 2027-2031 798 1 In 2022, CNA expects to contribute $5 million to its pension plans and $1 million to its postretirement health care benefit plans. Savings Plans CNA sponsors savings plans, which are generally contributory plans that allow most employees to contribute a maximum of 50% of their eligible compensation, subject to certain limitations prescribed by the IRS. The Company contributes matching amounts to participants amounting to 100% of the first 6% of eligible compensation contributed by the employee. In addition, eligible employees also receive a Company contribution of 5% of their eligible compensation, referred to as a basic contribution. Company contributions vest ratably over participants first five years of service. Benefit expense for the Company's savings plans was $65 million, $70 million and $71 million for the years ended December 31, 2021, 2020 and 2019. |
Stock-Based Compensation
Stock-Based Compensation | 12 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation The current CNAF Incentive Compensation Plan (the Plan) authorizes the grant of stock-based compensation to certain management personnel for up to 16 million shares of CNAF common stock. The Plan currently provides for awards of stock options, stock appreciation rights (SARs), restricted shares, restricted stock units (RSUs), performance-based RSUs and performance share units. These grants to employees are not designed to be spring-loaded. The number of shares available for the granting of stock-based compensation under the Plan as of December 31, 2021 was approximately 5.6 million. Substantially all of the Company's stock-based compensation is awarded under the Annual Performance Share Plan (PSP). The PSP provides officers with an opportunity to earn an award based upon attainment of specific performance goals achieved over a one-year performance period. Awards are granted in the form of performance share units at the beginning of each performance year and are generally subject to a two-year cliff vesting period after the Company’s annual performance has been determined. The performance share units become payable within a range of 0% to 200% of the number of performance share units initially granted. Additionally, the Company may grant RSUs under the Plan in certain circumstances. These awards generally vest over a one Stock-based compensation that is not fully vested prior to termination is generally forfeited upon termination, except in cases of retirement, death or disability, and as otherwise provided by contractual obligations. The fair value of stock-based compensation awards is based on the market value of the Company's common stock as of the date of grant, except for awards made to foreign participants, which is based on the current market value of the Company’s common stock. Payments made under the PSP are made entirely in shares of common stock granted under the Plan, except for awards made to foreign participants, which are paid in cash. The Company recorded stock-based compensation expense related to the Plan of $32 million, $37 million and $34 million for the years ended December 31, 2021, 2020 and 2019. The related income tax benefit recognized was $6 million, $6 million and $8 million for the years ended December 31, 2021, 2020 and 2019 . The compensation cost not yet recognized was $41 million, and the weighted average period over which it is expected to be recognized is 1.7 years as of December 31, 2021. The total fair value of RSUs and performance shares that vested during the years ended December 31, 2021, 2020 and 2019 was $36 million, $35 million and $31 million, respectively. The weighted average grant date fair value for RSUs and performance shares granted during the years ended December 31, 2021, 2020 and 2019 was $45.82, $34.36 and $43.86, respectively. The following table presents activity for non-vested RSUs and performance share units under the Plan in 2021. Number of Awards Weighted Average Grant Date Fair Value Balance as of January 1, 2021 2,439,141 $ 40.56 Awards granted 1,044,772 45.82 Awards vested (789,495) 46.13 Awards forfeited, canceled or expired (355,881) 40.19 Performance-based adjustment 37,061 43.70 Balance as of December 31, 2021 2,375,598 41.21 |
Other Intangible Assets
Other Intangible Assets | 12 Months Ended |
Dec. 31, 2021 | |
Intangible Assets, Gross (Excluding Goodwill) [Abstract] | |
Other Intangible Assets | Other Intangible Assets Other intangible assets are presented in the following table. December 31 2021 2020 (In millions) Economic Useful Life Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Finite-lived intangible assets: Trade name 8 years $ 7 7 $ 7 $ 7 Distribution channel 15 years 11 7 11 6 Total finite-lived intangible assets 18 14 18 13 Indefinite-lived intangible assets: Syndicate capacity 47 48 Agency force 16 16 Total indefinite-lived intangible assets 63 64 Total other intangible assets $ 81 $ 14 $ 82 $ 13 The Company's other intangible assets primarily relate to the purchase of Hardy, and the amortization of the finite-lived intangible assets is included in the Statement of Operations for the International segment. Amortization expense of $1 million was included in Other operating expenses for each of the years ended December 31, 2021, 2020 and 2019. The gross carrying amounts and accumulated amortization in the table above may change from period to period as a result of foreign currency translation. Estimated future annual amortization expense for other intangible assets is $1 million in each of the years 2022 through 2026. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Leases | Leases Total lease expense was $57 million, $57 million and $55 million for the years ended December 31, 2021, 2020 and 2019. Total lease expense includes operating lease expense of $38 million, $38 million and $37 million and variable lease expense of $19 million, $19 million and $18 million for the years ended December 31, 2021, 2020 and 2019. Cash paid for amounts included in operating lease liabilities was $44 million, $41 million and $34 million for the years ended December 31, 2021, 2020 and 2019. Operating lease ROU assets obtained in exchange for lease obligations was $11 million, $6 million and $12 million for the years ended December 31, 2021, 2020 and 2019. The following table presents operating lease ROU assets and lease liabilities. (In millions) December 31, 2021 December 31, 2020 Operating lease ROU assets $ 175 $ 199 Operating lease liabilities 248 279 The following table presents the maturities of operating lease liabilities (In millions) December 31, 2021 2022 $ 42 2023 37 2024 30 2025 25 2026 22 Thereafter 141 Total lease payments 297 Less: Discount (49) Total operating lease liabilities $ 248 The following table presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease ROU assets. December 31, 2021 December 31, 2020 Weighted average remaining lease term 9.8 years 10.3 years Weighted average discount rate 3.4 % 3.4 % |
Stockholders' Equity and Statut
Stockholders' Equity and Statutory Accounting Practices | 12 Months Ended |
Dec. 31, 2021 | |
Stockholders' Equity and Statutory Accounting Practices [Abstract] | |
Stockholders' Equity And Statutory Accounting Practices | Stockholders’ Equity and Statutory Accounting Practices Common Stock Dividends There are no restrictions on the retained earnings or net income of CNAF with regard to payment of dividends to its stockholders. However, given the holding company nature of CNAF, its ability to pay a dividend is significantly dependent on the receipt of dividends from its subsidiaries, particularly CCC, which directly or indirectly owns the vast majority of all significant subsidiaries. See the Statutory Accounting Practices section below for a discussion of the regulatory restrictions on CCC's availability to pay dividends. CNAF's ability to pay dividends may be indirectly limited by the minimum consolidated net worth covenant in the Company's line of credit agreement. See Note H to the Consolidated Financial Statements for further discussion of the Company's debt obligations. Statutory Accounting Practices CNAF’s insurance subsidiaries are domiciled in various jurisdictions. These subsidiaries prepare statutory financial statements in accordance with accounting practices prescribed or permitted by the respective jurisdictions’ insurance regulators. Domestic prescribed statutory accounting practices are set forth in a variety of publications of the National Association of Insurance Commissioners (NAIC) as well as state laws, regulations and general administrative rules. These statutory accounting principles vary in certain respects from GAAP. In converting from statutory accounting principles to GAAP, the more significant adjustments include deferral of policy acquisition costs and the inclusion of net unrealized holding gains or losses in stockholders’ equity relating to certain fixed maturity securities. The Company has a prescribed practice as it relates to the accounting under Statement of Statutory Accounting Principles No. 62R, Property and Casualty Reinsurance , paragraphs 88 and 89 in conjunction with the 2010 LPT with NICO which is further discussed in Note E to the Consolidated Financial Statements. The prescribed practice allows the Company to aggregate all third-party A&EP reinsurance balances administered by NICO in Schedule F and to utilize the LPT as collateral for the underlying third-party reinsurance balances for purposes of calculating the statutory reinsurance penalty. This prescribed practice increased statutory capital and surplus by $67 million and $91 million at December 31, 2021 and 2020. The payment of dividends by CNAF's insurance subsidiaries without prior approval of the insurance department of each subsidiary’s domiciliary jurisdiction is generally limited by formula. Dividends in excess of these amounts are subject to prior approval by the respective insurance regulator. Dividends from CCC are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance (the Department), are determined based on the greater of the prior year's statutory net income or 10% of statutory surplus as of the end of the prior year, as well as the timing and amount of dividends paid in the preceding twelve months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of December 31, 2021, CCC is in a positive earned surplus position. The maximum allowable dividend CCC could pay during 2022 that would not be subject to the Department’s prior approval is $1,201 million, less dividends paid during the preceding twelve months measured at that point in time. CCC paid dividends of $880 million in 2021. The actual level of dividends paid in any year is determined after an assessment of available dividend capacity, holding company liquidity and cash needs as well as the impact the dividends will have on the statutory surplus of the applicable insurance company. Combined statutory capital and surplus and statutory net income (loss) for the Combined Continental Casualty Companies are presented in the table below, determined in accordance with accounting practices prescribed or permitted by insurance and/or other regulatory authorities Statutory Capital and Surplus Statutory Net Income (Loss) December 31 Years ended December 31 (In millions) 2021 (1) 2020 2021 (1) 2020 2019 Combined Continental Casualty Companies $ 11,321 $ 10,708 $ 1,253 $ 800 $ 1,062 (1) Information derived from the statutory-basis financial statements to be filed with insurance regulators. CNAF’s domestic insurance subsidiaries are subject to risk-based capital (RBC) requirements. RBC is a method developed by the NAIC to determine the minimum amount of statutory capital appropriate for an insurance company to support its overall business operations in consideration of its size and risk profile. The formula for determining the amount of RBC specifies various factors, weighted based on the perceived degree of risk, which are applied to certain financial balances and financial activity. The adequacy of a company's actual capital is evaluated by a comparison to the RBC results, as determined by the formula. Companies below minimum RBC requirements are classified within certain levels, each of which requires specified corrective action. The statutory capital and surplus presented above for CCC was approximately 264% and 266% of company action level RBC as of December 31, 2021 and 2020. Company action level RBC is the level of RBC which triggers a heightened level of regulatory supervision. The statutory capital and surplus of the Company's foreign insurance subsidiaries, which is not significant to the overall statutory capital and surplus, also met or exceeded their respective regulatory and other capital requirements. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) by Component | 12 Months Ended |
Dec. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated Other Comprehensive Income (Loss) by Component | Accumulated Other Comprehensive Income (Loss) by Component The tables below display the changes in Accumulated other comprehensive income (loss) by component. (In millions) Net unrealized gains (losses) on investments with an allowance for credit losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2021 $ — $ 1,745 $ (848) $ (94) $ 803 Other comprehensive income (loss) before reclassifications (7) (625) 207 (19) (444) Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $1, $(21), $10, $— and $(10) (5) 81 (37) — 39 Other comprehensive income (loss) net of tax (expense) benefit of $1, $188, $(65), $— and $124 (2) (706) 244 (19) (483) Balance as of December 31, 2021 $ (2) $ 1,039 $ (604) $ (113) $ 320 (In millions) Net unrealized gains (losses) on investments with an allowance for credit losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2020 $ — $ 1,025 $ (833) $ (141) $ 51 Other comprehensive income (loss) before reclassifications (43) 763 (53) 47 714 Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $12, $(12), $10, $— and $10 (43) 43 (38) — (38) Other comprehensive income (loss) net of tax (expense) benefit of $—, $(189), $4, $— and $(185) — 720 (15) 47 752 Balance as of December 31, 2020 $ — $ 1,745 $ (848) $ (94) $ 803 Amounts reclassified from Accumulated other comprehensive income (loss) shown above are reported in Net income (loss) as follows: Component of AOCI Consolidated Statements of Operations Line Item Affected by Reclassifications Net unrealized gains (losses) on investments with an allowance for credit losses, Net unrealized gains (losses) on investments with OTTI losses and Net unrealized gains (losses) on other investments Net investment gains (losses) Pension and postretirement benefits Other operating expenses and Insurance claims and policyholders' benefits |
Business Segments
Business Segments | 12 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Business Segments | Business Segments The Company's property and casualty commercial insurance operations are managed and reported in three business segments: Specialty, Commercial and International. These three segments are collectively referred to as Property & Casualty Operations. Specialty provides management and professional liability and other coverages through property and casualty products and services using a network of brokers, independent agencies and managing general underwriters. Commercial works with a network of brokers and independent agents to market a broad range of property and casualty insurance products to all types of insureds targeting small business, construction, middle markets and other commercial customers. The International segment underwrites property and casualty coverages on a global basis through a branch operation in Canada, a European business consisting of insurance companies based in the U.K. and Luxembourg and Hardy, the Company's Lloyd's syndicate. The Company's operations outside of Property & Casualty Operations are managed and reported in two segments: Life & Group and Corporate & Other. Life & Group primarily includes the results of the long term care business that is in run-off. Corporate & Other primarily includes certain corporate expenses, including interest on corporate debt, and the results of certain property and casualty business in run-off, including CNA Re, A&EP, a legacy portfolio of EWC policies and certain legacy mass tort reserves. Effective January 1, 2021, and in connection with the ceding of certain legacy reserves under a retroactive reinsurance agreement executed in February 2021, management changed the segment presentation of a legacy portfolio of excess workers’ compensation policies relating to business written in 2007 and prior. This business, which was previously reported as part of the Commercial business segment, is now reported as part of the Corporate & Other business segment. Further information on this retroactive reinsurance agreement is provided in Note E. In addition, a determination was made to change the segment presentation of certain legacy mass tort reserves. Similar to the aforementioned excess workers’ compensation legacy business, these legacy mass tort reserves were previously reported in the Commercial business segment and are now reported as part of the Corporate & Other business segment. These changes were made to better reflect the manner in which the Company is organized for purposes of making operating decisions and assessing performance. Prior period information has been conformed to the new segment presentation. The accounting policies of the segments are the same as those described in Note A to the Consolidated Financial Statements. The Company manages most of its assets on a legal entity basis, while segment operations are generally conducted across legal entities. As such, only Insurance and Reinsurance receivables, Insurance reserves, Deferred acquisition costs, Goodwill and Deferred non-insurance warranty acquisition expense and revenue are readily identifiable for individual segments. Distinct investment portfolios are not maintained for every individual segment; accordingly, allocation of assets to each segment is not performed. Therefore, a significant portion of Net investment income and Net investment gains or losses are allocated primarily based on each segment's net carried insurance reserves, as adjusted. All significant intersegment income and expense have been eliminated. Income taxes have been allocated on the basis of the taxable income of the segments. Approximately 10%, 9% and 9% of the Company's direct written premiums were derived from outside the United States for the years ended December 31, 2021, 2020 and 2019. In the following tables, certain financial measures are presented to provide information used by management to monitor the Company's operating performance. Management utilizes these financial measures to monitor the Company's insurance operations and investment portfolio. The performance of the Company's insurance operations is monitored by management through core income (loss), which is derived from certain income statement amounts. The Company's investment portfolio is monitored by management through analysis of various factors including unrealized gains and losses on securities, portfolio duration and exposure to market and credit risk. Core income (loss) is calculated by excluding from net income (loss) the after-tax effects of net investment gains or losses and any cumulative effects of changes in accounting guidance. The calculation of core income (loss) excludes net investment gains or losses because net investment gains or losses are generally driven by economic factors that are not necessarily reflective of our primary operations. The Company's results of operations and selected balance sheet items by segment are presented in the following tables. Year ended December 31, 2021 Specialty Commercial International Life & Corporate (In millions) Eliminations Total Net written premiums $ 3,225 $ 3,595 $ 1,101 $ 485 $ — $ (1) $ 8,405 Operating revenues Net earned premiums $ 3,076 $ 3,552 $ 1,057 $ 491 $ — $ (1) $ 8,175 Net investment income 497 624 57 966 15 — 2,159 Non-insurance warranty revenue 1,430 — — — — — 1,430 Other revenues 1 23 — — 6 (6) 24 Total operating revenues 5,004 4,199 1,114 1,457 21 (7) 11,788 Claims, benefits and expenses Net incurred claims and benefits 1,787 2,540 652 1,239 109 — 6,327 Policyholders’ dividends 3 19 — — — — 22 Amortization of deferred acquisition costs 643 594 206 — — — 1,443 Non-insurance warranty expense 1,328 — — — — — 1,328 Other insurance related expenses 296 511 144 103 9 (1) 1,062 Other expenses 47 38 (2) 10 155 (6) 242 Total claims, benefits and expenses 4,104 3,702 1,000 1,352 273 (7) 10,424 Core income (loss) before income tax 900 497 114 105 (252) — 1,364 Income tax (expense) benefit on core income (loss) (196) (103) (28) 21 48 — (258) Core income (loss) $ 704 $ 394 $ 86 $ 126 $ (204) $ — 1,106 Net investment gains (losses) 120 Income tax (expense) benefit on net investment gains (losses) (24) Net investment gains (losses), after tax 96 Net income (loss) $ 1,202 December 31, 2021 (In millions) Reinsurance receivables $ 1,200 $ 923 $ 381 $ 401 $ 2,579 $ — $ 5,484 Insurance receivables 1,136 1,488 340 6 4 — 2,974 Deferred acquisition costs 363 278 96 — — — 737 Goodwill 117 — 31 — — — 148 Deferred non-insurance warranty acquisition expense 3,476 — — — — — 3,476 Insurance reserves Claim and claim adjustment expenses 6,433 8,890 2,280 3,754 2,817 — 24,174 Unearned premiums 3,001 2,066 585 109 — — 5,761 Future policy benefits — — — 13,236 — — 13,236 Deferred non-insurance warranty revenue 4,503 — — — — — 4,503 Year ended December 31, 2020 Specialty Commercial International Life & Corporate (In millions) Eliminations Total Net written premiums $ 3,040 $ 3,565 $ 961 $ 494 $ — $ (1) $ 8,059 Operating revenues Net earned premiums $ 2,883 $ 3,323 $ 940 $ 504 $ — $ (1) $ 7,649 Net investment income 449 513 58 851 64 — 1,935 Non-insurance warranty revenue 1,252 — — — — — 1,252 Other revenues 1 25 — — 5 (5) 26 Total operating revenues 4,585 3,861 998 1,355 69 (6) 10,862 Claims, benefits and expenses Net incurred claims and benefits 1,792 2,375 629 1,286 67 — 6,149 Policyholders’ dividends 3 18 — — — — 21 Amortization of deferred acquisition costs 621 592 197 — — — 1,410 Non-insurance warranty expense 1,159 — — — — — 1,159 Other insurance related expenses 280 506 136 109 (2) (1) 1,028 Other expenses 50 34 (7) 7 141 (5) 220 Total claims, benefits and expenses 3,905 3,525 955 1,402 206 (6) 9,987 Core income (loss) before income tax 680 336 43 (47) (137) — 875 Income tax (expense) benefit on core income (loss) (145) (69) (5) 56 23 — (140) Core income (loss) $ 535 $ 267 $ 38 $ 9 $ (114) $ — 735 Net investment gains (losses) (54) Income tax (expense) benefit on net investment gains (losses) 9 Net investment gains (losses), after tax (45) Net income (loss) $ 690 December 31, 2020 (In millions) Reinsurance receivables $ 886 $ 848 $ 302 $ 390 $ 2,052 $ — $ 4,478 Insurance receivables 1,052 1,254 328 4 2 — 2,640 Deferred acquisition costs 330 281 97 — — — 708 Goodwill 117 — 31 — — — 148 Deferred non-insurance warranty acquisition expense 3,068 — — — — — 3,068 Insurance reserves Claim and claim adjustment expenses 5,748 8,250 2,091 3,743 2,874 — 22,706 Unearned premiums 2,635 1,824 546 114 — — 5,119 Future policy benefits — — — 13,318 — — 13,318 Deferred non-insurance warranty revenue 4,023 — — — — — 4,023 Year ended December 31, 2019 Specialty Commercial Life & Corporate (In millions) International Eliminations Total Net written premiums $ 2,848 $ 3,315 $ 971 $ 523 $ 1 $ (2) $ 7,656 Operating revenues Net earned premiums $ 2,773 $ 3,162 $ 974 $ 520 $ 1 $ (2) $ 7,428 Net investment income 556 605 63 820 74 — 2,118 Non-insurance warranty revenue 1,161 — — — — — 1,161 Other revenues 1 29 — — 6 (5) 31 Total operating revenues 4,491 3,796 1,037 1,340 81 (7) 10,738 Claims, benefits and expenses Net incurred claims and benefits 1,595 2,086 624 1,416 62 — 5,783 Policyholders’ dividends 5 18 — — — — 23 Amortization of deferred acquisition costs 610 537 236 — — — 1,383 Non-insurance warranty expense 1,082 — — — — — 1,082 Other insurance related expenses 292 505 130 115 (2) (2) 1,038 Other expenses 48 32 8 8 144 (5) 235 Total claims, benefits and expenses 3,632 3,178 998 1,539 204 (7) 9,544 Core income (loss) before income tax 859 618 39 (199) (123) — 1,194 Income tax (expense) benefit on core income (loss) (188) (138) (9) 90 30 — (215) Core income (loss) $ 671 $ 480 $ 30 $ (109) $ (93) $ — 979 Net investment gains (losses) 29 Income tax (expense) benefit on net investment gains (losses) (8) Net investment gains (losses), after tax 21 Net income (loss) $ 1,000 The following table presents operating revenues by line of business for each reportable segment. Years ended December 31 (In millions) 2021 2020 2019 Specialty Management & Professional Liability $ 2,776 $ 2,577 $ 2,572 Surety 604 596 596 Warranty & Alternative Risks 1,624 1,412 1,323 Specialty revenues 5,004 4,585 4,491 Commercial Middle Market 1,508 1,444 1,439 Construction 1,322 1,120 1,043 Small Business 558 482 504 Other Commercial 811 815 810 Commercial revenues 4,199 3,861 3,796 International Canada 344 291 277 Europe 473 389 363 Hardy 297 318 397 International revenues 1,114 998 1,037 Life & Group revenues 1,457 1,355 1,340 Corporate & Other revenues 21 69 81 Eliminations (7) (6) (7) Total operating revenues 11,788 10,862 10,738 Net investment gains (losses) 120 (54) 29 Total revenues $ 11,908 $ 10,808 $ 10,767 |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party TransactionsThe Company reimburses Loews for, or pays directly, fees and expenses of investment facilities and services provided to the Company. Additionally, the Company provides investment-related processing services to Loews and charges Loews for these services. The net amounts incurred by the Company for these fees, expenses and services were $47 million, $47 million and $44 million for the years ended December 31, 2021, 2020 and 2019. Net amounts due to Loews related to these services, included in Other liabilities and payable in the first quarter of the subsequent year, were $23 million and $22 million as of December 31, 2021 and 2020. In addition, the Company reimbursed Loews for general corporate services and related travel expenses of $1 million and less than $1 million for the years ended December 31, 2021 and 2020. The CNA Tax Group is included in the consolidated federal income tax return of Loews and its eligible subsidiaries. The related payable due to Loews, included in Other liabilities, was $33 million and $67 million as of December 31, 2021 and 2020. For a detailed description of the income tax agreement with Loews see Note D to the Consolidated Financial Statements. In 2021, the Company wrote an appeal bond for Loews at standard rates. In addition, the Company writes, at standard rates, a limited amount of insurance for Loews and its subsidiaries. The earned premiums for each of the years ended December 31, 2021, 2020 and 2019 were $2 million. |
Non-Insurance Revenues from Con
Non-Insurance Revenues from Contracts with Customers | 12 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Non-Insurance Revenues from Contracts with Customers | Non-Insurance Revenues from Contracts with Customers Non-Insurance revenue is recognized when obligations under the terms of a contract with a customer are satisfied; generally this occurs over time as obligations are fulfilled. Revenue is measured as the amount of consideration the Company expects to receive in exchange for providing services. Deferred Non-Insurance Warranty Revenue The Company had deferred non-insurance warranty revenue balances of $4.5 billion and $4.0 billion reported in Deferred non-insurance warranty revenue as of December 31, 2021 and 2020. The increase in the deferred revenue balance for the year ended December 31, 2021 was primarily driven by deferrals outpacing revenue recognized in the period due to growth in the business. For the year ended December 31, 2021, the Company recognized $1.2 billion of revenues that were included in the deferred revenue balance as of January 1, 2021. For the year ended December 31, 2020, the Company recognized $1.1 billion of revenues that were included in the deferred revenue balance as of January 1, 2020. For the years ended December 31, 2021 and 2020, Non-insurance warranty revenue recognized from performance obligations related to prior periods due to a change in estimate was not material. The Company expects to recognize approximately $1.3 billion of the deferred revenue in 2022, $1.0 billion in 2023, $0.8 billion in 2024 and $1.3 billion thereafter. Cost to Obtain and Fulfill Non-Insurance Warranty Contracts with Customers For the years ended December 31, 2021 and 2020, capitalized commission costs were $3.5 billion and $3.1 billion and capitalized administrator service costs were $47 million and $37 million. For the years ended December 31, 2021 and 2020, the amount of amortization of capitalized costs was $1.1 billion and $0.9 billion and there were no impairment losses related to the costs capitalized. There were no adjustments to deferred costs recorded for the years ended December 31, 2021 and 2020. |
Schedule I. Summary of Investme
Schedule I. Summary of Investments - Other Than Investments in Related Parties | 12 Months Ended |
Dec. 31, 2021 | |
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] | |
Schedule I. Summary of Investments - Other than Investments in Related Parties | SCHEDULE I. SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES Incorporated herein by reference to Note B to the Consolidated Financial Statements included under Item 8. |
Schedule II. Condensed Financia
Schedule II. Condensed Financial Information of Registrant (Parent Company) | 12 Months Ended |
Dec. 31, 2021 | |
Condensed Financial Information Disclosure [Abstract] | |
Schedule II. Condensed Financial Information of Registrant (Parent Company) | SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT (PARENT COMPANY) CNA Financial Corporation Statements of Operations and Comprehensive Income Years ended December 31 (In millions) 2021 2020 2019 Revenues Net investment income $ — $ 3 $ 13 Net investment losses — (20) (21) Total revenues — (17) (8) Expenses Administrative and general 1 1 1 Interest 112 122 131 Total expenses 113 123 132 Loss from operations before income taxes and equity in net income of subsidiaries (113) (140) (140) Income tax benefit 11 18 21 Loss before equity in net income of subsidiaries (102) (122) (119) Equity in net income of subsidiaries 1,304 812 1,119 Net income 1,202 690 1,000 Equity in other comprehensive (loss) income of subsidiaries (483) 752 929 Total comprehensive income $ 719 $ 1,442 $ 1,929 See accompanying Notes to Condensed Financial Information as well as the Consolidated Financial Statements and accompanying Notes. CNA Financial Corporation Balance Sheets December 31 (In millions, except share data) 2021 2020 Assets Investment in subsidiaries $ 14,937 $ 14,996 Cash 1 — Short term investments 685 522 Amounts due from affiliates 3 4 Other assets — 1 Total assets $ 15,626 $ 15,523 Liabilities Long term debt $ 2,779 $ 2,776 Other liabilities 38 40 Total liabilities 2,817 2,816 Stockholders' Equity Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 271,363,999 and 271,391,603 shares outstanding) 683 683 Additional paid-in capital 2,215 2,211 Retained earnings 9,663 9,081 Accumulated other comprehensive income 320 803 Treasury stock (1,676,244 and 1,648,640 shares), at cost (72) (71) Total stockholders' equity 12,809 12,707 Total liabilities and stockholders' equity $ 15,626 $ 15,523 See accompanying Notes to Condensed Financial Information as well as the Consolidated Financial Statements and accompanying Notes. CNA Financial Corporation Statements of Cash Flows Years ended December 31 (In millions) 2021 2020 2019 Cash Flows from Operating Activities Net income $ 1,202 $ 690 $ 1,000 Adjustments to reconcile net income to net cash flows provided by operating activities: Equity in net income of subsidiaries (1,304) (812) (1,119) Dividends received from subsidiaries 880 975 1,065 Net investment income — 20 21 Other, net 33 26 13 Net cash flows provided by operating activities 811 899 980 Cash Flows from Investing Activities Change in short term investments (163) 2 10 Capital contributions to subsidiaries — (1) (2) Other, net — — — Net cash flows (used) provided by investing activities (163) 1 8 Cash Flows from Financing Activities Dividends paid to common stockholders (621) (950) (929) Proceeds from the issuance of debt — 495 496 Repayment of debt — (419) (520) Purchase of treasury stock (18) (18) (23) Other, net (8) (9) (12) Net cash flows used by financing activities (647) (901) (988) Net change in cash 1 (1) — Cash, beginning of year — 1 1 Cash, end of year $ 1 $ — $ 1 See accompanying Notes to Condensed Financial Information as well as the Consolidated Financial Statements and accompanying Notes. Notes to Condensed Financial Information A. Summary of Significant Accounting Policies Basis of Presentation The condensed financial information of CNA Financial Corporation (CNAF or the Parent Company) should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in Item 8 of this Form 10-K. CNAF’s subsidiaries are accounted for using the equity method of accounting. Equity in net income of these subsidiaries is presented on the Condensed Statements of Operations as Equity in net income of subsidiaries. Loews owned approximately 89.6% of the outstanding common stock of CNAF as of December 31, 2021. |
Schedule III. Supplementary Ins
Schedule III. Supplementary Insurance Information | 12 Months Ended |
Dec. 31, 2021 | |
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] | |
Schedule III. Supplementary Insurance Information | SCHEDULE III. SUPPLEMENTARY INSURANCE INFORMATIONIncorporated herein by reference to Note O to the Consolidated Financial Statements included under Item 8. |
Schedule IV. Reinsurance
Schedule IV. Reinsurance | 12 Months Ended |
Dec. 31, 2021 | |
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] | |
Schedule IV. Reinsurance | SCHEDULE IV. REINSURANCE Incorporated herein by reference to Note G to the Consolidated Financial Statements included under Item 8. |
Schedule V. Valuation and Quali
Schedule V. Valuation and Qualifying Accounts | 12 Months Ended |
Dec. 31, 2021 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Schedule V. Valuation and Qualifying Accounts | SCHEDULE V. VALUATION AND QUALIFYING ACCOUNTS (In millions) Balance at Beginning of Period Charged to Costs and Expenses Charged to Other Accounts Deductions Balance at End of Period Year ended December 31, 2021 Allowance for uncollectible: Mortgage loan receivables $ 26 $ — $ (10) $ — $ 16 Insurance and reinsurance receivables $ 54 $ 4 $ — $ (8) $ 50 Allowance for credit losses: Fixed maturity securities $ 40 $ — $ 30 $ (52) $ 18 Year ended December 31, 2020 Allowance for uncollectible: Mortgage loan receivables $ 7 $ — $ 19 $ — $ 26 Insurance and reinsurance receivables $ 57 $ 4 $ — $ (7) $ 54 Allowance for credit losses: Fixed maturity securities $ 6 $ — $ 92 $ (58) $ 40 Year ended December 31, 2019 Allowance for uncollectible: Insurance and reinsurance receivables $ 71 $ (6) $ — $ (8) $ 57 Effects of foreign currency translation, changes in the estimate of the allowance for uncollectible mortgage loan receivables, increases in the estimate of the allowance for credit losses on fixed maturity securities and allowances established with respect to assets purchased with credit deterioration are presented within the Charged to Other Accounts column in the table above. Write-offs of uncollectible amounts and reductions to the allowance for credit losses due to securities sold during the period or the reversal for securities that had an allowance recorded in a previous period are presented within the Deductions column in the table above. |
Schedule VI. Supplemental Infor
Schedule VI. Supplemental Information Concerning Property and Casualty Insurance Operations | 12 Months Ended |
Dec. 31, 2021 | |
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Abstract] | |
Schedule VI. Supplemental Information Concerning Property and Casualty Insurance Operations | SCHEDULE VI. SUPPLEMENTAL INFORMATION CONCERNING PROPERTY AND CASUALTY INSURANCE OPERATIONS As of and for the years ended December 31 Consolidated Property and Casualty Operations (In millions) 2021 2020 2019 Balance Sheet Data Deferred acquisition costs $ 737 $ 708 Reserves for unpaid claim and claim adjustment expenses 24,174 22,706 Discount deducted from claim and claim adjustment expense reserves above (based on interest rates ranging from 3.5% to 6.4%) 1,146 1,209 Unearned premiums 5,761 5,119 Statement of Operations Data Net written premiums $ 8,405 $ 8,059 $ 7,656 Net earned premiums 8,175 7,649 7,428 Net investment income 2,111 1,896 2,063 Incurred claim and claim adjustment expenses related to current year 5,970 5,793 5,356 Incurred claim and claim adjustment expenses related to prior years (104) (119) (127) Amortization of deferred acquisition costs 1,443 1,410 1,383 Paid claim and claim adjustment expenses 4,844 5,164 5,576 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | The Consolidated Financial Statements include the accounts of CNA Financial Corporation (CNAF) and its subsidiaries. Collectively, CNAF and its subsidiaries are referred to as CNA or the Company. Loews Corporation (Loews) owned approximately 89.6% of the outstanding common stock of CNAF as of December 31, 2021.The accompanying Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). Intercompany amounts have been eliminated. |
Use of Estimates | The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. |
Recently Adopted Accounting Standards Updates and Accounting Standards Pending Adoption | ASU 2016-13: In June 2016 the Financial Accounting Standards Board (FASB) issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . The updated accounting guidance required changes to the recognition of credit losses on financial instruments not accounted for at fair value through the Company’s results of operations. For financial assets measured at cost, the expected credit loss model requires immediate recognition of estimated credit losses over the life of the asset and presentation of the asset at the net amount expected to be collected. This updated guidance applies to mortgage loan investments, reinsurance and insurance receivables and other financing receivables. For available-for-sale fixed maturity securities carried at fair value, estimated credit losses will continue to be measured at the present value of expected cash flows, however, the other than temporary impairment (OTTI) concept has been eliminated. Under the previous guidance, estimated credit impairments resulted in a write-down of amortized cost. Under the updated guidance, estimated credit losses are recognized through an allowance and reversals of the allowance are permitted if the estimate of credit losses declines. For available-for-sale fixed maturity securities where the Company has an intent to sell, impairment will continue to result in a write-down of amortized cost. On January 1, 2020, the Company adopted the updated guidance using a modified retrospective method with a cumulative effect adjustment recorded to beginning Retained earnings. Prior period amounts have not been adjusted and continue to be reported in accordance with the previous accounting guidance. A prospective transition approach is required for available-for-sale fixed maturity securities that were purchased with credit deterioration (PCD assets) or have recognized an OTTI write-down prior to the effective date. The cumulative effect of the accounting change resulted in a $5 million decrease in Retained earnings, with a corresponding $7 million allowance for credit losses recorded for Mortgage loans partially offset by a $2 million tax impact. The allowance for uncollectible reinsurance and insurance receivables was unchanged as a result of adopting the updated guidance. At adoption, an allowance for credit losses of $6 million was established for available-for-sale fixed maturity securities that were PCD assets, with a corresponding increase to amortized cost, resulting in no adjustment to the carrying value of the securities. See the accounting policy discussion within this Note, as well as Notes B and G to the Consolidated Financial Statements for additional information regarding credit losses. Accounting Standards Pending Adoption In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts. The updated accounting guidance requires changes to the measurement and disclosure of long-duration contracts. Entities will be required to update cash flow assumptions (including morbidity and persistency) at least annually, and to update discount rate assumptions quarterly using an upper-medium grade fixed-income instrument yield. The effect of changes in cash flow assumptions will be recorded in the Company's results of operations and the effect of changes in discount rate assumptions will be recorded in Other comprehensive income. The guidance is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted, and may be applied using either a modified retrospective transition method or a full retrospective transition method. Restatement of prior periods presented is required. The Company will adopt the new guidance effective January 1, 2023, using the modified retrospective method applied as of the transition date of January 1, 2021. The most significant impact at the transition date will be the effect of updating the discount rate assumption to reflect an upper-medium grade fixed-income instrument yield, which will be partially offset by the de-recognition of shadow adjustments associated with long duration contracts. The Company expects the net impact of these changes will be a material decrease in Accumulated other comprehensive income as of the transition date. The requirement to update cash flow assumptions at least annually is expected to change the pattern of earnings emergence being recognized. Adoption will also significantly expand the Company’s disclosures, and will impact systems, processes, and controls. While the requirements of the new guidance represent a material change from existing GAAP, the new guidance will not impact capital and surplus under statutory accounting practices, related cash flows, or the underlying economics of the business. |
Premiums | Insurance premiums on property and casualty insurance contracts are recognized in proportion to the underlying risk insured and are principally earned ratably over the term of the policies. Premiums on long term care contracts are earned ratably over the policy year in which they are due. The reserve for unearned premiums represents the portion of premiums written relating to the unexpired terms of coverage. Property and casualty contracts that are retrospectively rated or subject to audit premiums contain provisions that result in an adjustment to the initial policy premium depending on the contract provisions. These provisions stipulate the adjustment due to loss experience of the insured during the coverage period, or changes in the level of exposure to insurance risk. For such contracts, the Company estimates the amount of ultimate premiums that the Company may earn upon completion of the coverage period and recognizes either an asset or a liability for the difference between the initial policy premium and the estimated ultimate premium. The Company either adjusts such estimated ultimate premium amounts during the course of the coverage period based on actual results to date, or by conducting premium audits after the policy has expired to determine the final exposure to insured risks. The resulting adjustment is recorded as either a reduction of or an increase to the earned premiums for the period. Insurance receivables include balances due currently or in the future, including amounts due from insureds related to paid losses under high deductible policies, and are presented at unpaid balances, net of an allowance for uncollectible receivables. A loss rate methodology is used to determine expected credit losses for premium receivables. This methodology uses the Company’s historical annual credit losses relative to gross premium written to develop a range of credit loss rates for each dollar of gross written premium underwritten. Additionally, an expected credit loss for amounts due from insureds under high deductible and retrospectively rated policies is calculated on a pool basis, informed by historical default rate data obtained from major rating agencies. Changes in the allowance are presented as a component of Other operating expenses on the Consolidated Statements of Operations. Amounts are considered past due based on policy payment terms. Insurance receivables and any related allowance are written off after collection efforts are exhausted or a negotiated settlement is reached. See the Credit Losses section of this note for additional information on the Company’s allowances for expected credit losses. |
Claim and claim adjustment expense reserves | Claim and claim adjustment expense reserves, except reserves for structured settlements not associated with asbestos and environmental pollution (A&EP), workers' compensation lifetime claims and long term care claims, are not discounted and are based on i) case basis estimates for losses reported on direct business, adjusted in the aggregate for ultimate loss expectations; ii) estimates of incurred but not reported (IBNR) losses; iii) estimates of losses on assumed reinsurance; iv) estimates of future expenses to be incurred in the settlement of claims; v) estimates of salvage and subrogation recoveries and vi) estimates of amounts due from insureds related to losses under high deductible policies. Management considers current conditions and trends as well as past Company and industry experience in establishing these estimates. The effects of inflation, which can be significant, are implicitly considered in the reserving process and are part of the recorded reserve balance. Ceded claim and claim adjustment expense reserves are reported as a component of Reinsurance receivables on the Consolidated Balance Sheets. |
Future policy benefits reserves | Future policy benefit reserves represent the active life reserves related to the Company's long term care policies for policyholders that are not currently receiving benefits and are computed using the net level premium method, which incorporates actuarial assumptions as to morbidity, persistency, inclusive of mortality, discount rate, future premium rate adjustments and expenses. Expense assumptions primarily relate to claim adjudication. These assumptions are locked in over the life of the policy; however if a premium deficiency emerges, the assumptions are unlocked and the future policy benefit reserves are increased. The September 30, 2021 gross premium valuation (GPV) indicated that recorded reserves included a margin of approximately $72 million. |
Insurance-relate assessments | Liabilities for insurance-related assessments are accrued when an assessment is probable, when it can be reasonably estimated and when the event obligating the entity to pay an imposed or probable assessment has occurred. Liabilities for insurance-related assessments are not discounted and are included as part of Other liabilities on the Consolidated Balance Sheets. |
Reinsurance | Reinsurance accounting allows for contractual cash flows to be reflected as premiums and losses. To qualify for reinsurance accounting, reinsurance agreements must include risk transfer. To meet risk transfer requirements, a reinsurance contract must include both insurance risk, consisting of underwriting and timing risk, and a reasonable possibility of a significant loss for the assuming entity. Reinsurance receivables related to paid losses are presented at unpaid balances. Reinsurance receivables related to unpaid losses are estimated in a manner consistent with claim and claim adjustment expense reserves or future policy benefit reserves. Reinsurance receivables are reported net of an allowance for uncollectible amounts on the Consolidated Balance Sheets. The cost of reinsurance is primarily accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies or over the reinsurance contract period. The ceding of insurance does not discharge the primary liability of the Company. The Company has established an allowance for uncollectible reinsurance receivables which relates to both amounts already billed on ceded paid losses as well as ceded reserves that will be billed when losses are paid in the future. For assessing expected credit losses, the Company separates reinsurance receivables into two pools: voluntary reinsurance receivables and involuntary receivables related to mandatory pools. The Company has not recorded an allowance for involuntary pools as there is no perceived credit risk. The principal credit quality indicator used in the valuation of the allowance on voluntary reinsurance receivables is the financial strength rating of the reinsurer sourced from major rating agencies. If the reinsurer is unrated, an internal financial strength rating is assigned based on the Company’s historical loss experience and the Company’s assessment of reinsurance counterparty risk profile, which generally corresponds with a B rating. Reinsurer financial strength ratings are updated and reviewed on an annual basis or sooner if the Company becomes aware of significant changes related to a reinsurer. The allowance for uncollectible reinsurance receivables is estimated on the basis of periodic evaluations of balances due from reinsurers, reinsurer financial strength rating and solvency, industry experience and current and forecast economic conditions. Because billed receivables generally approximate 5% or less of total reinsurance receivables, the age of the reinsurance receivables related to paid losses is not a significant input into the allowance analysis. Changes in the allowance for uncollectible reinsurance receivables are presented as a component of Insurance claims and policyholders' benefits on the Consolidated Statements of Operations. See the Credit Losses section of this note for additional information on the Company's allowances for expected credit losses. Amounts are considered past due based on the reinsurance contract terms. Reinsurance receivables related to paid losses and any related allowance are written off after collection efforts have been exhausted or a negotiated settlement is reached with the reinsurer. Reinsurance receivables from insolvent insurers related to paid losses are written off when the settlement due from the estate can be reasonably estimated. At the time reinsurance receivables related to paid losses are written off, any required adjustment to reinsurance receivables related to unpaid losses is recorded as a component of Insurance claims and policyholders' benefits on the Consolidated Statements of Operations. A loss portfolio transfer is a retroactive reinsurance contract. If the cumulative claim and allocated claim adjustment expenses ceded under a loss portfolio transfer exceed the consideration paid, the resulting gain from such excess is deferred and amortized into earnings in future periods in proportion to actual recoveries under the loss portfolio transfer. In any period in which there is a revised estimate of claim and allocated claim adjustment expenses and the loss portfolio transfer is in a gain position, the deferred gain is recalculated as if the revised estimate was available at the inception date of the loss portfolio transfer and the change in the deferred gain is recognized in earnings. |
Deferred acquisition costs | Deferrable acquisition costs include commissions, premium taxes and certain underwriting and policy issuance costs which are incremental direct costs of successful contract acquisitions. Acquisition costs related to property and casualty business are deferred and amortized ratably over the period the related premiums are earned. Deferred acquisition costs are presented net of ceding commissions and other ceded acquisition costs.The Company evaluates deferred acquisition costs for recoverability. Anticipated investment income is considered in the determination of the recoverability of deferred acquisition costs. Adjustments, if necessary, are recorded in current period results of operations. |
Policyholder dividends | Policyholder dividends are paid to participating policyholders within the workers' compensation and surety lines of business. Net written premiums for participating dividend policies were approximately 1% of total net written premiums for each of the years ended December 31, 2021, 2020 and 2019. Dividends to policyholders are accrued according to the Company's best estimate of the amount to be paid in accordance with contractual provisions and applicable state laws. Dividends to policyholders are presented as a component of Insurance claims & policyholders' benefits on the Consolidated Statements of Operations and Other liabilities on the Consolidated Balance Sheets. |
Investments | The Company classifies its fixed maturity securities as either available-for-sale or trading, and as such, they are carried at fair value. Changes in fair value of trading securities are reported within Net investment income on the Consolidated Statements of Operations. Changes in fair value related to available-for-sale securities are reported as a component of Other comprehensive income. The cost of fixed maturity securities classified as available-for-sale is adjusted for amortization of premiums and accretion of discounts, which are included in Net investment income on the Consolidated Statements of Operations. The amortization of premium and accretion of discount for fixed maturity securities takes into consideration call and maturity dates that produce the lowest yield. For asset-backed securities included in fixed maturity securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments predominantly using the retrospective method. To the extent that unrealized gains on fixed maturity securities supporting structured settlements not funded by annuities were realized, or that unrealized gains on fixed maturity securities supporting long term care products would result in a premium deficiency if realized, a related increase in Insurance reserves is recorded, net of tax, as a reduction of net unrealized gains through Other comprehensive income (Shadow Adjustments). Shadow Adjustments, net of tax, decreased $296 million and increased $575 million for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, net unrealized gains on investments included in Accumulated other comprehensive income (AOCI) were correspondingly reduced by Shadow Adjustments of $2,477 million and $2,773 million, respectively. Equity securities are carried at fair value. The Company's non-redeemable preferred stock contain characteristics of debt securities, are priced similarly to bonds and are held primarily for income generation through periodic dividends. While recognition of gains and losses on these securities is not discretionary, management does not consider the changes in fair value of non-redeemable preferred stock to be reflective of our primary operations. As such, the changes in the fair value of these securities are recorded through Net investment gains (losses) on the Consolidated Statements of Operations. The Company owns certain common stock with the intention of holding the securities primarily for market appreciation and as such, the changes in the fair value of these securities are recorded through Net investment income. The Company's carrying value of investments in limited partnerships is its share of the net asset value of each partnership, as determined by the general partner. Certain partnerships for which results are not available on a timely basis are reported on a lag, primarily three months or less. Changes in net asset values are accounted for under the equity method and recorded within Net investment income on the Consolidated Statements of Operations. Mortgage loans are commercial in nature, are carried at unpaid principal balance, net of unamortized fees and an allowance for expected credit losses, and are recorded once funded. The allowance for expected credit losses is developed by assessing the credit quality of pools of mortgage loans in good standing using debt service coverage ratios (DSCR) and loan-to-value ratios (LTV). The DSCR compares a property’s net operating income to its debt service payments, including principal and interest. The LTV ratio compares the current unpaid principal balance of the loan to the estimated fair value of the underlying property collateralizing the loan. The pools developed to measure the credit loss allowance use increments of DSCR and LTV to draw distinctions between risk levels. The Company applies expected credit loss rates by pool to the outstanding receivable balances. Changes in the allowance for mortgage loans are presented as a component of Net investment gains (losses) on the Consolidated Statements of Operations. Prior to 2020, mortgage loans were evaluated on an individual loan basis considering the collection experience of each loan and other credit quality indicators such as DSCR and the credit-worthiness of the borrower or tenants of credit tenant loan properties. Mortgage loans were considered to be impaired loans and a loss incurred when it was probable that contractual principal and interest payments would not be collected and any impairment losses were recognized as a direct write-down of amortized cost. See the Credit Losses section of this note for additional information on the Company’s allowances for expected credit losses. Interest income from mortgage loans is recognized on an accrual basis using the effective yield method. Other invested assets include overseas deposits. Overseas deposits are valued using the net asset value per share (or equivalent) practical expedient. They are primarily short-term government securities, agency securities and corporate bonds held in trusts that are managed by Lloyd's of London. These funds are required of Lloyd's syndicates to protect policyholders in overseas markets and may be denominated in local currency. Short term investments are carried at fair value, with the exception of cash accounts earning interest, which are carried at cost and approximate fair value. Changes in fair value are reported as a component of Other comprehensive income. Purchases and sales of all securities are recorded on the trade date, except for private placement securities, including bank loan participations, which are recorded once funded. Net investment gains and losses are determined on the basis of the cost or amortized cost of the specific securities sold. |
Variable interest entities | In the normal course of investing activities, the Company enters into relationships with variable interest entities (VIEs), as both an investor in limited partnerships and asset-backed securities issued by third-party VIEs. The Company is not the primary beneficiary of these VIEs, and therefore does not consolidate them. The Company determines whether it is the primary beneficiary of a VIE based on a qualitative assessment of the relative power and benefits of the Company and the other participants in the VIE. The Company’s maximum exposure to loss with respect to these investments is limited to the investment carrying values included in the Company’s Consolidated Balance Sheets and any unfunded commitments. An available-for-sale security is impaired if the fair value of the security is less than its cost adjusted for accretion, amortization and allowance for credit losses. When a security is impaired, it is evaluated to determine whether the Company intends to sell the security before recovery of amortized cost or whether a credit loss exists. Losses on securities that the Company intends to sell are recognized as impairment losses within Net investment gains (losses) on the Consolidated Statements of Operations. If a credit loss exists, an allowance is established and the corresponding amount is recognized as an impairment loss within Net |
Impairments, other than temporary | Significant judgment is required in the determination of whether an impairment loss has occurred for a security. The Company follows a consistent and systematic process for determining and recording an impairment loss, including the evaluation of securities in an unrealized loss position and securities with an allowance for credit losses on at least a quarterly basis. The Company’s assessment of whether an impairment loss has occurred incorporates both quantitative and qualitative information. A credit loss exists if the present value of cash flows expected to be collected is less than the amortized cost basis. Significant assumptions enter into these cash flow projections including delinquency rates, probable risk of default, loss severity upon a default, over collateralization and interest coverage triggers and credit support from lower level tranches. The Company considers all available evidence when determining whether an investment requires a credit loss write-down or allowance to be recorded. Examples of such evidence may include the financial condition and near-term and long-term prospects of the issuer, whether the issuer is current with interest and principal payments, credit ratings on the security or changes in ratings over time, general market conditions and industry, sector or other specific factors and whether it is likely that the Company will recover its amortized cost through the collection of cash flows. See the Credit Losses section of this note for additional information on the Company’s allowances for expected credit losses. Prior to 2020, the Company’s assessment of whether an impairment loss occurred also incorporated both quantitative and qualitative information. Fixed maturity securities in an unrealized loss position that the Company intended to sell, or it more likely than not would be required to sell before recovery of amortized cost, were considered to be impaired and the entire difference between the amortized cost basis and fair value of the security was recognized as an impairment loss in earnings as a direct write-down of amortized cost. The remaining fixed maturity securities in an unrealized loss position were evaluated to determine if a credit loss existed. If a credit loss was determined to exist, the credit loss was recognized in earnings as a direct write-down of amortized cost. |
Credit Losses | The allowances for credit losses on fixed maturity securities, mortgage loans, reinsurance receivables and insurance receivables are valuation accounts that are reported as a reduction of a financial asset’s cost basis and are measured on a pool basis when similar risk characteristics exist. Management estimates the allowance using relevant available information from both internal and external sources. Historical credit loss experience provides the basis for the estimation of expected credit losses and adjustments may be made to reflect current conditions and reasonable and supportable forecasts. Adjustments to historical loss information are made for any additional factors that come to the Company’s attention. This could include significant shifts in counterparty financial strength ratings, aging of past due receivables, amounts sent to collection agencies, or other underlying portfolio changes. Amounts are considered past due when payments have not been received according to contractual terms. The Company also considers current and forecast economic conditions, using a variety of economic metrics and forecast indices. The sensitivity of expected credit losses relative to changes to these forecast economic conditions can vary by financial asset class. The Company considers a reasonable and supportable forecast period to be up to 24 months from the balance sheet date. After the forecast period, the Company reverts to historical credit experience. The Company uses collateral arrangements such as letters of credit and amounts held in beneficiary trusts to mitigate credit risk, which are considered in the estimate of net amount expected to be collected. Amounts are written off against the allowance when determined to be uncollectible.The Company has made a policy election to present accrued interest balances separately from the amortized cost basis of assets and has elected the practical expedient to exclude the accrued interest from the tabular disclosures for mortgage loans and available-for-sale securities. The Company has elected not to estimate an allowance for credit losses on accrued interest receivable. The accrual of interest income is discontinued and the asset is placed on nonaccrual status within 90 days of the interest becoming delinquent. Interest accrued but not received for assets on nonaccrual status is reversed through investment income. Interest received for assets that are on nonaccrual status is recognized as payment is received. The asset is returned to accrual status when the principal and interest amounts contractually due are brought current and future payments are expected. Interest receivable is presented as a component of accrued investment income on the Consolidated Balance Sheet.Prior to 2020, the allowance for uncollectible reinsurance and insurance receivables was measured using an incurred loss methodology. |
Deferred Non-Insurance Warranty Revenue and Acquisition Expense | Non-insurance warranty revenue is primarily generated from separately-priced service contracts that provide mechanical breakdown and other coverages to vehicle or consumer goods owners. The warranty contracts generally provide coverage from 1 month to 10 years. For warranty products where the Company acts as the principal in the transaction, Non-insurance warranty revenue is reported on a gross basis, with amounts paid by customers reported as Non-insurance warranty revenue and commissions paid to agents reported as Non-insurance warranty expense. Non-insurance warranty revenue is reported net of any premiums related to contractual liability coverage issued by the Company's insurance operations. Additionally, the Company provides warranty administration services for dealer and manufacturer obligor warranty products, which include limited warranties and guaranteed asset protection waivers. The Company recognizes Non-insurance warranty revenue over the service period in proportion to the actuarially determined expected claims emergence pattern. Customers predominantly pay in full at the inception of the warranty contract. The liability for deferred revenue represents the unearned portion of revenue in advance of the Company's performance. The deferred revenue balance includes amounts which are refundable on a pro rata basis upon cancellation. Dealers, retailers and agents earn commission for assisting the Company in obtaining non-insurance warranty contracts. Additionally, the Company utilizes third-parties to perform warranty administrator services for its consumer goods warranties. These costs, which are deferred and recorded as Deferred non-insurance warranty acquisition expense, are amortized to Non-insurance warranty expense consistent with how the related revenue is recognized. The Company evaluates deferred costs for recoverability including consideration of anticipated investment income. Adjustments to deferred costs, if necessary, are recorded in the current period results of operations. |
Income Taxes | The Company and its eligible subsidiaries (CNA Tax Group) are included in the consolidated federal income tax return of Loews and its eligible subsidiaries. The Company accounts for income taxes under the asset and liability method. Under the asset and liability method, deferred income taxes are recognized for temporary differences between the financial statement and tax return bases of assets and liabilities, based on enacted tax rates and other provisions of the tax law. The effect of a change in tax laws or rates on deferred tax assets and liabilities is recognized in income in the period in which such change is enacted. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not, and a valuation allowance is established for any portion of a deferred tax asset that management believes will not be realized. The Company releases tax effects from AOCI utilizing the security-by-security approach for Net unrealized gains (losses) on investments with an allowance for credit losses and Net unrealized gains (losses) on other investments. For Pension and postretirement benefits, tax effects from AOCI are released at enacted tax rates based on the pre-tax adjustments to pension liabilities or assets recognized within Other comprehensive income. |
Pension and Postretirement Benefits | The Company recognizes the overfunded or underfunded status of its defined benefit plans in Other assets or Other liabilities on the Consolidated Balance Sheets. Changes in funded status related to prior service costs and credits, and actuarial gains and losses arising from differences between actual experience and actuarial assumptions, are recognized in the year in which the changes occur through Other comprehensive income. Unrecognized actuarial gains and losses in excess of 10% of the greater of the beginning of the year projected benefit obligation or fair value of plan assets (the corridor) are amortized as a component of net periodic pension cost (benefit) over the average remaining life expectancy of the plan participants. Annual service cost, interest cost, expected return on plan assets, amortization of prior service costs and credits and amortization of actuarial gains and losses are recognized on the Consolidated Statements of Operations. The vested benefit obligation for the CNA Retirement Plan is determined based on eligible compensation and accrued service for previously entitled employees. Effective June 30, 2015, future benefit accruals under the CNA Retirement Plan were eliminated and the benefit obligations were frozen. |
Stock-Based Compensation | The Company records compensation expense using the fair value method for all awards it grants, modifies or cancels primarily on a straight-line basis over the requisite service period, generally three years. |
Foreign Currency | The Company's foreign subsidiaries' balance sheet accounts are translated at the exchange rates in effect at each reporting date and income statement accounts are either translated at the exchange rates on the date of the transaction or at average exchange rates. Foreign currency translation gains and losses are reflected in Stockholders' equity as a component of AOCI. |
Leases | A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. Operating lease right-of-use (ROU) assets and lease liabilities are included in Other assets Other liabilities |
Property and Equipment | Property and equipment are carried at cost less accumulated depreciation. Depreciation is based on the estimated useful lives of the various classes of property and equipment and is determined principally on the straight-line method. Furniture and fixtures are depreciated over seven years. Office equipment is depreciated over five years. The estimated lives for data processing equipment and software generally range from three |
Goodwill | Goodwill represents the excess of purchase price over the fair value of the net assets of acquired entities and businesses. Goodwill in the International segment may change from period to period as a result of foreign currency translation. Goodwill is tested for impairment annually or when certain triggering events require such tests. As a result of reviews completed for the year ended December 31, 2021, the Company determined that the estimated fair value of the reporting units were in excess of their carrying value including Goodwill. Changes in future periods in assumptions about the level of economic capital, business growth, earnings projections or the weighted average cost of capital could result in goodwill impairment. |
Other Intangible Assets | Other intangible assets are reported within Other assets on the Consolidated Balance Sheets. Finite-lived intangible assets are amortized over their estimated useful lives. Indefinite-lived other intangible assets are tested for impairment annually or when certain triggering events require such tests. |
Earnings (Loss) Per Share Data | Earnings (loss) per share is based on weighted average number of outstanding common shares. Basic earnings (loss) per share excludes the impact of dilutive securities and is computed by dividing Net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. |
Investments (Tables)
Investments (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Investments [Abstract] | |
Net investment income | The significant components of Net investment income are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Fixed maturity securities $ 1,707 $ 1,728 $ 1,817 Equity securities 83 65 85 Limited partnership investments 362 121 180 Mortgage loans 61 57 51 Short term investments 1 9 34 Trading portfolio 9 18 9 Other — 1 5 Gross investment income 2,223 1,999 2,181 Investment expense (64) (64) (63) Net investment income $ 2,159 $ 1,935 $ 2,118 |
Net realized investment gains (losses) | Net investment gains (losses) are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Net investment gains (losses): Fixed maturity securities: Gross gains $ 186 $ 220 $ 125 Gross losses (90) (220) (131) Net investment gains (losses) on fixed maturity securities 96 — (6) Equity securities 4 (3) 66 Derivatives 6 (10) (11) Mortgage loans 10 (21) — Short term investments and other 4 (20) (20) Net investment gains (losses) $ 120 $ (54) $ 29 |
Debt securities, available-for-sale, allowance for credit loss | Accrued interest receivable on available-for-sale fixed maturity securities totaled $369 million and $371 million as of December 31, 2021 and 2020 and is excluded from the estimate of expected credit losses and the amortized cost basis in the table included within this Note. (In millions) Corporate and other bonds Asset-backed Total Allowance for credit losses: Balance as of January 1, 2021 $ 23 $ 17 $ 40 Additions to the allowance for credit losses: Securities for which credit losses were not previously recorded 14 — 14 Available-for-sale securities accounted for as PCD assets 5 6 11 Reductions to the allowance for credit losses: Securities sold during the period (realized) 7 17 24 Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis — — — Write-offs charged against the allowance 16 — 16 Recoveries of amounts previously written off — — — Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period (8) 1 (7) Balance as of December 31, 2021 $ 11 $ 7 $ 18 (In millions) Corporate and other bonds Asset-backed Total Allowance for credit losses: Balance as of January 1, 2020 $ — $ — $ — Additions to the allowance for credit losses: Impact of adopting ASC 326 6 — 6 Securities for which credit losses were not previously recorded 67 12 79 Available-for-sale securities accounted for as PCD assets 5 — 5 Reductions to the allowance for credit losses: Securities sold during the period (realized) 22 — 22 Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis 1 — 1 Write-offs charged against the allowance — — — Recoveries of amounts previously written off — — — Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period (32) 5 (27) Balance as of December 31, 2020 $ 23 $ 17 $ 40 |
Components of net other than temporary impairment losses recognized in earnings by asset type | The table includes losses on securities with an intention to sell and changes in the allowance for credit losses on securities since acquisition date. Years ended December 31 (In millions) 2021 2020 2019 Fixed maturity securities available-for-sale: Corporate and other bonds $ 11 $ 87 $ 33 Asset-backed 20 24 11 Impairment (gains) losses recognized in earnings $ 31 $ 111 $ 44 |
Summary of fixed maturity securities | The following tables present a summary of fixed maturity securities. December 31, 2021 Cost or Gross Gross Allowance for Credit Losses Estimated (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 21,444 $ 2,755 $ 56 $ 11 $ 24,132 States, municipalities and political subdivisions 10,358 1,599 14 — 11,943 Asset-backed: Residential mortgage-backed 2,893 71 8 — 2,956 Commercial mortgage-backed 1,987 63 19 — 2,031 Other asset-backed 2,561 54 10 7 2,598 Total asset-backed 7,441 188 37 7 7,585 U.S. Treasury and obligations of government-sponsored enterprises 132 1 3 — 130 Foreign government 570 15 2 — 583 Total fixed maturity securities available-for-sale 39,945 4,558 112 18 44,373 Total fixed maturity securities trading 7 — — — 7 Total fixed maturity securities $ 39,952 $ 4,558 $ 112 $ 18 $ 44,380 December 31, 2020 Cost or Gross Gross Allowance for Credit Losses Estimated (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 20,792 $ 3,578 $ 22 $ 23 $ 24,325 States, municipalities and political subdivisions 9,729 1,863 — — 11,592 Asset-backed: Residential mortgage-backed 3,442 146 1 — 3,587 Commercial mortgage-backed 1,933 93 42 17 1,967 Other asset-backed 2,179 81 9 — 2,251 Total asset-backed 7,554 320 52 17 7,805 U.S. Treasury and obligations of government-sponsored enterprises 339 2 3 — 338 Foreign government 512 32 — — 544 Total fixed maturity securities available-for-sale 38,926 5,795 77 40 44,604 Total fixed maturity securities trading 27 — — — 27 Total fixed maturity securities $ 38,953 $ 5,795 $ 77 $ 40 $ 44,631 |
Securities in a gross unrealized loss position | The following tables present the estimated fair value and gross unrealized losses of fixed maturity securities in a gross unrealized loss position for which an allowance for credit loss has not been recorded, by the length of time in which the securities have continuously been in that position. Less than 12 Months 12 Months or Longer Total December 31, 2021 Estimated Gross Estimated Gross Estimated Gross (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 2,389 $ 48 $ 136 $ 8 $ 2,525 $ 56 States, municipalities and political subdivisions 730 14 — — 730 14 Asset-backed: Residential mortgage-backed 1,043 8 — — 1,043 8 Commercial mortgage-backed 527 7 167 12 694 19 Other asset-backed 840 10 62 — 902 10 Total asset-backed 2,410 25 229 12 2,639 37 U.S. Treasury and obligations of government-sponsored enterprises 69 3 5 — 74 3 Foreign government 97 2 — — 97 2 Total $ 5,695 $ 92 $ 370 $ 20 $ 6,065 $ 112 Less than 12 Months 12 Months or Longer Total December 31, 2020 Estimated Gross Estimated Gross Estimated Gross (In millions) Fixed maturity securities available-for-sale: Corporate and other bonds $ 609 $ 21 $ 12 $ 1 $ 621 $ 22 States, municipalities and political subdivisions 33 — — — 33 — Asset-backed: Residential mortgage-backed 71 1 11 — 82 1 Commercial mortgage-backed 533 40 28 2 561 42 Other asset-backed 344 9 13 — 357 9 Total asset-backed 948 50 52 2 1,000 52 U.S. Treasury and obligations of government-sponsored enterprises 63 3 — — 63 3 Foreign government 13 — — — 13 — Total $ 1,666 $ 74 $ 64 $ 3 $ 1,730 $ 77 |
Contractual maturity | The following table presents available-for-sale fixed maturity securities by contractual maturity. December 31 2021 2020 (In millions) Cost or Estimated Cost or Estimated Due in one year or less $ 1,603 $ 1,624 $ 1,456 $ 1,458 Due after one year through five years 10,637 11,229 12,304 13,098 Due after five years through ten years 13,294 14,338 12,319 13,878 Due after ten years 14,411 17,182 12,847 16,170 Total $ 39,945 $ 44,373 $ 38,926 $ 44,604 |
Financing receivable credit quality indicators | The following table presents the amortized cost basis of mortgage loans for each credit quality indicator by year of origination. December 31, 2021 Mortgage Loans Amortized Cost Basis by Origination Year (1) (In millions) 2021 2020 2019 2018 2017 Prior Total DSCR ≥1.6x LTV less than 55% $ 2 $ 75 $ 6 $ 38 $ 99 $ 181 $ 401 LTV 55% to 65% 5 38 15 17 — 24 99 LTV greater than 65% 17 — 8 — — — 25 DSCR 1.2x - 1.6x LTV less than 55% 14 14 95 — 5 42 170 LTV 55% to 65% 36 — — 24 10 — 70 LTV greater than 65% — 24 — — 8 — 32 DSCR ≤1.2 LTV less than 55% — — 35 — 30 — 65 LTV 55% to 65% — — 28 — — — 28 LTV greater than 65% 21 9 62 — — 7 99 Total $ 95 $ 160 $ 249 $ 79 $ 152 $ 254 $ 989 (1) The values in the table above reflect DSCR on a standardized amortization period and LTV based on the most recent appraised values trended forward using changes in a commercial real estate price index. |
Fair Value (Tables)
Fair Value (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Assets and liabilities measured at fair value on a recurring basis | Assets and liabilities measured at fair value on a recurring basis are presented in the following tables. Corporate bonds and other includes obligations of the U.S. Treasury, government-sponsored enterprises, foreign governments and redeemable preferred stock. December 31, 2021 Total (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate bonds and other $ 140 $ 23,775 $ 937 $ 24,852 States, municipalities and political subdivisions — 11,887 56 11,943 Asset-backed — 7,029 556 7,585 Total fixed maturity securities 140 42,691 1,549 44,380 Equity securities: Common stock 220 — 13 233 Non-redeemable preferred stock 65 721 16 802 Total equity securities 285 721 29 1,035 Short term and other 1,798 74 — 1,872 Total assets $ 2,223 $ 43,486 $ 1,578 $ 47,287 Liabilities Other liabilities $ — $ 12 $ — $ 12 Total liabilities $ — $ 12 $ — $ 12 December 31, 2020 Total (In millions) Level 1 Level 2 Level 3 Assets Fixed maturity securities: Corporate bonds and other $ 355 $ 24,109 $ 770 $ 25,234 States, municipalities and political subdivisions — 11,546 46 11,592 Asset-backed — 7,497 308 7,805 Total fixed maturity securities 355 43,152 1,124 44,631 Equity securities: Common stock 175 — 20 195 Non-redeemable preferred stock 68 722 7 797 Total equity securities 243 722 27 992 Short term and other 1,761 28 — 1,789 Total assets $ 2,359 $ 43,902 $ 1,151 $ 47,412 Liabilities Other liabilities $ — $ 19 $ — $ 19 Total liabilities $ — $ 19 $ — $ 19 |
Table of reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs | The tables below present a reconciliation for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3). Level 3 (In millions) Corporate bonds and other States, municipalities and political subdivisions Asset-backed Equity securities Total Balance as of January 1, 2021 $ 770 $ 46 $ 308 $ 27 $ 1,151 Total realized and unrealized investment gains (losses): Reported in Net investment gains (losses) (10) — — (2) (12) Reported in Net investment income — — 7 2 9 Reported in Other comprehensive income (loss) (32) (1) (10) — (43) Total realized and unrealized investment gains (losses) (42) (1) (3) — (46) Purchases 312 12 287 1 612 Sales (3) — (9) (20) (32) Settlements (68) (1) (61) — (130) Transfers into Level 3 20 — 109 21 150 Transfers out of Level 3 (52) — (75) — (127) Balance as of December 31, 2021 $ 937 $ 56 $ 556 $ 29 $ 1,578 Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2021 recognized in Net income (loss) in the period $ — $ — $ — $ (2) $ (2) Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2021 recognized in Other comprehensive income (loss) in the period (32) (1) (11) — (44) Level 3 (In millions) Corporate bonds and other States, municipalities and political subdivisions Asset-backed Equity securities Total Balance as of January 1, 2020 $ 468 $ — $ 165 $ 18 $ 651 Total realized and unrealized investment gains (losses): Reported in Net investment gains (losses) 1 — (1) (4) (4) Reported in Net investment income — — 2 (2) — Reported in Other comprehensive income (loss) 43 1 16 — 60 Total realized and unrealized investment gains (losses) 44 1 17 (6) 56 Purchases 264 45 154 15 478 Sales (3) — (9) — (12) Settlements (13) — (32) — (45) Transfers into Level 3 10 — 30 — 40 Transfers out of Level 3 — — (17) — (17) Balance as of December 31, 2020 $ 770 $ 46 $ 308 $ 27 $ 1,151 Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2020 recognized in Net income (loss) in the period $ — $ — $ — $ (6) $ (6) Unrealized gains (losses) on Level 3 assets and liabilities held as of December 31, 2020 recognized in Other comprehensive income (loss) in the period 43 1 18 — 62 |
Quantitative information about significant unobservable inputs in the fair value measurement of level 3 assets | The following tables present quantitative information about the significant unobservable inputs utilized by the Company in the fair value measurements of Level 3 assets. Valuations for assets and liabilities not presented in the tables below are primarily based on broker/dealer quotes for which there is a lack of transparency as to inputs used to develop the valuations. The quantitative detail of these unobservable inputs is neither provided nor reasonably available to the Company. The weighted average rate is calculated based on fair value. December 31, 2021 Estimated Fair Value Valuation Technique(s) Unobservable Input(s) Range Fixed maturity securities $ 1,225 Discounted cash flow Credit spread 1% - 7% (2%) December 31, 2020 Estimated Fair Value Valuation Technique(s) Unobservable Input(s) Range Fixed maturity securities $ 966 Discounted cash flow Credit spread 1% - 8% (3%) |
Carrying amount and estimated fair value of financial instrument assets and liabilities not measured at fair value | The carrying amount and estimated fair value of the Company's financial assets and liabilities which are not measured at fair value on the Consolidated Balance Sheets are presented in the following tables. December 31, 2021 Carrying Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 973 $ — $ — $ 1,018 $ 1,018 Liabilities Long term debt $ 2,779 $ — $ 2,978 $ — $ 2,978 December 31, 2020 Carrying Estimated Fair Value (In millions) Level 1 Level 2 Level 3 Total Assets Mortgage loans $ 1,068 $ — $ — $ 1,151 $ 1,151 Liabilities Long term debt $ 2,776 $ — $ 3,148 $ — $ 3,148 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Reconciliation between the Company's federal income tax (expense) benefit at statutory rates and the recorded income tax (expense) benefit | The following table presents a reconciliation between the Company's income tax expense at statutory rates and the recorded income tax expense. Years ended December 31 (In millions) 2021 2020 2019 Income tax expense at statutory rates $ (312) $ (172) $ (257) Tax benefit from tax exempt income 51 52 53 Foreign taxes and credits (3) 2 (1) State income tax expense (13) (6) (14) Other tax expense (5) (7) (4) Income tax expense $ (282) $ (131) $ (223) |
Current and deferred components of the Company's income tax (expense) benefit | The following table presents the current and deferred components of the Company's income tax expense. Years ended December 31 (In millions) 2021 2020 2019 Current tax expense $ (235) $ (180) $ (269) Deferred tax (expense) benefit (47) 49 46 Total income tax expense $ (282) $ (131) $ (223) |
Significant components of the Company's deferred tax assets and liabilities | The deferred tax effects of the significant components of the Company's deferred tax assets and liabilities are presented in the following table. December 31 (In millions) 2021 2020 Deferred Tax Assets: Insurance reserves: Property and casualty claim and claim adjustment expense reserves $ 173 $ 157 Unearned premium reserves 193 174 Deferred Revenue 64 62 Employee benefits 46 122 Deferred retroactive reinsurance benefit 90 83 Other assets 88 92 Gross deferred tax assets 654 690 Deferred Tax Liabilities: Investment valuation differences 93 28 Deferred acquisition costs 99 93 Net unrealized gains 272 453 Software and hardware 27 31 Other liabilities 21 19 Gross deferred tax liabilities 512 624 Net deferred tax asset $ 142 $ 66 |
Claim, Claim Adjustment Expen_2
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration insurance contracts, reconciliation of claims development to liability | The table below reconciles the net liability for unpaid claim and claim adjustment expenses to the amount presented on the Consolidated Balance Sheets. As of December 31 (In millions) 2021 Net liability for unpaid claim and claim adjustment expenses: Specialty $ 5,265 Commercial 8,065 International 1,940 Life & Group (1) 3,641 Corporate & Other 294 Total net claim and claim adjustment expenses 19,205 Reinsurance receivables: (2) Specialty 1,168 Commercial 825 International 340 Life & Group 113 Corporate & Other (3) 2,523 Total reinsurance receivables 4,969 Total gross liability for unpaid claim and claim adjustment expenses $ 24,174 (1) The Life & Group segment amounts are primarily related to long term care claim reserves, but also include amounts related to unfunded structured settlements arising from short-duration contracts. Long term care policies are long-duration contracts. (2) Reinsurance receivables presented are gross of the allowance for uncollectible reinsurance and do not include reinsurance receivables related to paid losses. (3) The Corporate & Other Reinsurance receivables are primarily related to A&EP claims covered under the Loss Portfolio Transfer (LPT). |
Schedule of liability for unpaid claims and claims adjustment expense | The following table presents a reconciliation between beginning and ending claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves of the Life & Group segment. As of or for the years ended December 31 (In millions) 2021 2020 2019 Reserves, beginning of year: Gross $ 22,706 $ 21,720 $ 21,984 Ceded 4,005 3,835 4,019 Net reserves, beginning of year 18,701 17,885 17,965 Reduction of net reserves due to Excess Workers' Compensation Loss Portfolio Transfer (632) — — Net incurred claim and claim adjustment expenses: Provision for insured events of current year 5,970 5,793 5,356 Increase (decrease) in provision for insured events of prior years (104) (119) (127) Amortization of discount 174 183 184 Total net incurred (1) 6,040 5,857 5,413 Net payments attributable to: Current year events (1,014) (948) (992) Prior year events (3,830) (4,216) (4,584) Total net payments (4,844) (5,164) (5,576) Foreign currency translation adjustment and other (60) 123 83 Net reserves, end of year 19,205 18,701 17,885 Ceded reserves, end of year 4,969 4,005 3,835 Gross reserves, end of year $ 24,174 $ 22,706 $ 21,720 (1) Total net incurred above does not agree to Insurance claims and policyholders' benefits as reflected on the Consolidated Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting, the loss on the Excess Workers' Compensation LPT, uncollectible reinsurance and benefit expenses related to future policy benefits, which are not reflected in the table above. |
Gross and net carried claim and claim adjustment expense reserves | The following tables present the gross and net carried reserves. December 31, 2021 Specialty Commercial International Life & Group Corporate & Other Total (In millions) Gross Case Reserves $ 1,578 $ 3,184 $ 859 $ 3,383 $ 1,551 $ 10,555 Gross IBNR Reserves 4,855 5,706 1,421 371 1,266 13,619 Total Gross Carried Claim and Claim Adjustment Expense Reserves $ 6,433 $ 8,890 $ 2,280 $ 3,754 $ 2,817 $ 24,174 Net Case Reserves $ 1,338 $ 2,850 $ 744 $ 3,291 $ 146 $ 8,369 Net IBNR Reserves 3,927 5,215 1,196 350 148 10,836 Total Net Carried Claim and Claim Adjustment Expense Reserves $ 5,265 $ 8,065 $ 1,940 $ 3,641 $ 294 $ 19,205 December 31, 2020 Specialty Commercial International Life & Group Corporate & Other Total (In millions) Gross Case Reserves $ 1,567 $ 3,215 $ 892 $ 3,406 $ 1,614 $ 10,694 Gross IBNR Reserves 4,181 5,035 1,199 337 1,260 12,012 Total Gross Carried Claim and Claim Adjustment Expense Reserves $ 5,748 $ 8,250 $ 2,091 $ 3,743 $ 2,874 $ 22,706 Net Case Reserves $ 1,410 $ 2,885 $ 777 $ 3,298 $ 560 $ 8,930 Net IBNR Reserves 3,488 4,590 1,045 317 331 9,771 Total Net Carried Claim and Claim Adjustment Expense Reserves $ 4,898 $ 7,475 $ 1,822 $ 3,615 $ 891 $ 18,701 |
Net prior year development | The following table presents development recorded for the Specialty, Commercial, International and Corporate & Other segments. Years ended December 31 (In millions) 2021 2020 2019 Pretax (favorable) unfavorable development: Specialty $ (45) $ (61) $ (92) Commercial (6) (7) (40) International 2 (2) 21 Corporate & Other 60 50 38 Total pretax (favorable) unfavorable development $ 11 $ (20) $ (73) |
Impact of loss portfolio transfer on the consolidated statement of operations | The following table presents the impact of the Loss Portfolio Transfer on the Consolidated Statements of Operations. Years ended December 31 (In millions) 2021 2020 2019 Additional amounts ceded under LPT: Net A&EP adverse development before consideration of LPT $ 143 $ 125 $ 150 Provision for uncollectible third-party reinsurance on A&EP (5) (25) (25) Total additional amounts ceded under LPT 138 100 125 Retroactive reinsurance benefit recognized (107) (94) (107) Pretax impact of deferred retroactive reinsurance $ 31 $ 6 $ 18 |
Specialty | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration insurance contracts, reconciliation of claims development to liability | The table below provides the line of business composition of the net liability for unpaid claim and claim adjustment expenses for the Specialty segment. As of December 31 (In millions) 2021 Net liability for unpaid claim and claim adjustment expenses: Medical Professional Liability $ 1,556 Other Professional Liability and Management Liability 3,159 Surety 406 Warranty 44 Other 100 Total net liability for unpaid claim and claim adjustment expenses $ 5,265 |
Net prior year claim and allocated claim adjustment expense reserve development | The following table presents further detail of the development recorded for the Specialty segment. Years ended December 31 (In millions) 2021 2020 2019 Pretax (favorable) unfavorable development: Medical Professional Liability $ 23 $ 35 $ 75 Other Professional Liability and Management Liability 24 (15) (69) Surety (73) (69) (92) Warranty (14) (7) (15) Other (5) (5) 9 Total pretax (favorable) unfavorable development $ (45) $ (61) $ (92) |
Commercial | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration insurance contracts, reconciliation of claims development to liability | The table below provides the line of business composition of the net liability for unpaid claim and claim adjustment expenses for the Commercial segment. As of December 31 (In millions) 2021 Net Claim and claim adjustment expenses: Commercial Auto $ 673 General Liability 2,911 Workers' Compensation 3,850 Property and Other 631 Total net liability for claim and claim adjustment expenses $ 8,065 |
Net prior year claim and allocated claim adjustment expense reserve development | The following table presents further detail of the development recorded for the Commercial segment. Years ended December 31 (In millions) 2021 2020 2019 Pretax (favorable) unfavorable development: Commercial Auto $ 53 $ 33 $ (25) General Liability 15 15 16 Workers' Compensation (82) (96) (13) Property and Other 8 41 (18) Total pretax (favorable) unfavorable development $ (6) $ (7) $ (40) |
International | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration insurance contracts, reconciliation of claims development to liability | The table below provides the composition of the net liability for unpaid claim and claim adjustment expenses for the International segment. As of December 31 (In millions) 2021 Net Claim and claim adjustment expenses: International excluding Hardy $ 1,400 Hardy 540 Total net liability for claim and claim adjustment expenses $ 1,940 |
Net prior year claim and allocated claim adjustment expense reserve development | The following table presents further detail of the development recorded for the International segment. Years ended December 31 (In millions) 2021 2020 2019 Pretax (favorable) unfavorable development: Commercial $ (35) (2) $ (8) Specialty 36 3 37 Other 1 (3) (8) Total pretax (favorable) unfavorable development $ 2 $ (2) $ 21 (1) Effective December 31, 2021 the International lines of business were consolidated to align with domestic operations. Prior period information has been conformed to the new line of business presentation. |
CNAF Consolidated | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Schedule of historical claims duration | The table below presents information about average historical claims duration as of December 31, 2021 and is presented as required supplementary information, which is unaudited. Average Annual Percentage Payout of Ultimate Net Incurred Claim and Allocated Claim Adjustment Expenses in Year: 1 2 3 4 5 6 7 8 9 10 Specialty Medical Professional Liability 3.6 % 18.3 % 23.7 % 18.2 % 12.0 % 8.3 % 5.1 % 2.8 % 0.7 % 1.0 % Other Professional Liability and Management Liability 6.7 % 21.9 % 21.1 % 16.7 % 9.9 % 6.4 % 4.3 % 3.5 % 1.7 % 0.5 % Surety (1) 14.1 % 48.7 % 18.9 % 2.6 % 1.1 % 1.3 % — % 0.4 % (0.8) % — % Commercial Commercial Auto 26.7 % 23.2 % 18.0 % 13.6 % 10.1 % 3.2 % 1.5 % 0.4 % — % 0.3 % General Liability 4.1 % 14.1 % 18.0 % 19.0 % 13.5 % 8.7 % 5.6 % 4.1 % 2.2 % 0.8 % Workers' Compensation 14.7 % 21.7 % 13.9 % 9.5 % 6.4 % 2.7 % 1.1 % 1.5 % 0.4 % 0.5 % International International - Excluding Hardy 19.0 % 23.7 % 10.8 % 7.4 % 6.1 % 5.7 % 6.8 % 2.6 % 1.6 % 1.2 % International - Hardy (2) 20.4 % 36.1 % 13.4 % 6.9 % 4.4 % 3.9 % 1.0 % 0.6 % 0.7 % (1) Due to the nature of the Surety business, average annual percentage payout of ultimate net incurred claim and allocated claim adjustment expenses has been calculated using only the payouts of mature accident years presented in the loss reserve development tables. (2) Average historical claims duration for Hardy is presented prospectively beginning with the first full year subsequent to acquisition, 2013. |
Hardy | International | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) Net Claim and Allocated Claim Adjustment Expense Reserves at Acquisition Net Incurred Claim and Allocated Claim Adjustment Expenses in 2012 (1)(2) Total Acquired Net Claim and Allocated Claim Adjustment Expense Reserves and 2012 Incurreds 2013 (1)(2) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 34 $ 71 $ 105 $ 105 $ 112 $ 120 $ 113 $ 114 $ 116 $ 115 $ 113 $ 114 $ (3) 7,045 2013 132 147 139 140 142 145 146 146 144 7 7,893 2014 186 184 178 171 172 173 172 169 (6) 8,493 2015 191 181 179 180 178 180 181 (1) 9,669 2016 231 249 238 226 228 222 (1) 10,746 2017 246 256 244 246 253 8 13,029 2018 275 306 310 316 36 14,868 2019 224 228 223 42 10,891 2020 215 205 87 5,963 2021 181 128 2,244 Total $ 2,008 $ 297 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1)(2) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 14 $ 80 $ 100 $ 109 $ 107 $ 109 $ 110 $ 111 $ 112 $ 115 2013 38 102 122 128 132 135 139 140 141 2014 56 124 142 152 157 163 165 166 2015 30 99 130 146 158 166 164 2016 64 146 174 183 196 208 2017 53 152 185 207 215 2018 55 176 205 236 2019 44 104 142 2020 28 79 2021 13 Total $ 1,479 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 529 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 3 Liability for unallocated claim adjustment expenses for accident years presented 8 Total net liability for unpaid claim and claim adjustment expenses $ 540 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1)(2) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total (3) Accident Year 2012 $ — $ 7 $ 8 $ (7) $ 1 $ 2 $ (1) $ (2) $ 1 $ 9 2013 15 (8) 1 2 3 1 — (2) 12 2014 (2) (6) (7) 1 1 (1) (3) (17) 2015 (10) (2) 1 (2) 2 1 (10) 2016 18 (11) (12) 2 (6) (9) 2017 10 (12) 2 7 7 2018 31 4 6 41 2019 4 (5) (1) 2020 (10) (10) (1) Data presented for these calendar years is required supplemental information, which is unaudited. (2) Data presented for this calendar year is post-acquisition of Hardy. |
Medical Professional Liability | Specialty | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 464 $ 469 $ 508 $ 498 $ 493 $ 484 $ 493 $ 499 $ 497 $ 497 $ 4 17,755 2013 462 479 500 513 525 535 545 531 530 11 19,565 2014 450 489 537 530 535 529 527 524 8 19,800 2015 433 499 510 494 488 510 501 28 18,170 2016 427 487 485 499 508 510 24 16,085 2017 412 449 458 460 455 41 15,197 2018 404 429 431 448 60 14,997 2019 430 445 458 156 13,804 2020 477 476 347 9,935 2021 377 337 6,761 Total $ 4,776 $ 1,016 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 14 $ 117 $ 221 $ 323 $ 388 $ 427 $ 457 $ 479 $ 482 $ 487 2013 17 119 255 355 414 462 495 508 512 2014 23 136 258 359 417 472 489 497 2015 22 101 230 313 384 420 444 2016 18 121 246 339 401 436 2017 19 107 235 308 355 2018 21 115 211 290 2019 17 91 183 2020 11 61 2021 11 Total $ 3,276 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 1,500 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 28 Liability for unallocated claim adjustment expenses for accident years presented 28 Total net liability for unpaid claim and claim adjustment expenses $ 1,556 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 5 $ 39 $ (10) $ (5) $ (9) $ 9 $ 6 $ (2) $ — $ 33 2013 17 21 13 12 10 10 (14) (1) 68 2014 39 48 (7) 5 (6) (2) (3) 74 2015 66 11 (16) (6) 22 (9) 68 2016 60 (2) 14 9 2 83 2017 37 9 2 (5) 43 2018 25 2 17 44 2019 15 13 28 2020 (1) (1) Total net development for the accident years presented above 52 32 13 Total net development for accident years prior to 2012 21 3 3 Total unallocated claim adjustment expense development 2 — 7 Total $ 75 $ 35 $ 23 (1) Data presented for these calendar years is required supplemental information, which is unaudited. |
Other Professional Liability and Management Liability | Specialty | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 923 $ 909 $ 887 $ 878 $ 840 $ 846 $ 833 $ 831 $ 850 $ 848 $ 18 18,506 2013 884 894 926 885 866 863 850 846 833 30 17,950 2014 878 898 885 831 835 854 845 841 37 17,577 2015 888 892 877 832 807 813 836 41 17,436 2016 901 900 900 904 907 891 84 17,968 2017 847 845 813 791 775 152 18,159 2018 850 864 869 906 202 19,926 2019 837 845 856 283 19,357 2020 930 944 568 19,095 2021 1,037 911 15,487 Total $ 8,767 $ 2,326 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 56 $ 248 $ 400 $ 573 $ 651 $ 711 $ 755 $ 792 $ 812 $ 816 2013 54 249 447 618 702 754 771 779 787 2014 51 223 392 515 647 707 743 787 2015 60 234 404 542 612 677 725 2016 64 248 466 625 701 736 2017 57 222 394 498 557 2018 54 282 473 599 2019 64 263 422 2020 67 248 2021 58 Total $ 5,735 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 3,032 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 74 Liability for unallocated claim adjustment expenses for accident years presented 53 Total net liability for unpaid claim and claim adjustment expenses $ 3,159 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ (14) $ (22) $ (9) $ (38) $ 6 $ (13) $ (2) $ 19 $ (2) $ (75) 2013 10 32 (41) (19) (3) (13) (4) (13) (51) 2014 20 (13) (54) 4 19 (9) (4) (37) 2015 4 (15) (45) (25) 6 23 (52) 2016 (1) — 4 3 (16) (10) 2017 (2) (32) (22) (16) (72) 2018 14 5 37 56 2019 8 11 19 2020 14 14 Total net development for the accident years presented above (35) 6 34 Total net development for accident years prior to 2012 (20) (21) (12) Total unallocated claim adjustment expense development (14) — 2 Total $ (69) $ (15) $ 24 (1) Data presented for these calendar years is required supplemental information, which is unaudited. |
Surety | Specialty | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 120 $ 122 $ 98 $ 70 $ 52 $ 45 $ 39 $ 38 $ 37 $ 36 $ 1 5,586 2013 120 121 115 106 91 87 83 82 82 2 5,088 2014 123 124 94 69 60 45 45 43 1 5,118 2015 131 131 104 79 63 58 53 9 5,055 2016 124 124 109 84 67 64 10 5,521 2017 120 115 103 84 71 9 5,795 2018 114 108 91 62 19 6,097 2019 119 112 98 44 5,816 2020 128 119 104 4,006 2021 137 129 2,592 Total $ 765 $ 328 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 5 $ 32 $ 34 $ 35 $ 35 $ 36 $ 37 $ 37 $ 36 $ 36 2013 16 40 69 78 78 78 77 78 79 2014 7 30 38 36 38 38 39 39 2015 7 26 38 40 42 44 42 2016 5 37 45 45 43 43 2017 23 37 41 46 49 2018 5 25 34 39 2019 12 34 44 2020 4 20 2021 5 Total $ 396 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 369 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 17 Liability for unallocated claim adjustment expenses for accident years presented 20 Total net liability for unpaid claim and claim adjustment expenses $ 406 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 2 $ (24) $ (28) $ (18) $ (7) $ (6) $ (1) $ (1) $ (1) $ (84) 2013 1 (6) (9) (15) (4) (4) (1) — (38) 2014 1 (30) (25) (9) (15) — (2) (80) 2015 — (27) (25) (16) (5) (5) (78) 2016 — (15) (25) (17) (3) (60) 2017 (5) (12) (19) (13) (49) 2018 (6) (17) (29) (52) 2019 (7) (14) (21) 2020 (9) (9) Total net development for the accident years presented above (79) (67) (76) Total net development for accident years prior to 2012 (3) (2) 3 Total unallocated claim adjustment expense development (10) — — Total $ (92) $ (69) $ (73) (1) Data presented for these calendar years is required supplemental information, which is unaudited. |
Commercial Auto | Commercial | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 275 $ 289 $ 299 $ 303 $ 307 $ 299 $ 299 $ 297 $ 296 $ 295 $ 1 46,288 2013 246 265 265 249 245 245 241 241 241 2 39,430 2014 234 223 212 205 205 201 201 202 2 33,628 2015 201 199 190 190 183 181 183 3 30,427 2016 198 186 186 186 190 195 3 30,449 2017 199 198 200 221 232 5 30,940 2018 229 227 227 245 8 34,292 2019 257 266 289 31 37,142 2020 310 303 107 28,837 2021 397 271 27,182 Total $ 2,582 $ 433 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 78 $ 160 $ 220 $ 259 $ 282 $ 285 $ 290 $ 291 $ 291 $ 292 2013 74 135 168 200 225 234 238 239 239 2014 64 102 137 166 187 196 198 199 2015 52 96 130 153 172 175 178 2016 52 93 126 154 175 185 2017 58 107 150 178 203 2018 66 128 175 212 2019 77 147 203 2020 71 134 2021 83 Total $ 1,928 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 654 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 5 Liability for unallocated claim adjustment expenses for accident years presented 14 Total net liability for unpaid claim and claim adjustment expenses $ 673 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 14 $ 10 $ 4 $ 4 $ (8) $ — $ (2) $ (1) $ (1) $ 20 2013 19 — (16) (4) — (4) — — (5) 2014 (11) (11) (7) — (4) — 1 (32) 2015 (2) (9) — (7) (2) 2 (18) 2016 (12) — — 4 5 (3) 2017 (1) 2 21 11 33 2018 (2) — 18 16 2019 9 23 32 2020 (7) (7) Total net development for the accident years presented above (17) 31 52 Total net development for accident years prior to 2012 (7) 2 1 Total unallocated claim adjustment expense development (1) — — Total $ (25) $ 33 $ 53 (1) Data presented for these calendar years is required supplemental information, which is unaudited. |
General Liability | Commercial | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 587 $ 611 $ 639 $ 636 $ 619 $ 635 $ 635 $ 630 $ 632 $ 632 $ 20 35,313 2013 650 655 650 655 613 623 620 623 624 24 33,706 2014 653 658 654 631 635 658 659 659 28 28,064 2015 581 576 574 589 600 602 617 42 24,118 2016 623 659 667 671 673 683 68 24,511 2017 632 632 632 634 630 67 22,195 2018 653 644 646 639 205 19,917 2019 680 682 682 330 18,602 2020 723 722 516 13,028 2021 782 706 9,759 Total $ 6,670 $ 2,006 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 28 $ 132 $ 247 $ 374 $ 454 $ 510 $ 559 $ 579 $ 597 $ 602 2013 31 128 240 352 450 510 551 572 582 2014 31 119 247 376 481 547 569 607 2015 19 110 230 357 446 501 530 2016 32 163 279 407 481 524 2017 23 118 250 399 471 2018 33 107 228 307 2019 25 98 181 2020 23 99 2021 26 Total $ 3,929 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 2,741 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 119 Liability for unallocated claim adjustment expenses for accident years presented 51 Total net liability for unpaid claim and claim adjustment expenses $ 2,911 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 24 $ 28 $ (3) $ (17) $ 16 $ — $ (5) $ 2 $ — $ 45 2013 5 (5) 5 (42) 10 (3) 3 1 (26) 2014 5 (4) (23) 4 23 1 — 6 2015 (5) (2) 15 11 2 15 36 2016 36 8 4 2 10 60 2017 — — 2 (4) (2) 2018 (9) 2 (7) (14) 2019 2 — 2 2020 (1) (1) Total net development for the accident years presented above 21 16 14 Total net development for accident years prior to 2012 (4) (1) (1) Total unallocated claim adjustment expense development (1) — 2 Total $ 16 $ 15 $ 15 (1) Data presented for these calendar years is required supplemental information, which is unaudited. |
Workers' Compensation | Commercial | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 601 $ 627 $ 659 $ 669 $ 678 $ 673 $ 671 $ 668 $ 663 $ 664 $ 66 42,804 2013 537 572 592 618 593 582 561 552 548 91 38,867 2014 467 480 479 452 450 446 439 448 105 33,502 2015 422 431 406 408 394 382 372 101 31,894 2016 426 405 396 382 366 355 104 31,981 2017 440 432 421 400 402 92 33,121 2018 450 440 428 415 104 34,851 2019 452 449 437 134 34,248 2020 477 466 228 29,188 2021 468 300 25,711 Total $ 4,575 $ 1,325 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 87 $ 232 $ 342 $ 416 $ 470 $ 509 $ 524 $ 536 $ 538 $ 541 2013 80 213 300 370 417 419 411 414 417 2014 61 159 215 258 282 290 297 306 2015 51 131 180 212 231 243 251 2016 53 129 169 198 219 227 2017 63 151 207 243 265 2018 68 163 229 259 2019 71 169 223 2020 65 147 2021 67 Total $ 2,703 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 1,872 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 1,941 Other (2) (14) Liability for unallocated claim adjustment expenses for accident years presented 51 Total net liability for unpaid claim and claim adjustment expenses $ 3,850 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total Accident Year 2012 $ 26 $ 32 $ 10 $ 9 $ (5) $ (2) $ (3) $ (5) $ 1 $ 63 2013 35 20 26 (25) (11) (21) (9) (4) 11 2014 13 (1) (27) (2) (4) (7) 9 (19) 2015 9 (25) 2 (14) (12) (10) (50) 2016 (21) (9) (14) (16) (11) (71) 2017 (8) (11) (21) 2 (38) 2018 (10) (12) (13) (35) 2019 (3) (12) (15) 2020 (11) (11) Total net development for the accident years presented above (77) (85) (49) Adjustment for development on a discounted basis 3 2 2 Total net development for accident years prior to 2012 38 (13) (35) Total unallocated claim adjustment expense development 23 — — Total $ (13) $ (96) $ (82) (1) Data presented for these calendar years is required supplemental information, which is unaudited. (2) Other includes the effect of discounting lifetime claim reserves. |
Excluding Hardy | International | |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | |
Short-duration contracts net incurred claims and allocated claim adjustment expenses | Cumulative Net Incurred Claim and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year As of December 31, 2021 (In millions, except reported claims data) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 IBNR Cumulative Number of Claims Accident Year 2012 $ 278 $ 285 $ 269 $ 262 $ 261 $ 254 $ 247 $ 241 $ 236 $ 250 $ 16 24,998 2013 285 301 293 273 269 260 251 247 251 12 23,967 2014 288 303 303 291 283 300 301 294 16 24,946 2015 301 317 316 298 292 294 297 27 23,357 2016 296 315 300 297 287 302 37 17,776 2017 312 378 401 393 388 84 18,470 2018 384 402 407 406 81 20,726 2019 357 371 368 91 17,974 2020 398 389 184 13,909 2021 426 297 10,401 Total $ 3,371 $ 845 |
Short-duration contracts net cumulative paid claim adjustment expenses reconciliation of total liability for unpaid claim and claim adjustment expense | Cumulative Net Paid Claims and Allocated Claim Adjustment Expenses are presented in the following table. As of December 31 Calendar Year (In millions) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Accident Year 2012 $ 46 $ 117 $ 151 $ 172 $ 188 $ 200 $ 210 $ 213 $ 215 $ 218 2013 51 116 144 161 176 186 206 218 224 2014 54 126 154 173 190 211 245 250 2015 58 137 168 189 213 228 239 2016 68 136 164 188 200 223 2017 67 152 193 223 247 2018 94 173 221 252 2019 76 171 209 2020 62 133 2021 58 Total $ 2,053 Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented $ 1,318 Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 47 Liability for unallocated claim adjustment expenses for accident years presented 35 Total net liability for unpaid claim and claim adjustment expenses $ 1,400 |
Short-duration contracts reserve development | Net strengthening (releases) of prior accident year reserves is presented in the following table. For the years ended December 31 Calendar Year (In millions) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 Total (2) Accident Year 2012 $ 7 $ (16) $ (7) $ (1) $ (7) $ (7) $ (6) $ (5) $ 14 $ (28) 2013 16 (8) (20) (4) (9) (9) (4) 4 (34) 2014 15 — (12) (8) 17 1 (7) 6 2015 16 (1) (18) (6) 2 3 (4) 2016 19 (15) (3) (10) 15 6 2017 66 23 (8) (5) 76 2018 18 5 (1) 22 2019 14 (3) 11 2020 (9) (9) (1) Data presented for these calendar years is required supplemental information, which is unaudited. |
Reinsurance (Tables)
Reinsurance (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Reinsurance Disclosures [Abstract] | |
Components of Reinsurance Receivables | The following table presents the amounts receivable from reinsurers. December 31 (In millions) 2021 2020 Reinsurance receivables related to insurance reserves: Ceded claim and claim adjustment expenses $ 4,969 $ 4,005 Ceded future policy benefits 288 263 Reinsurance receivables related to paid losses 227 210 Reinsurance receivables 5,484 4,478 Allowance for uncollectible reinsurance (21) (21) Reinsurance receivables, net of allowance for uncollectible reinsurance $ 5,463 $ 4,457 |
Reinsurance Recoverable, Credit Quality Indicator | The following table summarizes the outstanding amount of voluntary reinsurance receivables, gross of any collateral arrangements, by financial strength rating. (In millions) December 31, 2021 A- to A++ 3,812 B- to B++ 987 Insolvent 3 Total voluntary reinsurance outstanding balance (1) $ 4,802 (1) Expected credit losses for legacy A&EP receivables are ceded to NICO and the reinsurance limit on the LPT has not been exhausted, therefore no allowance is recorded for these receivables and they are excluded from the table above. Refer to Note E to the Consolidated Financial Statements for information regarding the LPT. The Company has also excluded receivables from involuntary pools. |
Components of Earned and Written Premiums | The effects of reinsurance on earned premiums and written premiums are presented in the following tables. (In millions) Direct Assumed Ceded Net Assumed/ 2021 Earned Premiums Property and casualty $ 12,554 $ 240 $ 5,110 $ 7,684 3.1 % Long term care 443 48 — 491 9.8 % Total earned premiums $ 12,997 $ 288 $ 5,110 $ 8,175 3.5 % 2020 Earned Premiums Property and casualty $ 11,547 $ 238 $ 4,640 $ 7,145 3.3 % Long term care 454 50 — 504 9.9 % Total earned premiums $ 12,001 $ 288 $ 4,640 $ 7,649 3.8 % 2019 Earned Premiums Property and casualty $ 11,021 $ 288 $ 4,401 $ 6,908 4.2 % Long term care 470 50 — 520 9.6 % Total earned premiums $ 11,491 $ 338 $ 4,401 $ 7,428 4.6 % (In millions) Direct Assumed Ceded Net Assumed/ 2021 Written Premiums Property and casualty $ 13,150 $ 255 $ 5,485 $ 7,920 3.2 % Long term care 437 48 — 485 9.9 % Total written premiums $ 13,587 $ 303 $ 5,485 $ 8,405 3.6 % 2020 Written Premiums Property and casualty $ 12,168 $ 229 $ 4,832 $ 7,565 3.0 % Long term care 444 50 — 494 10.1 % Total written premiums $ 12,612 $ 279 $ 4,832 $ 8,059 3.5 % 2019 Written Premiums Property and casualty $ 11,421 $ 281 $ 4,569 $ 7,133 3.9 % Long term care 473 50 — 523 9.6 % Total written premiums $ 11,894 $ 331 $ 4,569 $ 7,656 4.3 % |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of debt instruments | Debt is composed of the following long term obligations. December 31 (In millions) 2021 2020 Senior notes of CNAF: 3.950%, face amount of $550, due May 15, 2024 549 548 4.500%, face amount of $500, due March 1, 2026 499 499 3.450%, face amount of $500, due August 15, 2027 497 496 3.900%, face amount of $500, due May 1, 2029 496 496 2.050%, face amount of $500, due August 15, 2030 495 495 Debenture of CNAF, 7.250%, face amount of $243, due November 15, 2023 243 242 Total $ 2,779 $ 2,776 |
Maturity of debt | The combined aggregate maturities for debt as of December 31, 2021 are presented in the following table. (In millions) 2022 $ — 2023 243 2024 550 2025 — 2026 500 Thereafter 1,500 Less: discount (14) Total $ 2,779 |
Benefit Plans (Tables)
Benefit Plans (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Retirement Benefits [Abstract] | |
Funded status | The following table presents a reconciliation of benefit obligations and plan assets. Pension Benefits Postretirement Benefits (In millions) 2021 2020 2021 2020 Benefit obligation as of January 1 $ 2,769 $ 2,661 $ 7 $ 8 Changes in benefit obligation: Interest cost 62 80 — — Participants' contributions — — 3 2 Actuarial (gain) loss (84) 205 1 2 Benefits paid (182) (173) (5) (5) Foreign currency translation and other (2) 3 — — Settlements (2) (7) — — Benefit obligation as of December 31 2,561 2,769 6 7 Fair value of plan assets as of January 1 2,420 2,285 — — Change in plan assets: Actual return on plan assets 332 295 — — Company contributions 10 16 2 3 Participants' contributions — — 3 2 Benefits paid (182) (173) (5) (5) Foreign currency translation and other (1) 4 — — Settlements (2) (7) — — Fair value of plan assets as of December 31 2,577 2,420 — — Funded status $ 16 $ (349) $ (6) $ (7) Amounts recognized on the Consolidated Balance Sheets as of December 31: Other assets $ 77 $ 2 $ — $ — Other liabilities (61) (351) (6) (7) Net amount recognized $ 16 $ (349) $ (6) $ (7) Amounts recognized in Accumulated other comprehensive income, not yet recognized in net periodic cost (benefit): Net actuarial (gain) loss $ 763 $ 1,073 $ 1 $ — Net amount recognized $ 763 $ 1,073 $ 1 $ — |
Components of net periodic cost (benefit) | The components of net periodic pension cost (benefit) are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Net periodic pension cost (benefit) Interest cost on projected benefit obligation $ 62 $ 80 $ 100 Expected return on plan assets (154) (155) (142) Amortization of net actuarial (gain) loss 46 45 39 Settlement loss 1 3 — Total net periodic pension cost (benefit) $ (45) $ (27) $ (3) The following table indicates the line items in which the non-service cost (benefit) is presented in the Consolidated Statements of Operations. Years ended December 31 (In millions) 2021 2020 2019 Non-Service Cost (benefit): Insurance claims and policyholder's benefits $ (13) $ (8) $ (1) Other operating expenses (32) (19) (2) Total net periodic pension cost (benefit) $ (45) $ (27) $ (3) |
Schedule of amounts recognized in Other comprehensive income | The amounts recognized in Other comprehensive income are presented in the following table. Years ended December 31 (In millions) 2021 2020 2019 Pension and postretirement benefits Amounts arising during the period $ 262 $ (67) $ (112) Settlement 1 3 — Reclassification adjustment relating to prior service credit — — — Reclassification adjustment relating to actuarial loss 46 45 39 Total increase (decrease) in Other comprehensive income $ 309 $ (19) $ (73) |
Actuarial assumptions for benefit obligations and for net cost or benefit | Actuarial assumptions used for the CNA Retirement Plan and CNA Health and Group Benefits Program to determine benefit obligations are presented in the following table. The interest crediting rate is the weighted average interest rate applied to the individual pension balances for employees who elected to cease accruals effective December 31, 1999. December 31 2021 2020 Pension benefits Discount rate 2.750 % 2.350 % Interest crediting rate 3.000 3.000 Postretirement benefits Discount rate 2.250 % 1.600 % Actuarial assumptions used for the CNA Retirement Plan and CNA Health and Group Benefits Program to determine net cost or benefit are presented in the following table. Years ended December 31 2021 2020 2019 Pension benefits Discount rate 2.350 % 3.150 % 4.250 % Expected long term rate of return 6.750 7.250 7.500 Interest crediting rate 3.000 5.000 5.000 Postretirement benefits Discount rate 1.600 % 2.300 % 3.550 % |
Fair value of plan assets measured on a recurring basis | Pension plan assets measured at fair value on a recurring basis as well as cash are presented in the following tables. December 31, 2021 (In millions) Level 1 Level 2 Level 3 Total Assets Fixed maturity securities: Corporate bonds and other $ — $ 645 $ 8 $ 653 States, municipalities and political subdivisions — 30 — 30 Asset-backed — 110 — 110 Total fixed maturity securities — 785 8 793 Equity securities 732 141 — 873 Short term investments 45 — — 45 Other assets — 8 — 8 Cash — — — — Total assets measured at fair value $ 777 $ 934 $ 8 1,719 Total equity securities measured at net asset value (1) 20 Total limited partnerships measured at net asset value (1) 838 Total $ 2,577 December 31, 2020 (In millions) Level 1 Level 2 Level 3 Total Assets Fixed maturity securities: Corporate bonds and other $ — $ 643 $ 9 $ 652 States, municipalities and political subdivisions — 32 — 32 Asset-backed — 98 — 98 Total fixed maturity securities — 773 9 782 Equity securities 666 137 — 803 Short term investments 20 38 — 58 Other assets — 8 — 8 Cash 13 — — 13 Total assets measured at fair value $ 699 $ 956 $ 9 1,664 Total limited partnerships measured at net asset value (1) 756 Total $ 2,420 (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table for these investments are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Plan's Statement of Financial Position. |
Schedule of expected benefit payments | The table below presents the estimated future minimum benefit payments to participants as of December 31, 2021. (In millions) Pension Benefits Postretirement Benefits 2022 $ 182 $ 1 2023 179 1 2024 177 1 2025 175 — 2026 173 — 2027-2031 798 1 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Restricted shares, performance-based restricted share units and performance share unit activity | The following table presents activity for non-vested RSUs and performance share units under the Plan in 2021. Number of Awards Weighted Average Grant Date Fair Value Balance as of January 1, 2021 2,439,141 $ 40.56 Awards granted 1,044,772 45.82 Awards vested (789,495) 46.13 Awards forfeited, canceled or expired (355,881) 40.19 Performance-based adjustment 37,061 43.70 Balance as of December 31, 2021 2,375,598 41.21 |
Other Intangible Assets (Tables
Other Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Intangible Assets, Gross (Excluding Goodwill) [Abstract] | |
Schedule of Other Intangible Assets | Other intangible assets are presented in the following table. December 31 2021 2020 (In millions) Economic Useful Life Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Finite-lived intangible assets: Trade name 8 years $ 7 7 $ 7 $ 7 Distribution channel 15 years 11 7 11 6 Total finite-lived intangible assets 18 14 18 13 Indefinite-lived intangible assets: Syndicate capacity 47 48 Agency force 16 16 Total indefinite-lived intangible assets 63 64 Total other intangible assets $ 81 $ 14 $ 82 $ 13 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Leases [Abstract] | |
Assets and liabilities | The following table presents operating lease ROU assets and lease liabilities. (In millions) December 31, 2021 December 31, 2020 Operating lease ROU assets $ 175 $ 199 Operating lease liabilities 248 279 |
Operating lease, liability, maturity | The following table presents the maturities of operating lease liabilities (In millions) December 31, 2021 2022 $ 42 2023 37 2024 30 2025 25 2026 22 Thereafter 141 Total lease payments 297 Less: Discount (49) Total operating lease liabilities $ 248 |
Lease cost | The following table presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease ROU assets. December 31, 2021 December 31, 2020 Weighted average remaining lease term 9.8 years 10.3 years Weighted average discount rate 3.4 % 3.4 % |
Stockholders' Equity and Stat_2
Stockholders' Equity and Statutory Accounting Practices (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Stockholders' Equity and Statutory Accounting Practices [Abstract] | |
Combined statutory capital and surplus and net income (loss) | Combined statutory capital and surplus and statutory net income (loss) for the Combined Continental Casualty Companies are presented in the table below, determined in accordance with accounting practices prescribed or permitted by insurance and/or other regulatory authorities Statutory Capital and Surplus Statutory Net Income (Loss) December 31 Years ended December 31 (In millions) 2021 (1) 2020 2021 (1) 2020 2019 Combined Continental Casualty Companies $ 11,321 $ 10,708 $ 1,253 $ 800 $ 1,062 (1) Information derived from the statutory-basis financial statements to be filed with insurance regulators. |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) by Component (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated Other Comprehensive Income (Loss) by Component | The tables below display the changes in Accumulated other comprehensive income (loss) by component. (In millions) Net unrealized gains (losses) on investments with an allowance for credit losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2021 $ — $ 1,745 $ (848) $ (94) $ 803 Other comprehensive income (loss) before reclassifications (7) (625) 207 (19) (444) Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $1, $(21), $10, $— and $(10) (5) 81 (37) — 39 Other comprehensive income (loss) net of tax (expense) benefit of $1, $188, $(65), $— and $124 (2) (706) 244 (19) (483) Balance as of December 31, 2021 $ (2) $ 1,039 $ (604) $ (113) $ 320 (In millions) Net unrealized gains (losses) on investments with an allowance for credit losses Net unrealized gains (losses) on other investments Pension and postretirement benefits Cumulative foreign currency translation adjustment Total Balance as of January 1, 2020 $ — $ 1,025 $ (833) $ (141) $ 51 Other comprehensive income (loss) before reclassifications (43) 763 (53) 47 714 Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $12, $(12), $10, $— and $10 (43) 43 (38) — (38) Other comprehensive income (loss) net of tax (expense) benefit of $—, $(189), $4, $— and $(185) — 720 (15) 47 752 Balance as of December 31, 2020 $ — $ 1,745 $ (848) $ (94) $ 803 |
Reclassification out of Accumulated Other Comprehensive Income | Amounts reclassified from Accumulated other comprehensive income (loss) shown above are reported in Net income (loss) as follows: Component of AOCI Consolidated Statements of Operations Line Item Affected by Reclassifications Net unrealized gains (losses) on investments with an allowance for credit losses, Net unrealized gains (losses) on investments with OTTI losses and Net unrealized gains (losses) on other investments Net investment gains (losses) Pension and postretirement benefits Other operating expenses and Insurance claims and policyholders' benefits |
Business Segments (Tables)
Business Segments (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Significant components of the Company's continuing operations and selected balance sheet items | The Company's results of operations and selected balance sheet items by segment are presented in the following tables. Year ended December 31, 2021 Specialty Commercial International Life & Corporate (In millions) Eliminations Total Net written premiums $ 3,225 $ 3,595 $ 1,101 $ 485 $ — $ (1) $ 8,405 Operating revenues Net earned premiums $ 3,076 $ 3,552 $ 1,057 $ 491 $ — $ (1) $ 8,175 Net investment income 497 624 57 966 15 — 2,159 Non-insurance warranty revenue 1,430 — — — — — 1,430 Other revenues 1 23 — — 6 (6) 24 Total operating revenues 5,004 4,199 1,114 1,457 21 (7) 11,788 Claims, benefits and expenses Net incurred claims and benefits 1,787 2,540 652 1,239 109 — 6,327 Policyholders’ dividends 3 19 — — — — 22 Amortization of deferred acquisition costs 643 594 206 — — — 1,443 Non-insurance warranty expense 1,328 — — — — — 1,328 Other insurance related expenses 296 511 144 103 9 (1) 1,062 Other expenses 47 38 (2) 10 155 (6) 242 Total claims, benefits and expenses 4,104 3,702 1,000 1,352 273 (7) 10,424 Core income (loss) before income tax 900 497 114 105 (252) — 1,364 Income tax (expense) benefit on core income (loss) (196) (103) (28) 21 48 — (258) Core income (loss) $ 704 $ 394 $ 86 $ 126 $ (204) $ — 1,106 Net investment gains (losses) 120 Income tax (expense) benefit on net investment gains (losses) (24) Net investment gains (losses), after tax 96 Net income (loss) $ 1,202 December 31, 2021 (In millions) Reinsurance receivables $ 1,200 $ 923 $ 381 $ 401 $ 2,579 $ — $ 5,484 Insurance receivables 1,136 1,488 340 6 4 — 2,974 Deferred acquisition costs 363 278 96 — — — 737 Goodwill 117 — 31 — — — 148 Deferred non-insurance warranty acquisition expense 3,476 — — — — — 3,476 Insurance reserves Claim and claim adjustment expenses 6,433 8,890 2,280 3,754 2,817 — 24,174 Unearned premiums 3,001 2,066 585 109 — — 5,761 Future policy benefits — — — 13,236 — — 13,236 Deferred non-insurance warranty revenue 4,503 — — — — — 4,503 Year ended December 31, 2020 Specialty Commercial International Life & Corporate (In millions) Eliminations Total Net written premiums $ 3,040 $ 3,565 $ 961 $ 494 $ — $ (1) $ 8,059 Operating revenues Net earned premiums $ 2,883 $ 3,323 $ 940 $ 504 $ — $ (1) $ 7,649 Net investment income 449 513 58 851 64 — 1,935 Non-insurance warranty revenue 1,252 — — — — — 1,252 Other revenues 1 25 — — 5 (5) 26 Total operating revenues 4,585 3,861 998 1,355 69 (6) 10,862 Claims, benefits and expenses Net incurred claims and benefits 1,792 2,375 629 1,286 67 — 6,149 Policyholders’ dividends 3 18 — — — — 21 Amortization of deferred acquisition costs 621 592 197 — — — 1,410 Non-insurance warranty expense 1,159 — — — — — 1,159 Other insurance related expenses 280 506 136 109 (2) (1) 1,028 Other expenses 50 34 (7) 7 141 (5) 220 Total claims, benefits and expenses 3,905 3,525 955 1,402 206 (6) 9,987 Core income (loss) before income tax 680 336 43 (47) (137) — 875 Income tax (expense) benefit on core income (loss) (145) (69) (5) 56 23 — (140) Core income (loss) $ 535 $ 267 $ 38 $ 9 $ (114) $ — 735 Net investment gains (losses) (54) Income tax (expense) benefit on net investment gains (losses) 9 Net investment gains (losses), after tax (45) Net income (loss) $ 690 December 31, 2020 (In millions) Reinsurance receivables $ 886 $ 848 $ 302 $ 390 $ 2,052 $ — $ 4,478 Insurance receivables 1,052 1,254 328 4 2 — 2,640 Deferred acquisition costs 330 281 97 — — — 708 Goodwill 117 — 31 — — — 148 Deferred non-insurance warranty acquisition expense 3,068 — — — — — 3,068 Insurance reserves Claim and claim adjustment expenses 5,748 8,250 2,091 3,743 2,874 — 22,706 Unearned premiums 2,635 1,824 546 114 — — 5,119 Future policy benefits — — — 13,318 — — 13,318 Deferred non-insurance warranty revenue 4,023 — — — — — 4,023 Year ended December 31, 2019 Specialty Commercial Life & Corporate (In millions) International Eliminations Total Net written premiums $ 2,848 $ 3,315 $ 971 $ 523 $ 1 $ (2) $ 7,656 Operating revenues Net earned premiums $ 2,773 $ 3,162 $ 974 $ 520 $ 1 $ (2) $ 7,428 Net investment income 556 605 63 820 74 — 2,118 Non-insurance warranty revenue 1,161 — — — — — 1,161 Other revenues 1 29 — — 6 (5) 31 Total operating revenues 4,491 3,796 1,037 1,340 81 (7) 10,738 Claims, benefits and expenses Net incurred claims and benefits 1,595 2,086 624 1,416 62 — 5,783 Policyholders’ dividends 5 18 — — — — 23 Amortization of deferred acquisition costs 610 537 236 — — — 1,383 Non-insurance warranty expense 1,082 — — — — — 1,082 Other insurance related expenses 292 505 130 115 (2) (2) 1,038 Other expenses 48 32 8 8 144 (5) 235 Total claims, benefits and expenses 3,632 3,178 998 1,539 204 (7) 9,544 Core income (loss) before income tax 859 618 39 (199) (123) — 1,194 Income tax (expense) benefit on core income (loss) (188) (138) (9) 90 30 — (215) Core income (loss) $ 671 $ 480 $ 30 $ (109) $ (93) $ — 979 Net investment gains (losses) 29 Income tax (expense) benefit on net investment gains (losses) (8) Net investment gains (losses), after tax 21 Net income (loss) $ 1,000 |
Revenues by line of business | The following table presents operating revenues by line of business for each reportable segment. Years ended December 31 (In millions) 2021 2020 2019 Specialty Management & Professional Liability $ 2,776 $ 2,577 $ 2,572 Surety 604 596 596 Warranty & Alternative Risks 1,624 1,412 1,323 Specialty revenues 5,004 4,585 4,491 Commercial Middle Market 1,508 1,444 1,439 Construction 1,322 1,120 1,043 Small Business 558 482 504 Other Commercial 811 815 810 Commercial revenues 4,199 3,861 3,796 International Canada 344 291 277 Europe 473 389 363 Hardy 297 318 397 International revenues 1,114 998 1,037 Life & Group revenues 1,457 1,355 1,340 Corporate & Other revenues 21 69 81 Eliminations (7) (6) (7) Total operating revenues 11,788 10,862 10,738 Net investment gains (losses) 120 (54) 29 Total revenues $ 11,908 $ 10,808 $ 10,767 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
Sep. 30, 2021 | Sep. 30, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Jan. 01, 2020 | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Retained earnings | $ 9,663 | $ 9,081 | ||||
Mortgage loans on real estate commercial and consumer allowance for credit loss | 16 | 26 | ||||
Deferred income taxes | 142 | 66 | ||||
Marketable securities fixed maturities allowance for credit loss | 18 | 40 | ||||
Anticipated amounts due from insureds related to losses under deductible policies | $ 1,100 | $ 1,200 | ||||
Structured settlement annuities, interest rate, low end | 6.40% | |||||
Structured settlement annuities, interest rate, high end | 6.50% | |||||
Discounted reserves for unfunded structured settlements | $ 503 | $ 520 | ||||
Discounted reserves for unfunded structure settlements, discount amount | 621 | 657 | ||||
Amount of interest recognized on the discounted reserves of unfunded structured settlements | $ 36 | $ 35 | $ 36 | |||
Interest rates at which workers' compensation lifetime claim reserves are discounted at | 3.50% | 3.50% | ||||
Workers' compensation liability | $ 228 | $ 258 | ||||
Discounted reserves for workers’ compensation lifetime claim reserves, discount amount | 97 | 113 | ||||
Amount of interest accretion recognized on the discounted reserves of workers’ compensation lifetime claim reserves | $ 12 | $ 15 | $ 21 | |||
Long term care claim reserves weighted average discounted interest rate | 5.80% | 5.80% | ||||
Discounted reserves for long term care claim reserves | $ 2,700 | $ 2,700 | ||||
Premium deficiency | $ 428 | $ 439 | ||||
Liability for future policy benefits, gross premium valuation, pretax margin | $ 72 | $ 72 | ||||
Minimum interest rate used to calculate reserves for long term care products | 5.30% | 5.40% | ||||
Liability balance for guaranty fund | $ 79 | $ 82 | ||||
Percentage of billed receivables compared to total reinsurance receivable | 5.00% | |||||
Policyholder dividends, rate on policy earnings | 1.00% | 1.00% | 1.00% | |||
Increase (decrease) in shadow adjustment, net of tax | $ (296) | $ 575 | ||||
Reduction of net unrealized gains on investments included in AOCI due to shadow adjustments | 2,477 | 2,773 | ||||
Foreign currency transaction gain (loss), before tax | $ (1) | $ 13 | $ 1 | |||
Operating lease, right-of-use asset, statement of financial position [Extensible List] | Other assets | Other assets | ||||
Operating lease, liability, statement of financial position [Extensible List] | Other liabilities | Other liabilities | ||||
Weighted average number diluted shares outstanding adjustment (in shares) | 1,000 | 770 | 960 | |||
Antidilutive securities excluded from computation of earnings per share, amount | 1 | 8 | 1 | |||
Interest paid, net | $ 110 | $ 124 | $ 136 | |||
Income taxes paid | $ 278 | $ 108 | $ 255 | |||
Furniture and Fixtures | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Property, plant and equipment, useful life | 7 years | |||||
Office Equipment | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Property, plant and equipment, useful life | 5 years | |||||
Computer Software, Intangible Asset | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Property, plant and equipment, useful life | 10 years | |||||
Minimum | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Warranty coverage term | 1 month | |||||
Requisite service period for stock- based compensation expense | 3 years | |||||
Minimum | Computer Software, Intangible Asset | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Property, plant and equipment, useful life | 3 years | |||||
Maximum | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Warranty coverage term | 10 years | |||||
Maximum | Computer Software, Intangible Asset | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Property, plant and equipment, useful life | 5 years | |||||
ASU 2016-13 | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Retained earnings | $ (5) | |||||
Mortgage loans on real estate commercial and consumer allowance for credit loss | 7 | |||||
Deferred income taxes | 2 | |||||
Marketable securities fixed maturities allowance for credit loss | $ 6 | |||||
CNAF Consolidated | Loews | ||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||
Noncontrolling interest, ownership percentage by parent | 89.60% |
Investments (Net investment inc
Investments (Net investment income) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Net Investment Income [Line Items] | |||
Gross investment income | $ 2,223 | $ 1,999 | $ 2,181 |
Investment expense | (64) | (64) | (63) |
Net investment income | 2,159 | 1,935 | 2,118 |
Fixed maturity securities | |||
Net Investment Income [Line Items] | |||
Gross investment income | 1,707 | 1,728 | 1,817 |
Equity securities | |||
Net Investment Income [Line Items] | |||
Gross investment income | 83 | 65 | 85 |
Limited partnership investments | |||
Net Investment Income [Line Items] | |||
Gross investment income | 362 | 121 | 180 |
Mortgage loans | |||
Net Investment Income [Line Items] | |||
Gross investment income | 61 | 57 | 51 |
Short term investments | |||
Net Investment Income [Line Items] | |||
Gross investment income | 1 | 9 | 34 |
Trading portfolio | |||
Net Investment Income [Line Items] | |||
Gross investment income | 9 | 18 | 9 |
Other | |||
Net Investment Income [Line Items] | |||
Gross investment income | $ 0 | $ 1 | $ 5 |
Investments (Narrative) (Detail
Investments (Narrative) (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Gain (Loss) on Securities [Line Items] | |||
Non-income producing fixed maturity securities | $ 1,000,000 | $ 1,000,000 | |
Investments that exceed ten percent of stockholders' equity | 0 | 0 | |
Mortgage loan losses due to changes in expected credit losses | (10,000,000) | 21,000,000 | $ 0 |
Limited partnership investments | 1,859,000,000 | 1,619,000,000 | |
Undistributed earnings of limited partnership investments | $ 266,000,000 | $ 235,000,000 | |
Percentage of limited partnerships reported on a current basis | 32.00% | ||
Percentage of limited partnerships reported on a one month lag | 6.00% | ||
Percentage of limited partnerships employing hedge fund strategies focused on fixed income and equity investments | 32.00% | 51.00% | |
Limited partnerships invested in private debt and equity | 68.00% | 49.00% | |
Carrying value of ten largest limited partnerships | $ 665,000,000 | $ 775,000,000 | |
Carrying value of limited partnerships as percentage of aggregate partnership equity | 1.00% | 2.00% | |
Income as percentage of change in partnership equity for all limited partnerships | 2.00% | 2.00% | 2.00% |
Obligation to return cash | $ 0 | $ 0 | |
Notional value | 270,000,000 | 190,000,000 | |
Derivative liability, fair value, gross liability | (12,000,000) | (19,000,000) | |
Commitments to purchase or fund privately placed debt securities | 1,230,000,000 | ||
Commitments to sell various privately placed debt securities | 90,000,000 | ||
Carrying value of securities deposited under requirements of regulatory authorities | 3,000,000,000 | 3,000,000,000 | |
Cash and securities deposited as collateral for letters of credit | 1,200,000,000 | 1,100,000,000 | |
Non-Income Producing Mortgage Loans | 7,000,000 | 0 | |
5.875% face amount of $500, due August 15, 2020 | Senior Notes | |||
Gain (Loss) on Securities [Line Items] | |||
Realized investment gains (losses) | (20,000,000) | $ 21,000,000 | |
Face amount | 400,000,000 | 500,000,000 | |
Common Stock | |||
Gain (Loss) on Securities [Line Items] | |||
Equity securities, FV-NI, gain (loss) | 28,000,000 | 34,000,000 | |
Non-redeemable preferred stock | |||
Gain (Loss) on Securities [Line Items] | |||
Equity securities, FV-NI, gain (loss) | 2,000,000 | (3,000,000) | |
Fixed maturity securities | |||
Gain (Loss) on Securities [Line Items] | |||
Debt securities, available-for-sale, accrued interest, after allowance for credit loss | 369,000,000 | 371,000,000 | |
OCI, debt securities, available-for-sale, gain (loss), after adjustment, before tax | (1,272,000,000) | $ 1,637,000,000 | $ 2,620,000,000 |
Mortgage loans | |||
Gain (Loss) on Securities [Line Items] | |||
Financing receivable, accrued interest, after allowance for credit loss | $ 3,000,000 |
Investments (Net realized inves
Investments (Net realized investment gains (losses)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Fixed maturity securities: | |||
Gross gains | $ 186 | $ 220 | $ 125 |
Gross losses | (90) | (220) | (131) |
Net investment gains (losses) on fixed maturity securities | 96 | 0 | (6) |
Equity securities | 4 | (3) | 66 |
Derivatives | 6 | (10) | (11) |
Mortgage loans | 10 | (21) | 0 |
Short term investments and other | 4 | (20) | (20) |
Net investment gains (losses) | $ 120 | $ (54) | $ 29 |
Investments (Allowance on avail
Investments (Allowance on available-for-sale securities with credit impairments and PCD assets activity) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Allowance for credit losses: | ||
Balance, beginning of period | $ 40 | $ 0 |
Additions to the allowance for credit losses: | ||
Securities for which credit losses were not previously recorded | 14 | 79 |
Available-for-sale securities accounted for as PCD assets | 11 | 5 |
Reductions to the allowance for credit losses: | ||
Securities sold during the period (realized) | 24 | 22 |
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis | 0 | 1 |
Write-offs charged against the allowance | 16 | 0 |
Recoveries of amounts previously written off | 0 | 0 |
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period | (7) | (27) |
Balance, end of period | 18 | 40 |
Impact of adopting ASC 326 | ||
Allowance for credit losses: | ||
Balance, beginning of period | 6 | |
Corporate and other bonds | ||
Allowance for credit losses: | ||
Balance, beginning of period | 23 | 0 |
Additions to the allowance for credit losses: | ||
Securities for which credit losses were not previously recorded | 14 | 67 |
Available-for-sale securities accounted for as PCD assets | 5 | 5 |
Reductions to the allowance for credit losses: | ||
Securities sold during the period (realized) | 7 | 22 |
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis | 0 | 1 |
Write-offs charged against the allowance | 16 | 0 |
Recoveries of amounts previously written off | 0 | 0 |
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period | (8) | (32) |
Balance, end of period | 11 | 23 |
Corporate and other bonds | Impact of adopting ASC 326 | ||
Allowance for credit losses: | ||
Balance, beginning of period | 6 | |
Asset-backed | ||
Allowance for credit losses: | ||
Balance, beginning of period | 17 | 0 |
Additions to the allowance for credit losses: | ||
Securities for which credit losses were not previously recorded | 0 | 12 |
Available-for-sale securities accounted for as PCD assets | 6 | 0 |
Reductions to the allowance for credit losses: | ||
Securities sold during the period (realized) | 17 | 0 |
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis | 0 | 0 |
Write-offs charged against the allowance | 0 | 0 |
Recoveries of amounts previously written off | 0 | 0 |
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period | 1 | 5 |
Balance, end of period | $ 7 | 17 |
Asset-backed | Impact of adopting ASC 326 | ||
Allowance for credit losses: | ||
Balance, beginning of period | $ 0 |
Investments (Components of othe
Investments (Components of other-than-temporary impairment losses recognized in earnings) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Debt Securities, Available-for-sale [Line Items] | |||
Impairment (gains) losses recognized in earnings | $ 31 | $ 111 | $ 44 |
Corporate and other bonds | |||
Debt Securities, Available-for-sale [Line Items] | |||
Impairment (gains) losses recognized in earnings | 11 | 87 | 33 |
Asset-backed | |||
Debt Securities, Available-for-sale [Line Items] | |||
Impairment (gains) losses recognized in earnings | $ 20 | $ 24 | $ 11 |
Investments (Summary of fixed m
Investments (Summary of fixed maturity and equity securities) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Fixed maturity securities available-for-sale: | |||
Gross Unrealized Gains | $ 4,558 | $ 5,795 | |
Gross Unrealized Losses | 112 | 77 | |
Allowance for Credit Losses | 18 | 40 | $ 0 |
Estimated Fair Value | 44,373 | 44,604 | |
Total fixed maturity securities trading | |||
Debt securities, amortized cost | 39,952 | 38,953 | |
Total fixed maturity securities | 44,380 | 44,631 | |
Corporate and other bonds | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 21,444 | 20,792 | |
Gross Unrealized Gains | 2,755 | 3,578 | |
Gross Unrealized Losses | 56 | 22 | |
Allowance for Credit Losses | 11 | 23 | 0 |
Estimated Fair Value | 24,132 | 24,325 | |
Total fixed maturity securities trading | |||
Total fixed maturity securities | 24,852 | 25,234 | |
States, municipalities and political subdivisions | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 10,358 | 9,729 | |
Gross Unrealized Gains | 1,599 | 1,863 | |
Gross Unrealized Losses | 14 | 0 | |
Allowance for Credit Losses | 0 | 0 | |
Estimated Fair Value | 11,943 | 11,592 | |
Total fixed maturity securities trading | |||
Total fixed maturity securities | 11,943 | 11,592 | |
Residential mortgage-backed | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 2,893 | 3,442 | |
Gross Unrealized Gains | 71 | 146 | |
Gross Unrealized Losses | 8 | 1 | |
Allowance for Credit Losses | 0 | 0 | |
Estimated Fair Value | 2,956 | 3,587 | |
Commercial mortgage-backed | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 1,987 | 1,933 | |
Gross Unrealized Gains | 63 | 93 | |
Gross Unrealized Losses | 19 | 42 | |
Allowance for Credit Losses | 0 | 17 | |
Estimated Fair Value | 2,031 | 1,967 | |
Other asset-backed | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 2,561 | 2,179 | |
Gross Unrealized Gains | 54 | 81 | |
Gross Unrealized Losses | 10 | 9 | |
Allowance for Credit Losses | 7 | 0 | |
Estimated Fair Value | 2,598 | 2,251 | |
Asset-backed | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 7,441 | 7,554 | |
Gross Unrealized Gains | 188 | 320 | |
Gross Unrealized Losses | 37 | 52 | |
Allowance for Credit Losses | 7 | 17 | $ 0 |
Estimated Fair Value | 7,585 | 7,805 | |
Total fixed maturity securities trading | |||
Total fixed maturity securities | 7,585 | 7,805 | |
U.S. Treasury and obligations of government-sponsored enterprises | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 132 | 339 | |
Gross Unrealized Gains | 1 | 2 | |
Gross Unrealized Losses | 3 | 3 | |
Allowance for Credit Losses | 0 | 0 | |
Estimated Fair Value | 130 | 338 | |
Foreign government | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 570 | 512 | |
Gross Unrealized Gains | 15 | 32 | |
Gross Unrealized Losses | 2 | 0 | |
Allowance for Credit Losses | 0 | 0 | |
Estimated Fair Value | 583 | 544 | |
Fixed maturity securities | |||
Fixed maturity securities available-for-sale: | |||
Cost or Amortized Cost | 39,945 | 38,926 | |
Gross Unrealized Gains | 4,558 | 5,795 | |
Gross Unrealized Losses | 112 | 77 | |
Allowance for Credit Losses | 18 | 40 | |
Estimated Fair Value | 44,373 | 44,604 | |
Total fixed maturity securities trading | |||
Total fixed maturity securities trading | |||
Cost or amortized cost, trading securities | 7 | 27 | |
Estimated fair value, trading securities | $ 7 | $ 27 |
Investments (Securities in a gr
Investments (Securities in a gross unrealized loss position) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | $ 5,695 | $ 1,666 |
Gross Unrealized Losses, Less than 12 Months | 92 | 74 |
Estimated Fair Value, 12 Months or Longer | 370 | 64 |
Gross Unrealized Losses, 12 Months or Longer | 20 | 3 |
Estimated Fair Value, Total | 6,065 | 1,730 |
Gross Unrealized Losses, Total | 112 | 77 |
Corporate and other bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 2,389 | 609 |
Gross Unrealized Losses, Less than 12 Months | 48 | 21 |
Estimated Fair Value, 12 Months or Longer | 136 | 12 |
Gross Unrealized Losses, 12 Months or Longer | 8 | 1 |
Estimated Fair Value, Total | 2,525 | 621 |
Gross Unrealized Losses, Total | 56 | 22 |
States, municipalities and political subdivisions | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 730 | 33 |
Gross Unrealized Losses, Less than 12 Months | 14 | 0 |
Estimated Fair Value, 12 Months or Longer | 0 | 0 |
Gross Unrealized Losses, 12 Months or Longer | 0 | 0 |
Estimated Fair Value, Total | 730 | 33 |
Gross Unrealized Losses, Total | 14 | |
Residential mortgage-backed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 1,043 | 71 |
Gross Unrealized Losses, Less than 12 Months | 8 | 1 |
Estimated Fair Value, 12 Months or Longer | 0 | 11 |
Gross Unrealized Losses, 12 Months or Longer | 0 | 0 |
Estimated Fair Value, Total | 1,043 | 82 |
Gross Unrealized Losses, Total | 8 | 1 |
Commercial mortgage-backed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 527 | 533 |
Gross Unrealized Losses, Less than 12 Months | 7 | 40 |
Estimated Fair Value, 12 Months or Longer | 167 | 28 |
Gross Unrealized Losses, 12 Months or Longer | 12 | 2 |
Estimated Fair Value, Total | 694 | 561 |
Gross Unrealized Losses, Total | 19 | 42 |
Other asset-backed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 840 | 344 |
Gross Unrealized Losses, Less than 12 Months | 10 | 9 |
Estimated Fair Value, 12 Months or Longer | 62 | 13 |
Gross Unrealized Losses, 12 Months or Longer | 0 | 0 |
Estimated Fair Value, Total | 902 | 357 |
Gross Unrealized Losses, Total | 10 | 9 |
Asset-backed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 2,410 | 948 |
Gross Unrealized Losses, Less than 12 Months | 25 | 50 |
Estimated Fair Value, 12 Months or Longer | 229 | 52 |
Gross Unrealized Losses, 12 Months or Longer | 12 | 2 |
Estimated Fair Value, Total | 2,639 | 1,000 |
Gross Unrealized Losses, Total | 37 | 52 |
U.S. Treasury and obligations of government-sponsored enterprises | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 69 | 63 |
Gross Unrealized Losses, Less than 12 Months | 3 | 3 |
Estimated Fair Value, 12 Months or Longer | 5 | 0 |
Gross Unrealized Losses, 12 Months or Longer | 0 | 0 |
Estimated Fair Value, Total | 74 | 63 |
Gross Unrealized Losses, Total | 3 | 3 |
Foreign government | ||
Debt Securities, Available-for-sale [Line Items] | ||
Estimated Fair Value, Less than 12 months | 97 | 13 |
Gross Unrealized Losses, Less than 12 Months | 2 | 0 |
Estimated Fair Value, 12 Months or Longer | 0 | 0 |
Gross Unrealized Losses, 12 Months or Longer | 0 | 0 |
Estimated Fair Value, Total | 97 | 13 |
Gross Unrealized Losses, Total | $ 2 | $ 0 |
Investments (Contractual maturi
Investments (Contractual maturity) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Investments [Abstract] | ||
Due in one year or less, cost or amortized cost | $ 1,603 | $ 1,456 |
Due after one year through five years, cost or amortized cost | 10,637 | 12,304 |
Due after five years through ten years, cost or amortized cost | 13,294 | 12,319 |
Due after ten years, cost or amortized cost | 14,411 | 12,847 |
Cost or Amortized Cost | 39,945 | 38,926 |
Due in one year or less, estimated fair value | 1,624 | 1,458 |
Due after one year through five years, estimated fair value | 11,229 | 13,098 |
Due after five years through ten years, estimated fair value | 14,338 | 13,878 |
Due after ten years, estimated fair value | 17,182 | 16,170 |
Estimated Fair Value | $ 44,373 | $ 44,604 |
Investments (Credit quality ind
Investments (Credit quality indicator) (Details) - Mortgage loans $ in Millions | Dec. 31, 2021USD ($) |
Debt Securities, Available-for-sale [Line Items] | |
2021 | $ 95 |
2020 | 160 |
2019 | 249 |
2018 | 79 |
2017 | 152 |
Prior | 254 |
Total | 989 |
DSCR ≥1.6x | LTV less than 55% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 2 |
2020 | 75 |
2019 | 6 |
2018 | 38 |
2017 | 99 |
Prior | 181 |
Total | 401 |
DSCR ≥1.6x | LTV 55% to 65% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 5 |
2020 | 38 |
2019 | 15 |
2018 | 17 |
2017 | 0 |
Prior | 24 |
Total | 99 |
DSCR ≥1.6x | LTV greater than 65% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 17 |
2020 | 0 |
2019 | 8 |
2018 | 0 |
2017 | 0 |
Prior | 0 |
Total | 25 |
DSCR 1.2x - 1.6x | LTV less than 55% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 14 |
2020 | 14 |
2019 | 95 |
2018 | 0 |
2017 | 5 |
Prior | 42 |
Total | 170 |
DSCR 1.2x - 1.6x | LTV 55% to 65% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 36 |
2020 | 0 |
2019 | 0 |
2018 | 24 |
2017 | 10 |
Prior | 0 |
Total | 70 |
DSCR 1.2x - 1.6x | LTV greater than 65% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 0 |
2020 | 24 |
2019 | 0 |
2018 | 0 |
2017 | 8 |
Prior | 0 |
Total | 32 |
DSCR ≤1.2 | LTV less than 55% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 0 |
2020 | 0 |
2019 | 35 |
2018 | 0 |
2017 | 30 |
Prior | 0 |
Total | 65 |
DSCR ≤1.2 | LTV 55% to 65% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 0 |
2020 | 0 |
2019 | 28 |
2018 | 0 |
2017 | 0 |
Prior | 0 |
Total | 28 |
DSCR ≤1.2 | LTV greater than 65% | |
Debt Securities, Available-for-sale [Line Items] | |
2021 | 21 |
2020 | 9 |
2019 | 62 |
2018 | 0 |
2017 | 0 |
Prior | 7 |
Total | $ 99 |
Fair Value (Assets and liabilit
Fair Value (Assets and liabilities measured at fair value on a recurring basis) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Fixed maturity securities: | ||
Fixed maturity securities | $ 44,380 | $ 44,631 |
Equity securities: | ||
Equity securities | 1,035 | 992 |
Short term and other | 1,872 | 1,789 |
Total assets | 47,287 | 47,412 |
Other liabilities | 12 | 19 |
Total liabilities | 12 | 19 |
Corporate and other bonds | ||
Fixed maturity securities: | ||
Fixed maturity securities | 24,852 | 25,234 |
States, municipalities and political subdivisions | ||
Fixed maturity securities: | ||
Fixed maturity securities | 11,943 | 11,592 |
Asset-backed | ||
Fixed maturity securities: | ||
Fixed maturity securities | 7,585 | 7,805 |
Common Stock | ||
Equity securities: | ||
Equity securities | 233 | 195 |
Non-redeemable preferred stock | ||
Equity securities: | ||
Equity securities | 802 | 797 |
Level 1 | ||
Fixed maturity securities: | ||
Fixed maturity securities | 140 | 355 |
Equity securities: | ||
Equity securities | 285 | 243 |
Short term and other | 1,798 | 1,761 |
Total assets | 2,223 | 2,359 |
Other liabilities | 0 | 0 |
Total liabilities | 0 | 0 |
Level 1 | Corporate and other bonds | ||
Fixed maturity securities: | ||
Fixed maturity securities | 140 | 355 |
Level 1 | States, municipalities and political subdivisions | ||
Fixed maturity securities: | ||
Fixed maturity securities | 0 | 0 |
Level 1 | Asset-backed | ||
Fixed maturity securities: | ||
Fixed maturity securities | 0 | 0 |
Level 1 | Common Stock | ||
Equity securities: | ||
Equity securities | 220 | 175 |
Level 1 | Non-redeemable preferred stock | ||
Equity securities: | ||
Equity securities | 65 | 68 |
Level 2 | ||
Fixed maturity securities: | ||
Fixed maturity securities | 42,691 | 43,152 |
Equity securities: | ||
Equity securities | 721 | 722 |
Short term and other | 74 | 28 |
Total assets | 43,486 | 43,902 |
Other liabilities | 12 | 19 |
Total liabilities | 12 | 19 |
Level 2 | Corporate and other bonds | ||
Fixed maturity securities: | ||
Fixed maturity securities | 23,775 | 24,109 |
Level 2 | States, municipalities and political subdivisions | ||
Fixed maturity securities: | ||
Fixed maturity securities | 11,887 | 11,546 |
Level 2 | Asset-backed | ||
Fixed maturity securities: | ||
Fixed maturity securities | 7,029 | 7,497 |
Level 2 | Common Stock | ||
Equity securities: | ||
Equity securities | 0 | 0 |
Level 2 | Non-redeemable preferred stock | ||
Equity securities: | ||
Equity securities | 721 | 722 |
Level 3 | ||
Fixed maturity securities: | ||
Fixed maturity securities | 1,549 | 1,124 |
Equity securities: | ||
Equity securities | 29 | 27 |
Short term and other | 0 | 0 |
Total assets | 1,578 | 1,151 |
Other liabilities | 0 | 0 |
Total liabilities | 0 | 0 |
Level 3 | Corporate and other bonds | ||
Fixed maturity securities: | ||
Fixed maturity securities | 937 | 770 |
Level 3 | States, municipalities and political subdivisions | ||
Fixed maturity securities: | ||
Fixed maturity securities | 56 | 46 |
Level 3 | Asset-backed | ||
Fixed maturity securities: | ||
Fixed maturity securities | 556 | 308 |
Level 3 | Common Stock | ||
Equity securities: | ||
Equity securities | 13 | 20 |
Level 3 | Non-redeemable preferred stock | ||
Equity securities: | ||
Equity securities | $ 16 | $ 7 |
Fair Value (Table of reconcilia
Fair Value (Table of reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, Beginning, Assets | $ 1,151 | $ 651 |
Reported in Other comprehensive income (loss) | (43) | 60 |
Total realized and unrealized investment gains (losses) | (46) | 56 |
Purchases | 612 | 478 |
Sales | (32) | (12) |
Settlements | (130) | (45) |
Transfers into Level 3 | 150 | 40 |
Transfers out of Level 3 | (127) | (17) |
Balance, Ending, Assets | 1,578 | 1,151 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Net income (loss) in the period | (2) | (6) |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Other comprehensive income (loss) in the period | (44) | 62 |
Corporate and other bonds | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, Beginning, Assets | 770 | 468 |
Reported in Other comprehensive income (loss) | (32) | 43 |
Total realized and unrealized investment gains (losses) | (42) | 44 |
Purchases | 312 | 264 |
Sales | (3) | (3) |
Settlements | (68) | (13) |
Transfers into Level 3 | 20 | 10 |
Transfers out of Level 3 | (52) | 0 |
Balance, Ending, Assets | 937 | 770 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Net income (loss) in the period | 0 | 0 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Other comprehensive income (loss) in the period | (32) | 43 |
States, municipalities and political subdivisions | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, Beginning, Assets | 46 | 0 |
Reported in Other comprehensive income (loss) | (1) | 1 |
Total realized and unrealized investment gains (losses) | (1) | 1 |
Purchases | 12 | 45 |
Sales | 0 | 0 |
Settlements | (1) | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Balance, Ending, Assets | 56 | 46 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Net income (loss) in the period | 0 | 0 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Other comprehensive income (loss) in the period | (1) | 1 |
Asset-backed | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, Beginning, Assets | 308 | 165 |
Reported in Other comprehensive income (loss) | (10) | 16 |
Total realized and unrealized investment gains (losses) | (3) | 17 |
Purchases | 287 | 154 |
Sales | (9) | (9) |
Settlements | (61) | (32) |
Transfers into Level 3 | 109 | 30 |
Transfers out of Level 3 | (75) | (17) |
Balance, Ending, Assets | 556 | 308 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Net income (loss) in the period | 0 | 0 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Other comprehensive income (loss) in the period | (11) | 18 |
Equity securities | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance, Beginning, Assets | 27 | 18 |
Reported in Other comprehensive income (loss) | 0 | 0 |
Total realized and unrealized investment gains (losses) | 0 | (6) |
Purchases | 1 | 15 |
Sales | (20) | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 21 | 0 |
Transfers out of Level 3 | 0 | 0 |
Balance, Ending, Assets | 29 | 27 |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Net income (loss) in the period | (2) | (6) |
Unrealized gains (losses) on Level 3 assets and liabilities recognized in Other comprehensive income (loss) in the period | 0 | 0 |
Reported in Net investment gains (losses) | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment gains (losses) | (12) | (4) |
Reported in Net investment gains (losses) | Corporate and other bonds | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment gains (losses) | (10) | 1 |
Reported in Net investment gains (losses) | States, municipalities and political subdivisions | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment gains (losses) | 0 | 0 |
Reported in Net investment gains (losses) | Asset-backed | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment gains (losses) | 0 | (1) |
Reported in Net investment gains (losses) | Equity securities | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment gains (losses) | (2) | (4) |
Reported in Net investment income | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment income | 9 | 0 |
Reported in Net investment income | Corporate and other bonds | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment income | 0 | 0 |
Reported in Net investment income | States, municipalities and political subdivisions | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment income | 0 | 0 |
Reported in Net investment income | Asset-backed | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment income | 7 | 2 |
Reported in Net investment income | Equity securities | ||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Reported in Net investment income | $ 2 | $ (2) |
Fair Value (Narrative) (Details
Fair Value (Narrative) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Fair Value Disclosures [Abstract] | ||
Other invested assets overseas deposit | $ 74 | $ 71 |
Fair Value (Quantitative inform
Fair Value (Quantitative information about significant unobservable inputs in the fair value measurement of level 3 assets) (Details) $ in Millions | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) |
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Estimated fair value | $ 47,287 | $ 47,412 |
Fixed maturity securities | Discounted cash flow | ||
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Estimated fair value | $ 1,225 | $ 966 |
Credit spread | Discounted cash flow | Minimum | ||
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Debt securities, available-for-sale, measurement Input | 0.01 | 0.01 |
Credit spread | Discounted cash flow | Maximum | ||
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Debt securities, available-for-sale, measurement Input | 0.07 | 0.08 |
Credit spread | Discounted cash flow | Weighted Average | ||
Fair Value Inputs, Assets, Quantitative Information [Line Items] | ||
Debt securities, available-for-sale, measurement Input | 0.02 | 0.03 |
Fair Value (Carrying amount and
Fair Value (Carrying amount and estimated fair value of financial instrument assets and liabilities which are not measured at fair value) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Assets | ||
Mortgage loans | $ 973 | $ 1,068 |
Liabilities | ||
Long term debt | 2,779 | 2,776 |
Carrying Amount | ||
Assets | ||
Mortgage loans | 973 | 1,068 |
Liabilities | ||
Long term debt | 2,779 | 2,776 |
Estimated Fair Value | ||
Assets | ||
Mortgage loans | 1,018 | 1,151 |
Liabilities | ||
Long term debt | 2,978 | 3,148 |
Level 1 | Estimated Fair Value | ||
Assets | ||
Mortgage loans | 0 | 0 |
Liabilities | ||
Long term debt | 0 | 0 |
Level 2 | Estimated Fair Value | ||
Assets | ||
Mortgage loans | 0 | 0 |
Liabilities | ||
Long term debt | 2,978 | 3,148 |
Level 3 | Estimated Fair Value | ||
Assets | ||
Mortgage loans | 1,018 | 1,151 |
Liabilities | ||
Long term debt | $ 0 | $ 0 |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Contingency [Line Items] | |||
Unrecognized tax benefits | $ 0 | $ 0 | |
Interest income (expense) | 0 | 0 | $ 0 |
Income tax penalties expense | 0 | 0 | 0 |
Accrued interest and penalties | 0 | 0 | |
Deferred tax liability on undistributed income related to a foreign subsidiary | 0 | ||
Foreign tax expense (benefit) on income from continuing operations | 18,000,000 | 16,000,000 | 19,000,000 |
Income (loss) from continuing foreign operations | 124,000,000 | 45,000,000 | 43,000,000 |
Operating loss carryforwards | 0 | ||
Tax credit carryforward, amount | 0 | ||
Valuation allowance | 0 | 0 | |
Federal Income Taxes | |||
Income Tax Contingency [Line Items] | |||
Related party transaction, amounts of transaction | 238,000,000 | $ 65,000,000 | $ 239,000,000 |
Foreign Tax Authority | |||
Income Tax Contingency [Line Items] | |||
Operating loss carryforwards | 138,000,000 | ||
Tax credit carryforward, amount | 4,000,000 | ||
Operating loss carryforwards, subject to expiration | 1,000,000 | ||
Operating loss carryforwards, not subject to expiration | $ 137,000,000 |
Income Taxes (Reconciliation be
Income Taxes (Reconciliation between the Company's federal income tax (expense) benefit at statutory rates and the recorded income tax (expense) benefit) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
Income tax expense at statutory rates | $ (312) | $ (172) | $ (257) |
Tax benefit from tax exempt income | 51 | 52 | 53 |
Foreign taxes and credits | (3) | 2 | (1) |
State income tax expense | (13) | (6) | (14) |
Other tax expense | (5) | (7) | (4) |
Income tax expense | $ (282) | $ (131) | $ (223) |
Income Taxes (Current and defer
Income Taxes (Current and deferred components of the Company's income tax (expense) benefit) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
Current tax expense | $ (235) | $ (180) | $ (269) |
Deferred tax (expense) benefit | (47) | 49 | 46 |
Income tax expense | $ (282) | $ (131) | $ (223) |
Income Taxes (Significant compo
Income Taxes (Significant components of the Company's deferred tax assets and liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Deferred Tax Assets: | ||
Property and casualty claim and claim adjustment expense reserves | $ 173 | $ 157 |
Unearned premium reserves | 193 | 174 |
Deferred Revenue | 64 | 62 |
Employee benefits | 46 | 122 |
Deferred retroactive reinsurance benefit | 90 | 83 |
Other assets | 88 | 92 |
Gross deferred tax assets | 654 | 690 |
Deferred Tax Liabilities: | ||
Investment valuation differences | 93 | 28 |
Deferred acquisition costs | 99 | 93 |
Net unrealized gains | 272 | 453 |
Software and hardware | 27 | 31 |
Other liabilities | 21 | 19 |
Gross deferred tax liabilities | 512 | 624 |
Net deferred tax asset | $ 142 | $ 66 |
Claim, Claim Adjustment Expen_3
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Reconciliation of Liability for Unpaid Claim and Claim Adjustment Expense) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 |
Reinsurance receivables | 4,969 | |||
Total gross liability for unpaid claim and claim adjustment expenses | 24,174 | 22,706 | ||
Specialty | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 5,265 | 4,898 | ||
Reinsurance receivables | 1,168 | |||
Commercial | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 8,065 | 7,475 | ||
Reinsurance receivables | 825 | |||
International | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 1,940 | 1,822 | ||
Reinsurance receivables | 340 | |||
Life and Group | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 3,641 | |||
Reinsurance receivables | 113 | |||
Corporate & Other | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 294 | $ 891 | ||
Reinsurance receivables | $ 2,523 |
Claim, Claim Adjustment Expen_4
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Reconciliation of Claim and Claim Adjustment Expense Reserves) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Reserves, beginning of year: | |||
Gross | $ 22,706 | $ 21,720 | $ 21,984 |
Ceded | 4,005 | 3,835 | 4,019 |
Net reserves, beginning of year | 18,701 | 17,885 | 17,965 |
Reduction of net reserves due to Excess Workers' Compensation Loss Portfolio Transfer | (632) | 0 | 0 |
Net incurred claim and claim adjustment expenses: | |||
Provision for insured events of current year | 5,970 | 5,793 | 5,356 |
Increase (decrease) in provision for insured events of prior years | (104) | (119) | (127) |
Amortization of discount | 174 | 183 | 184 |
Total net incurred | 6,040 | 5,857 | 5,413 |
Net payments attributable to: | |||
Current year events | (1,014) | (948) | (992) |
Prior year events | (3,830) | (4,216) | (4,584) |
Total net payments | (4,844) | (5,164) | (5,576) |
Foreign currency translation adjustment and other | (60) | 123 | 83 |
Net reserves, end of year | 19,205 | 18,701 | 17,885 |
Ceded reserves, end of year | 4,969 | 4,005 | 3,835 |
Gross reserves, end of year | $ 24,174 | $ 22,706 | $ 21,720 |
Claim, Claim Adjustment Expen_5
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Gross and Net Carried Claim and Claim Adjustment Expense Reserves) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Gross Case Reserves | $ 10,555 | $ 10,694 | ||
Gross IBNR Reserves | 13,619 | 12,012 | ||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | 24,174 | 22,706 | $ 21,720 | $ 21,984 |
Net Case Reserves | 8,369 | 8,930 | ||
Net IBNR Reserves | 10,836 | 9,771 | ||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 19,205 | 18,701 | $ 17,885 | $ 17,965 |
Specialty | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Gross Case Reserves | 1,578 | 1,567 | ||
Gross IBNR Reserves | 4,855 | 4,181 | ||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | 6,433 | 5,748 | ||
Net Case Reserves | 1,338 | 1,410 | ||
Net IBNR Reserves | 3,927 | 3,488 | ||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 5,265 | 4,898 | ||
Commercial | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Gross Case Reserves | 3,184 | 3,215 | ||
Gross IBNR Reserves | 5,706 | 5,035 | ||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | 8,890 | 8,250 | ||
Net Case Reserves | 2,850 | 2,885 | ||
Net IBNR Reserves | 5,215 | 4,590 | ||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 8,065 | 7,475 | ||
International | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Gross Case Reserves | 859 | 892 | ||
Gross IBNR Reserves | 1,421 | 1,199 | ||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | 2,280 | 2,091 | ||
Net Case Reserves | 744 | 777 | ||
Net IBNR Reserves | 1,196 | 1,045 | ||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 1,940 | 1,822 | ||
Life & Group | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Gross Case Reserves | 3,383 | 3,406 | ||
Gross IBNR Reserves | 371 | 337 | ||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | 3,754 | 3,743 | ||
Net Case Reserves | 3,291 | 3,298 | ||
Net IBNR Reserves | 350 | 317 | ||
Total Net Carried Claim and Claim Adjustment Expense Reserves | 3,641 | 3,615 | ||
Corporate & Other | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Gross Case Reserves | 1,551 | 1,614 | ||
Gross IBNR Reserves | 1,266 | 1,260 | ||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | 2,817 | 2,874 | ||
Net Case Reserves | 146 | 560 | ||
Net IBNR Reserves | 148 | 331 | ||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ 294 | $ 891 |
Claim, Claim Adjustment Expen_6
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Net Prior Year Development) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Segment Reporting Information [Line Items] | |||
Pretax (favorable) unfavorable premium development, excluding Life & Group | $ 11 | $ (20) | $ (73) |
Specialty | |||
Segment Reporting Information [Line Items] | |||
Pretax (favorable) unfavorable premium development, excluding Life & Group | (45) | (61) | (92) |
Commercial | |||
Segment Reporting Information [Line Items] | |||
Pretax (favorable) unfavorable premium development, excluding Life & Group | (6) | (7) | (40) |
International | |||
Segment Reporting Information [Line Items] | |||
Pretax (favorable) unfavorable premium development, excluding Life & Group | 2 | (2) | 21 |
Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Pretax (favorable) unfavorable premium development, excluding Life & Group | $ 60 | $ 50 | $ 38 |
Claim, Claim Adjustment Expen_7
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Narrative) (Details) - USD ($) | Feb. 05, 2021 | Mar. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Feb. 05, 2021 | Dec. 31, 2011 | Dec. 31, 2010 |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||||
Pretax (favorable) unfavorable premium development, excluding Life & Group | $ 11,000,000 | $ (20,000,000) | $ (73,000,000) | |||||
Funds held under reinsurance agreements, liability | $ 690,000,000 | 4,000,000,000 | 3,300,000,000 | $ 690,000,000 | ||||
Retroactive reinsurance agreement, maximum | 1,000,000,000 | 1,000,000,000 | ||||||
Reinsurance premiums paid | $ 697,000,000 | $ 64,000,000 | ||||||
Reinsurance, loss on uncollectible accounts in period, amount | $ 12,000,000 | |||||||
Securities held as collateral, at fair value | 634,000,000 | |||||||
Corporate & Other | ||||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||||
Pretax (favorable) unfavorable premium development, excluding Life & Group | 60,000,000 | 50,000,000 | 38,000,000 | |||||
Commercial | ||||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||||
Pretax (favorable) unfavorable premium development, excluding Life & Group | (6,000,000) | (7,000,000) | (40,000,000) | |||||
Asbestos and Environmental Reserves | ||||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||||
Net A&EP claim and allocated claim adjustment expense reserves ceded to NICO | $ 1,600,000,000 | |||||||
Aggregate limit under A&EP Loss Portfolio Transfer | 4,000,000,000 | |||||||
A&EP claim and allocated claim adjustment expense reserves ceded under existing third party reinsurance contracts transferred to NICO under A&EP Loss Portfolio Transfer | 1,200,000,000 | |||||||
Reinsurance premium paid to NICO under A&EP Loss Portfolio Transfer | 2,000,000,000 | |||||||
Net reinsurance receivables transferred to NICO under A&EP Loss Portfolio Transfer | 215,000,000 | |||||||
Total consideration paid to NICO under AEP Loss Portfolio Transfer | $ 2,200,000,000 | $ 2,200,000,000 | ||||||
Net A&EP adverse development before consideration of LPT | 143,000,000 | 125,000,000 | 150,000,000 | |||||
Provision for uncollectible third-party reinsurance, released | 5,000,000 | 25,000,000 | $ 25,000,000 | |||||
Cumulative amounts ceded under AEP Loss Portfolio Transfer | 3,400,000,000 | 3,300,000,000 | ||||||
Deferred reinsurance benefit yet to be recognized | 429,000,000 | $ 398,000,000 | ||||||
Fair value of collateral trust account established by NICO under A&EP Loss Portfolio Transfer | 3,100,000,000 | |||||||
Excess Workers' Compensation LPT | ||||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||||
Funds held under reinsurance agreements, liability | $ 690,000,000 |
Claim, Claim Adjustment Expen_8
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Net Prior Year Claim and Allocated Claim Adjustment Expense Reserve Development) (Details) - Specialty - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |||
Medical Professional Liability | $ 23 | $ 35 | $ 75 |
Other Professional Liability and Management Liability | 24 | (15) | (69) |
Surety | (73) | (69) | (92) |
Warranty | (14) | (7) | (15) |
Other | (5) | (5) | 9 |
Total pretax (favorable) unfavorable development | $ (45) | $ (61) | $ (92) |
Claim, Claim Adjustment Expen_9
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Line of Business Composition) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 |
Specialty | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 5,265 | $ 4,898 | ||
Medical Professional Liability | Specialty | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 1,556 | |||
Other Professional Liability and Management Liability | Specialty | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 3,159 | |||
Surety | Specialty | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 406 | |||
Warranty | Specialty | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 44 | |||
Other | Specialty | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | $ 100 |
Claim, Claim Adjustment Expe_10
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Medical Professional Liability - Cumulative Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - Medical Professional Liability - Specialty $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 4,776 | |||||||||
IBNR | 1,016 | |||||||||
2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 497 | $ 497 | $ 499 | $ 493 | $ 484 | $ 493 | $ 498 | $ 508 | $ 469 | $ 464 |
IBNR | $ 4 | |||||||||
Cumulative Number of Claims | claim | 17,755 | |||||||||
2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 530 | 531 | 545 | 535 | 525 | 513 | 500 | 479 | $ 462 | |
IBNR | $ 11 | |||||||||
Cumulative Number of Claims | claim | 19,565 | |||||||||
2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 524 | 527 | 529 | 535 | 530 | 537 | 489 | $ 450 | ||
IBNR | $ 8 | |||||||||
Cumulative Number of Claims | claim | 19,800 | |||||||||
2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 501 | 510 | 488 | 494 | 510 | 499 | $ 433 | |||
IBNR | $ 28 | |||||||||
Cumulative Number of Claims | claim | 18,170 | |||||||||
2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 510 | 508 | 499 | 485 | 487 | $ 427 | ||||
IBNR | $ 24 | |||||||||
Cumulative Number of Claims | claim | 16,085 | |||||||||
2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 455 | 460 | 458 | 449 | $ 412 | |||||
IBNR | $ 41 | |||||||||
Cumulative Number of Claims | claim | 15,197 | |||||||||
2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 448 | 431 | 429 | $ 404 | ||||||
IBNR | $ 60 | |||||||||
Cumulative Number of Claims | claim | 14,997 | |||||||||
2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 458 | 445 | $ 430 | |||||||
IBNR | $ 156 | |||||||||
Cumulative Number of Claims | claim | 13,804 | |||||||||
2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 476 | $ 477 | ||||||||
IBNR | $ 347 | |||||||||
Cumulative Number of Claims | claim | 9,935 | |||||||||
2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 377 | |||||||||
IBNR | $ 337 | |||||||||
Cumulative Number of Claims | claim | 6,761 |
Claim, Claim Adjustment Expe_11
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Medical Professional Liability - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 5,265 | 4,898 | ||||||||
Medical Professional Liability | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 3,276 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 1,500 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 28 | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 28 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 1,556 | |||||||||
Medical Professional Liability | 2012 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 487 | 482 | 479 | 457 | $ 427 | $ 388 | $ 323 | $ 221 | $ 117 | $ 14 |
Medical Professional Liability | 2013 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 512 | 508 | 495 | 462 | 414 | 355 | 255 | 119 | $ 17 | |
Medical Professional Liability | 2014 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 497 | 489 | 472 | 417 | 359 | 258 | 136 | $ 23 | ||
Medical Professional Liability | 2015 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 444 | 420 | 384 | 313 | 230 | 101 | $ 22 | |||
Medical Professional Liability | 2016 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 436 | 401 | 339 | 246 | 121 | $ 18 | ||||
Medical Professional Liability | 2017 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 355 | 308 | 235 | 107 | $ 19 | |||||
Medical Professional Liability | 2018 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 290 | 211 | 115 | $ 21 | ||||||
Medical Professional Liability | 2019 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 183 | 91 | $ 17 | |||||||
Medical Professional Liability | 2020 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 61 | $ 11 | ||||||||
Medical Professional Liability | 2021 | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 11 |
Claim, Claim Adjustment Expe_12
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Medical Professional Liability - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - Specialty - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
Claims Development [Line Items] | ||||||||||||||||||
Total | $ 23 | $ 35 | $ 75 | |||||||||||||||
Medical Professional Liability | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 13 | 32 | 52 | |||||||||||||||
Total net development for accident years prior to 2012 | 3 | 3 | 21 | |||||||||||||||
Total unallocated claim adjustment expense development | 7 | 0 | 2 | |||||||||||||||
Total | 23 | 35 | 75 | |||||||||||||||
Medical Professional Liability | 2012 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 0 | (2) | 6 | $ 9 | $ (9) | $ (5) | $ (10) | $ 39 | $ 5 | $ 33 | ||||||||
Medical Professional Liability | 2013 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (1) | (14) | 10 | 10 | 12 | 13 | 21 | $ 17 | $ 68 | |||||||||
Medical Professional Liability | 2014 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (3) | (2) | (6) | 5 | (7) | 48 | $ 39 | $ 74 | ||||||||||
Medical Professional Liability | 2015 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (9) | 22 | (6) | (16) | 11 | $ 66 | $ 68 | |||||||||||
Medical Professional Liability | 2016 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 2 | 9 | 14 | (2) | $ 60 | $ 83 | ||||||||||||
Medical Professional Liability | 2017 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (5) | 2 | 9 | $ 37 | $ 43 | |||||||||||||
Medical Professional Liability | 2018 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 17 | 2 | $ 25 | $ 44 | ||||||||||||||
Medical Professional Liability | 2019 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 13 | $ 15 | $ 28 | |||||||||||||||
Medical Professional Liability | 2020 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ (1) | $ (1) |
Claim, Claim Adjustment Expe_13
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Other Professional Liability and Management Liability - Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - Other Professional Liability and Management Liability - Specialty $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 8,767 | |||||||||
IBNR | 2,326 | |||||||||
2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 848 | $ 850 | $ 831 | $ 833 | $ 846 | $ 840 | $ 878 | $ 887 | $ 909 | $ 923 |
IBNR | $ 18 | |||||||||
Cumulative Number of Claims | claim | 18,506 | |||||||||
2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 833 | 846 | 850 | 863 | 866 | 885 | 926 | 894 | $ 884 | |
IBNR | $ 30 | |||||||||
Cumulative Number of Claims | claim | 17,950 | |||||||||
2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 841 | 845 | 854 | 835 | 831 | 885 | 898 | $ 878 | ||
IBNR | $ 37 | |||||||||
Cumulative Number of Claims | claim | 17,577 | |||||||||
2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 836 | 813 | 807 | 832 | 877 | 892 | $ 888 | |||
IBNR | $ 41 | |||||||||
Cumulative Number of Claims | claim | 17,436 | |||||||||
2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 891 | 907 | 904 | 900 | 900 | $ 901 | ||||
IBNR | $ 84 | |||||||||
Cumulative Number of Claims | claim | 17,968 | |||||||||
2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 775 | 791 | 813 | 845 | $ 847 | |||||
IBNR | $ 152 | |||||||||
Cumulative Number of Claims | claim | 18,159 | |||||||||
2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 906 | 869 | 864 | $ 850 | ||||||
IBNR | $ 202 | |||||||||
Cumulative Number of Claims | claim | 19,926 | |||||||||
2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 856 | 845 | $ 837 | |||||||
IBNR | $ 283 | |||||||||
Cumulative Number of Claims | claim | 19,357 | |||||||||
2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 944 | $ 930 | ||||||||
IBNR | $ 568 | |||||||||
Cumulative Number of Claims | claim | 19,095 | |||||||||
2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 1,037 | |||||||||
IBNR | $ 911 | |||||||||
Cumulative Number of Claims | claim | 15,487 |
Claim, Claim Adjustment Expe_14
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Other Professional Liability and Management Liability - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 5,265 | 4,898 | ||||||||
Other Professional Liability and Management Liability | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 5,735 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 3,032 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 74 | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 53 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 3,159 | |||||||||
Other Professional Liability and Management Liability | 2012 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 816 | 812 | 792 | 755 | $ 711 | $ 651 | $ 573 | $ 400 | $ 248 | $ 56 |
Other Professional Liability and Management Liability | 2013 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 787 | 779 | 771 | 754 | 702 | 618 | 447 | 249 | $ 54 | |
Other Professional Liability and Management Liability | 2014 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 787 | 743 | 707 | 647 | 515 | 392 | 223 | $ 51 | ||
Other Professional Liability and Management Liability | 2015 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 725 | 677 | 612 | 542 | 404 | 234 | $ 60 | |||
Other Professional Liability and Management Liability | 2016 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 736 | 701 | 625 | 466 | 248 | $ 64 | ||||
Other Professional Liability and Management Liability | 2017 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 557 | 498 | 394 | 222 | $ 57 | |||||
Other Professional Liability and Management Liability | 2018 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 599 | 473 | 282 | $ 54 | ||||||
Other Professional Liability and Management Liability | 2019 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 422 | 263 | $ 64 | |||||||
Other Professional Liability and Management Liability | 2020 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 248 | $ 67 | ||||||||
Other Professional Liability and Management Liability | 2021 | Specialty | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 58 |
Claim, Claim Adjustment Expe_15
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Other Professional Liability and Management Liability - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - Specialty - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
Claims Development [Line Items] | ||||||||||||||||||
Total | $ 24 | $ (15) | $ (69) | |||||||||||||||
Other Professional Liability and Management Liability | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 34 | 6 | (35) | |||||||||||||||
Total net development for accident years prior to 2012 | (12) | (21) | (20) | |||||||||||||||
Total unallocated claim adjustment expense development | 2 | 0 | (14) | |||||||||||||||
Total | 24 | (15) | (69) | |||||||||||||||
Other Professional Liability and Management Liability | 2012 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (2) | 19 | (2) | $ (13) | $ 6 | $ (38) | $ (9) | $ (22) | $ (14) | $ (75) | ||||||||
Other Professional Liability and Management Liability | 2013 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (13) | (4) | (13) | (3) | (19) | (41) | 32 | $ 10 | $ (51) | |||||||||
Other Professional Liability and Management Liability | 2014 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (4) | (9) | 19 | 4 | (54) | (13) | $ 20 | $ (37) | ||||||||||
Other Professional Liability and Management Liability | 2015 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 23 | 6 | (25) | (45) | (15) | $ 4 | $ (52) | |||||||||||
Other Professional Liability and Management Liability | 2016 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (16) | 3 | 4 | 0 | $ (1) | $ (10) | ||||||||||||
Other Professional Liability and Management Liability | 2017 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (16) | (22) | (32) | $ (2) | $ (72) | |||||||||||||
Other Professional Liability and Management Liability | 2018 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 37 | 5 | $ 14 | $ 56 | ||||||||||||||
Other Professional Liability and Management Liability | 2019 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 11 | $ 8 | $ 19 | |||||||||||||||
Other Professional Liability and Management Liability | 2020 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ 14 | $ 14 |
Claim, Claim Adjustment Expe_16
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Surety - Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - Surety - Specialty $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 765 | |||||||||
IBNR | 328 | |||||||||
2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 36 | $ 37 | $ 38 | $ 39 | $ 45 | $ 52 | $ 70 | $ 98 | $ 122 | $ 120 |
IBNR | $ 1 | |||||||||
Cumulative Number of Claims | claim | 5,586 | |||||||||
2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 82 | 82 | 83 | 87 | 91 | 106 | 115 | 121 | $ 120 | |
IBNR | $ 2 | |||||||||
Cumulative Number of Claims | claim | 5,088 | |||||||||
2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 43 | 45 | 45 | 60 | 69 | 94 | 124 | $ 123 | ||
IBNR | $ 1 | |||||||||
Cumulative Number of Claims | claim | 5,118 | |||||||||
2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 53 | 58 | 63 | 79 | 104 | 131 | $ 131 | |||
IBNR | $ 9 | |||||||||
Cumulative Number of Claims | claim | 5,055 | |||||||||
2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 64 | 67 | 84 | 109 | 124 | $ 124 | ||||
IBNR | $ 10 | |||||||||
Cumulative Number of Claims | claim | 5,521 | |||||||||
2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 71 | 84 | 103 | 115 | $ 120 | |||||
IBNR | $ 9 | |||||||||
Cumulative Number of Claims | claim | 5,795 | |||||||||
2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 62 | 91 | 108 | $ 114 | ||||||
IBNR | $ 19 | |||||||||
Cumulative Number of Claims | claim | 6,097 | |||||||||
2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 98 | 112 | $ 119 | |||||||
IBNR | $ 44 | |||||||||
Cumulative Number of Claims | claim | 5,816 | |||||||||
2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 119 | $ 128 | ||||||||
IBNR | $ 104 | |||||||||
Cumulative Number of Claims | claim | 4,006 | |||||||||
2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 137 | |||||||||
IBNR | $ 129 | |||||||||
Cumulative Number of Claims | claim | 2,592 |
Claim, Claim Adjustment Expe_17
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Surety - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 5,265 | 4,898 | ||||||||
Surety | Specialty | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 396 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 369 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 17 | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 20 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 406 | |||||||||
Surety | Specialty | 2012 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 36 | 36 | 37 | 37 | $ 36 | $ 35 | $ 35 | $ 34 | $ 32 | $ 5 |
Surety | Specialty | 2013 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 79 | 78 | 77 | 78 | 78 | 78 | 69 | 40 | $ 16 | |
Surety | Specialty | 2014 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 39 | 39 | 38 | 38 | 36 | 38 | 30 | $ 7 | ||
Surety | Specialty | 2015 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 42 | 44 | 42 | 40 | 38 | 26 | $ 7 | |||
Surety | Specialty | 2016 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 43 | 43 | 45 | 45 | 37 | $ 5 | ||||
Surety | Specialty | 2017 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 49 | 46 | 41 | 37 | $ 23 | |||||
Surety | Specialty | 2018 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 39 | 34 | 25 | $ 5 | ||||||
Surety | Specialty | 2019 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 44 | 34 | $ 12 | |||||||
Surety | Specialty | 2020 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 20 | $ 4 | ||||||||
Surety | Specialty | 2021 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 5 |
Claim, Claim Adjustment Expe_18
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Specialty - Surety - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - Specialty - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
Claims Development [Line Items] | ||||||||||||||||||
Total | $ (73) | $ (69) | $ (92) | |||||||||||||||
Surety | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (76) | (67) | (79) | |||||||||||||||
Total net development for accident years prior to 2012 | 3 | (2) | (3) | |||||||||||||||
Total unallocated claim adjustment expense development | 0 | 0 | (10) | |||||||||||||||
Total | (73) | (69) | (92) | |||||||||||||||
Surety | 2012 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (1) | (1) | (1) | $ (6) | $ (7) | $ (18) | $ (28) | $ (24) | $ 2 | $ (84) | ||||||||
Surety | 2013 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 0 | (1) | (4) | (4) | (15) | (9) | (6) | $ 1 | $ (38) | |||||||||
Surety | 2014 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (2) | 0 | (15) | (9) | (25) | (30) | $ 1 | $ (80) | ||||||||||
Surety | 2015 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (5) | (5) | (16) | (25) | (27) | $ 0 | $ (78) | |||||||||||
Surety | 2016 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (3) | (17) | (25) | (15) | $ 0 | $ (60) | ||||||||||||
Surety | 2017 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (13) | (19) | (12) | $ (5) | $ (49) | |||||||||||||
Surety | 2018 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (29) | (17) | $ (6) | $ (52) | ||||||||||||||
Surety | 2019 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (14) | $ (7) | $ (21) | |||||||||||||||
Surety | 2020 | ||||||||||||||||||
Claims Development [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ (9) | $ (9) |
Claim, Claim Adjustment Expe_19
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Net Prior Year Claim and Allocated Claim Adjustment Expense Reserve Development) (Details) - Commercial - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |||
Commercial | $ 53 | $ 33 | $ (25) |
General Liability | 15 | 15 | 16 |
Workers' Compensation | (82) | (96) | (13) |
Property and Other | 8 | 41 | (18) |
Total pretax (favorable) unfavorable development | $ (6) | $ (7) | $ (40) |
Claim, Claim Adjustment Expe_20
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Commercial Auto - Short Duration Contracts) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 |
Commercial | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 8,065 | $ 7,475 | ||
Commercial Auto | Commercial | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 673 | |||
General Liability | Commercial | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 2,911 | |||
Workers' Compensation | Commercial | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 3,850 | |||
Property and Other | Commercial | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | $ 631 |
Claim, Claim Adjustment Expe_21
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Commercial Auto - Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - Commercial Auto - Commercial $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 2,582 | |||||||||
IBNR | 433 | |||||||||
2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 295 | $ 296 | $ 297 | $ 299 | $ 299 | $ 307 | $ 303 | $ 299 | $ 289 | $ 275 |
IBNR | $ 1 | |||||||||
Cumulative Number of Claims | claim | 46,288 | |||||||||
2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 241 | 241 | 241 | 245 | 245 | 249 | 265 | 265 | $ 246 | |
IBNR | $ 2 | |||||||||
Cumulative Number of Claims | claim | 39,430 | |||||||||
2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 202 | 201 | 201 | 205 | 205 | 212 | 223 | $ 234 | ||
IBNR | $ 2 | |||||||||
Cumulative Number of Claims | claim | 33,628 | |||||||||
2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 183 | 181 | 183 | 190 | 190 | 199 | $ 201 | |||
IBNR | $ 3 | |||||||||
Cumulative Number of Claims | claim | 30,427 | |||||||||
2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 195 | 190 | 186 | 186 | 186 | $ 198 | ||||
IBNR | $ 3 | |||||||||
Cumulative Number of Claims | claim | 30,449 | |||||||||
2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 232 | 221 | 200 | 198 | $ 199 | |||||
IBNR | $ 5 | |||||||||
Cumulative Number of Claims | claim | 30,940 | |||||||||
2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 245 | 227 | 227 | $ 229 | ||||||
IBNR | $ 8 | |||||||||
Cumulative Number of Claims | claim | 34,292 | |||||||||
2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 289 | 266 | $ 257 | |||||||
IBNR | $ 31 | |||||||||
Cumulative Number of Claims | claim | 37,142 | |||||||||
2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 303 | $ 310 | ||||||||
IBNR | $ 107 | |||||||||
Cumulative Number of Claims | claim | 28,837 | |||||||||
2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 397 | |||||||||
IBNR | $ 271 | |||||||||
Cumulative Number of Claims | claim | 27,182 |
Claim, Claim Adjustment Expe_22
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Commercial Auto - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 8,065 | 7,475 | ||||||||
Commercial Auto | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 1,928 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 654 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 5 | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 14 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 673 | |||||||||
Commercial Auto | Commercial | 2012 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 292 | 291 | 291 | 290 | $ 285 | $ 282 | $ 259 | $ 220 | $ 160 | $ 78 |
Commercial Auto | Commercial | 2013 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 239 | 239 | 238 | 234 | 225 | 200 | 168 | 135 | $ 74 | |
Commercial Auto | Commercial | 2014 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 199 | 198 | 196 | 187 | 166 | 137 | 102 | $ 64 | ||
Commercial Auto | Commercial | 2015 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 178 | 175 | 172 | 153 | 130 | 96 | $ 52 | |||
Commercial Auto | Commercial | 2016 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 185 | 175 | 154 | 126 | 93 | $ 52 | ||||
Commercial Auto | Commercial | 2017 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 203 | 178 | 150 | 107 | $ 58 | |||||
Commercial Auto | Commercial | 2018 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 212 | 175 | 128 | $ 66 | ||||||
Commercial Auto | Commercial | 2019 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 203 | 147 | $ 77 | |||||||
Commercial Auto | Commercial | 2020 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 134 | $ 71 | ||||||||
Commercial Auto | Commercial | 2021 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 83 |
Claim, Claim Adjustment Expe_23
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Commercial Auto - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - Commercial - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Total | $ 53 | $ 33 | $ (25) | |||||||||||||||
Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 52 | 31 | (17) | |||||||||||||||
Total net development for accident years prior to 2012 | 1 | 2 | (7) | |||||||||||||||
Total unallocated claim adjustment expense development | 0 | 0 | (1) | |||||||||||||||
Total | 53 | 33 | (25) | |||||||||||||||
2012 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (1) | (1) | (2) | $ 0 | $ (8) | $ 4 | $ 4 | $ 10 | $ 14 | $ 20 | ||||||||
2013 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 0 | 0 | (4) | 0 | (4) | (16) | 0 | $ 19 | $ (5) | |||||||||
2014 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 1 | 0 | (4) | 0 | (7) | (11) | $ (11) | $ (32) | ||||||||||
2015 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 2 | (2) | (7) | 0 | (9) | $ (2) | $ (18) | |||||||||||
2016 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 5 | 4 | 0 | 0 | $ (12) | $ (3) | ||||||||||||
2017 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 11 | 21 | 2 | $ (1) | $ 33 | |||||||||||||
2018 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 18 | 0 | $ (2) | $ 16 | ||||||||||||||
2019 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 23 | $ 9 | $ 32 | |||||||||||||||
2020 | Commercial Auto | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ (7) | $ (7) |
Claim, Claim Adjustment Expe_24
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - General Liability - Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - General Liability - Commercial $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 6,670 | |||||||||
IBNR | 2,006 | |||||||||
2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 632 | $ 632 | $ 630 | $ 635 | $ 635 | $ 619 | $ 636 | $ 639 | $ 611 | $ 587 |
IBNR | $ 20 | |||||||||
Cumulative Number of Claims | claim | 35,313 | |||||||||
2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 624 | 623 | 620 | 623 | 613 | 655 | 650 | 655 | $ 650 | |
IBNR | $ 24 | |||||||||
Cumulative Number of Claims | claim | 33,706 | |||||||||
2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 659 | 659 | 658 | 635 | 631 | 654 | 658 | $ 653 | ||
IBNR | $ 28 | |||||||||
Cumulative Number of Claims | claim | 28,064 | |||||||||
2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 617 | 602 | 600 | 589 | 574 | 576 | $ 581 | |||
IBNR | $ 42 | |||||||||
Cumulative Number of Claims | claim | 24,118 | |||||||||
2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 683 | 673 | 671 | 667 | 659 | $ 623 | ||||
IBNR | $ 68 | |||||||||
Cumulative Number of Claims | claim | 24,511 | |||||||||
2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 630 | 634 | 632 | 632 | $ 632 | |||||
IBNR | $ 67 | |||||||||
Cumulative Number of Claims | claim | 22,195 | |||||||||
2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 639 | 646 | 644 | $ 653 | ||||||
IBNR | $ 205 | |||||||||
Cumulative Number of Claims | claim | 19,917 | |||||||||
2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 682 | 682 | $ 680 | |||||||
IBNR | $ 330 | |||||||||
Cumulative Number of Claims | claim | 18,602 | |||||||||
2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 722 | $ 723 | ||||||||
IBNR | $ 516 | |||||||||
Cumulative Number of Claims | claim | 13,028 | |||||||||
2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 782 | |||||||||
IBNR | $ 706 | |||||||||
Cumulative Number of Claims | claim | 9,759 |
Claim, Claim Adjustment Expe_25
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - General Liability - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 8,065 | 7,475 | ||||||||
General Liability | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 3,929 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 2,741 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 119 | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 51 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 2,911 | |||||||||
General Liability | Commercial | 2012 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 602 | 597 | 579 | 559 | $ 510 | $ 454 | $ 374 | $ 247 | $ 132 | $ 28 |
General Liability | Commercial | 2013 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 582 | 572 | 551 | 510 | 450 | 352 | 240 | 128 | $ 31 | |
General Liability | Commercial | 2014 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 607 | 569 | 547 | 481 | 376 | 247 | 119 | $ 31 | ||
General Liability | Commercial | 2015 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 530 | 501 | 446 | 357 | 230 | 110 | $ 19 | |||
General Liability | Commercial | 2016 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 524 | 481 | 407 | 279 | 163 | $ 32 | ||||
General Liability | Commercial | 2017 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 471 | 399 | 250 | 118 | $ 23 | |||||
General Liability | Commercial | 2018 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 307 | 228 | 107 | $ 33 | ||||||
General Liability | Commercial | 2019 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 181 | 98 | $ 25 | |||||||
General Liability | Commercial | 2020 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 99 | $ 23 | ||||||||
General Liability | Commercial | 2021 | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 26 |
Claim, Claim Adjustment Expe_26
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - General Liability - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - Commercial - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Total | $ 15 | $ 15 | $ 16 | |||||||||||||||
General Liability | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 14 | 16 | 21 | |||||||||||||||
Total net development for accident years prior to 2012 | (1) | (1) | (4) | |||||||||||||||
Total unallocated claim adjustment expense development | 2 | 0 | (1) | |||||||||||||||
Total | 15 | 15 | 16 | |||||||||||||||
General Liability | 2012 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 0 | 2 | (5) | $ 0 | $ 16 | $ (17) | $ (3) | $ 28 | $ 24 | $ 45 | ||||||||
General Liability | 2013 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 1 | 3 | (3) | 10 | (42) | 5 | (5) | $ 5 | $ (26) | |||||||||
General Liability | 2014 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 0 | 1 | 23 | 4 | (23) | (4) | $ 5 | $ 6 | ||||||||||
General Liability | 2015 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 15 | 2 | 11 | 15 | (2) | $ (5) | $ 36 | |||||||||||
General Liability | 2016 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 10 | 2 | 4 | 8 | $ 36 | $ 60 | ||||||||||||
General Liability | 2017 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (4) | 2 | 0 | $ 0 | $ (2) | |||||||||||||
General Liability | 2018 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (7) | 2 | $ (9) | $ (14) | ||||||||||||||
General Liability | 2019 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 0 | $ 2 | $ 2 | |||||||||||||||
General Liability | 2020 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ (1) | $ (1) |
Claim, Claim Adjustment Expe_27
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Workers' Compensation - Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - Workers' Compensation - Commercial $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 4,575 | |||||||||
IBNR | 1,325 | |||||||||
2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 664 | $ 663 | $ 668 | $ 671 | $ 673 | $ 678 | $ 669 | $ 659 | $ 627 | $ 601 |
IBNR | $ 66 | |||||||||
Cumulative Number of Claims | claim | 42,804 | |||||||||
2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 548 | 552 | 561 | 582 | 593 | 618 | 592 | 572 | $ 537 | |
IBNR | $ 91 | |||||||||
Cumulative Number of Claims | claim | 38,867 | |||||||||
2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 448 | 439 | 446 | 450 | 452 | 479 | 480 | $ 467 | ||
IBNR | $ 105 | |||||||||
Cumulative Number of Claims | claim | 33,502 | |||||||||
2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 372 | 382 | 394 | 408 | 406 | 431 | $ 422 | |||
IBNR | $ 101 | |||||||||
Cumulative Number of Claims | claim | 31,894 | |||||||||
2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 355 | 366 | 382 | 396 | 405 | $ 426 | ||||
IBNR | $ 104 | |||||||||
Cumulative Number of Claims | claim | 31,981 | |||||||||
2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 402 | 400 | 421 | 432 | $ 440 | |||||
IBNR | $ 92 | |||||||||
Cumulative Number of Claims | claim | 33,121 | |||||||||
2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 415 | 428 | 440 | $ 450 | ||||||
IBNR | $ 104 | |||||||||
Cumulative Number of Claims | claim | 34,851 | |||||||||
2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 437 | 449 | $ 452 | |||||||
IBNR | $ 134 | |||||||||
Cumulative Number of Claims | claim | 34,248 | |||||||||
2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 466 | $ 477 | ||||||||
IBNR | $ 228 | |||||||||
Cumulative Number of Claims | claim | 29,188 | |||||||||
2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 468 | |||||||||
IBNR | $ 300 | |||||||||
Cumulative Number of Claims | claim | 25,711 |
Claim, Claim Adjustment Expe_28
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Workers' Compensation - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 8,065 | 7,475 | ||||||||
Workers' Compensation | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 2,703 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 1,872 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 1,941 | |||||||||
Other | (14) | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 51 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 3,850 | |||||||||
Workers' Compensation | 2012 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 541 | 538 | 536 | 524 | $ 509 | $ 470 | $ 416 | $ 342 | $ 232 | $ 87 |
Workers' Compensation | 2013 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 417 | 414 | 411 | 419 | 417 | 370 | 300 | 213 | $ 80 | |
Workers' Compensation | 2014 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 306 | 297 | 290 | 282 | 258 | 215 | 159 | $ 61 | ||
Workers' Compensation | 2015 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 251 | 243 | 231 | 212 | 180 | 131 | $ 51 | |||
Workers' Compensation | 2016 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 227 | 219 | 198 | 169 | 129 | $ 53 | ||||
Workers' Compensation | 2017 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 265 | 243 | 207 | 151 | $ 63 | |||||
Workers' Compensation | 2018 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 259 | 229 | 163 | $ 68 | ||||||
Workers' Compensation | 2019 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 223 | 169 | $ 71 | |||||||
Workers' Compensation | 2020 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 147 | $ 65 | ||||||||
Workers' Compensation | 2021 | Commercial | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 67 |
Claim, Claim Adjustment Expe_29
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Commercial - Workers' Compensation - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - Commercial - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Total | $ (82) | $ (96) | $ (13) | |||||||||||||||
Workers' Compensation | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (49) | (85) | (77) | |||||||||||||||
Adjustment for development on a discounted basis | 2 | 2 | 3 | |||||||||||||||
Total net development for accident years prior to 2012 | (35) | (13) | 38 | |||||||||||||||
Total unallocated claim adjustment expense development | 0 | 0 | 23 | |||||||||||||||
Total | (82) | (96) | (13) | |||||||||||||||
Workers' Compensation | 2012 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 1 | (5) | (3) | $ (2) | $ (5) | $ 9 | $ 10 | $ 32 | $ 26 | $ 63 | ||||||||
Workers' Compensation | 2013 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (4) | (9) | (21) | (11) | (25) | 26 | 20 | $ 35 | $ 11 | |||||||||
Workers' Compensation | 2014 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 9 | (7) | (4) | (2) | (27) | (1) | $ 13 | $ (19) | ||||||||||
Workers' Compensation | 2015 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (10) | (12) | (14) | 2 | (25) | $ 9 | $ (50) | |||||||||||
Workers' Compensation | 2016 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (11) | (16) | (14) | (9) | $ (21) | $ (71) | ||||||||||||
Workers' Compensation | 2017 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 2 | (21) | (11) | $ (8) | $ (38) | |||||||||||||
Workers' Compensation | 2018 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (13) | (12) | $ (10) | $ (35) | ||||||||||||||
Workers' Compensation | 2019 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (12) | $ (3) | $ (15) | |||||||||||||||
Workers' Compensation | 2020 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ (11) | $ (11) |
Claim, Claim Adjustment Expe_30
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Net prior year claim and allocated claim adjustment expense reserve development) (Details) - International - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |||
Commercial | $ (35) | $ (2) | $ (8) |
Specialty | 36 | 3 | 37 |
Other | 1 | (3) | (8) |
Total pretax (favorable) unfavorable development | $ 2 | $ (2) | $ 21 |
Claim, Claim Adjustment Expe_31
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Short Duration Contracts) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 |
International | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 1,940 | $ 1,822 | ||
Excluding Hardy | International | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | 1,400 | |||
Hardy | International | ||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||
Total net liability for unpaid claim and claim adjustment expenses | $ 540 |
Claim, Claim Adjustment Expe_32
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Excluding Hardy - Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - Excluding Hardy - International $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 3,371 | |||||||||
IBNR | 845 | |||||||||
2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 250 | $ 236 | $ 241 | $ 247 | $ 254 | $ 261 | $ 262 | $ 269 | $ 285 | $ 278 |
IBNR | $ 16 | |||||||||
Cumulative Number of Claims | claim | 24,998 | |||||||||
2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 251 | 247 | 251 | 260 | 269 | 273 | 293 | 301 | $ 285 | |
IBNR | $ 12 | |||||||||
Cumulative Number of Claims | claim | 23,967 | |||||||||
2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 294 | 301 | 300 | 283 | 291 | 303 | 303 | $ 288 | ||
IBNR | $ 16 | |||||||||
Cumulative Number of Claims | claim | 24,946 | |||||||||
2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 297 | 294 | 292 | 298 | 316 | 317 | $ 301 | |||
IBNR | $ 27 | |||||||||
Cumulative Number of Claims | claim | 23,357 | |||||||||
2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 302 | 287 | 297 | 300 | 315 | $ 296 | ||||
IBNR | $ 37 | |||||||||
Cumulative Number of Claims | claim | 17,776 | |||||||||
2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 388 | 393 | 401 | 378 | $ 312 | |||||
IBNR | $ 84 | |||||||||
Cumulative Number of Claims | claim | 18,470 | |||||||||
2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 406 | 407 | 402 | $ 384 | ||||||
IBNR | $ 81 | |||||||||
Cumulative Number of Claims | claim | 20,726 | |||||||||
2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 368 | 371 | $ 357 | |||||||
IBNR | $ 91 | |||||||||
Cumulative Number of Claims | claim | 17,974 | |||||||||
2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 389 | $ 398 | ||||||||
IBNR | $ 184 | |||||||||
Cumulative Number of Claims | claim | 13,909 | |||||||||
2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 426 | |||||||||
IBNR | $ 297 | |||||||||
Cumulative Number of Claims | claim | 10,401 |
Claim, Claim Adjustment Expe_33
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Excluding Hardy - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 1,940 | 1,822 | ||||||||
Excluding Hardy | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 2,053 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 1,318 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 47 | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 35 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 1,400 | |||||||||
Excluding Hardy | 2012 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 218 | 215 | 213 | 210 | $ 200 | $ 188 | $ 172 | $ 151 | $ 117 | $ 46 |
Excluding Hardy | 2013 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 224 | 218 | 206 | 186 | 176 | 161 | 144 | 116 | $ 51 | |
Excluding Hardy | 2014 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 250 | 245 | 211 | 190 | 173 | 154 | 126 | $ 54 | ||
Excluding Hardy | 2015 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 239 | 228 | 213 | 189 | 168 | 137 | $ 58 | |||
Excluding Hardy | 2016 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 223 | 200 | 188 | 164 | 136 | $ 68 | ||||
Excluding Hardy | 2017 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 247 | 223 | 193 | 152 | $ 67 | |||||
Excluding Hardy | 2018 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 252 | 221 | 173 | $ 94 | ||||||
Excluding Hardy | 2019 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 209 | 171 | $ 76 | |||||||
Excluding Hardy | 2020 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 133 | $ 62 | ||||||||
Excluding Hardy | 2021 | International | ||||||||||
Short-Duration Insurance Contracts, Net Cumulative Paid Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 58 |
Claim, Claim Adjustment Expe_34
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Excluding Hardy - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - Excluding Hardy - International - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
2012 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ 14 | $ (5) | $ (6) | $ (7) | $ (7) | $ (1) | $ (7) | $ (16) | $ 7 | $ (28) | ||||||||
2013 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 4 | (4) | (9) | (9) | (4) | (20) | (8) | $ 16 | $ (34) | |||||||||
2014 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (7) | 1 | 17 | (8) | (12) | 0 | $ 15 | $ 6 | ||||||||||
2015 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 3 | 2 | (6) | (18) | (1) | $ 16 | $ (4) | |||||||||||
2016 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 15 | (10) | (3) | (15) | $ 19 | $ 6 | ||||||||||||
2017 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (5) | (8) | 23 | $ 66 | $ 76 | |||||||||||||
2018 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (1) | 5 | $ 18 | $ 22 | ||||||||||||||
2019 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (3) | $ 14 | $ 11 | |||||||||||||||
2020 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ (9) | $ (9) |
Claim, Claim Adjustment Expe_35
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Hardy - Net Incurred Claims and Allocated Claim Adjustment Expenses) (Details) - International $ in Millions | Dec. 31, 2021USD ($)claim | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | Dec. 31, 2013USD ($) | Dec. 31, 2012USD ($) |
Hardy | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 2,008 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 529 | |||||||||
IBNR | 297 | |||||||||
Hardy | 2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Net Claim and Allocated Claim Adjustment Expense Reserves at Acquisition | $ 34 | |||||||||
Incurred claims and allocated claim adjustment expense, net | 114 | $ 113 | $ 115 | $ 116 | $ 114 | $ 113 | $ 120 | $ 112 | $ 105 | 71 |
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 105 | |||||||||
IBNR | $ (3) | |||||||||
Cumulative Number of Claims | claim | 7,045,000,000 | |||||||||
Hardy | 2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 144 | 146 | 146 | 145 | 142 | 140 | 139 | 147 | 132 | |
IBNR | $ 7 | |||||||||
Cumulative Number of Claims | claim | 7,893,000,000 | |||||||||
Hardy | 2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 169 | 172 | 173 | 172 | 171 | 178 | 184 | 186 | ||
IBNR | $ (6) | |||||||||
Cumulative Number of Claims | claim | 8,493,000,000 | |||||||||
Hardy | 2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 181 | 180 | 178 | 180 | 179 | 181 | 191 | |||
IBNR | $ (1) | |||||||||
Cumulative Number of Claims | claim | 9,669,000,000 | |||||||||
Hardy | 2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 222 | 228 | 226 | 238 | 249 | 231 | ||||
IBNR | $ (1) | |||||||||
Cumulative Number of Claims | claim | 10,746,000,000 | |||||||||
Hardy | 2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 253 | 246 | 244 | 256 | 246 | |||||
IBNR | $ 8 | |||||||||
Cumulative Number of Claims | claim | 13,029,000,000 | |||||||||
Hardy | 2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 316 | 310 | 306 | 275 | ||||||
IBNR | $ 36 | |||||||||
Cumulative Number of Claims | claim | 14,868,000,000 | |||||||||
Hardy | 2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 223 | 228 | 224 | |||||||
IBNR | $ 42 | |||||||||
Cumulative Number of Claims | claim | 10,891,000,000 | |||||||||
Hardy | 2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 205 | 215 | ||||||||
IBNR | $ 87 | |||||||||
Cumulative Number of Claims | claim | 5,963,000,000 | |||||||||
Hardy | 2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 181 | |||||||||
IBNR | $ 128 | |||||||||
Cumulative Number of Claims | claim | 2,244,000,000 | |||||||||
Excluding Hardy | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 3,371 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 1,318 | |||||||||
IBNR | 845 | |||||||||
Excluding Hardy | 2012 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | 250 | 236 | 241 | 247 | 254 | 261 | 262 | 269 | 285 | $ 278 |
IBNR | $ 16 | |||||||||
Cumulative Number of Claims | claim | 24,998 | |||||||||
Excluding Hardy | 2013 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 251 | 247 | 251 | 260 | 269 | 273 | 293 | 301 | $ 285 | |
IBNR | $ 12 | |||||||||
Cumulative Number of Claims | claim | 23,967 | |||||||||
Excluding Hardy | 2014 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 294 | 301 | 300 | 283 | 291 | 303 | 303 | $ 288 | ||
IBNR | $ 16 | |||||||||
Cumulative Number of Claims | claim | 24,946 | |||||||||
Excluding Hardy | 2015 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 297 | 294 | 292 | 298 | 316 | 317 | $ 301 | |||
IBNR | $ 27 | |||||||||
Cumulative Number of Claims | claim | 23,357 | |||||||||
Excluding Hardy | 2016 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 302 | 287 | 297 | 300 | 315 | $ 296 | ||||
IBNR | $ 37 | |||||||||
Cumulative Number of Claims | claim | 17,776 | |||||||||
Excluding Hardy | 2017 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 388 | 393 | 401 | 378 | $ 312 | |||||
IBNR | $ 84 | |||||||||
Cumulative Number of Claims | claim | 18,470 | |||||||||
Excluding Hardy | 2018 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 406 | 407 | 402 | $ 384 | ||||||
IBNR | $ 81 | |||||||||
Cumulative Number of Claims | claim | 20,726 | |||||||||
Excluding Hardy | 2019 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 368 | 371 | $ 357 | |||||||
IBNR | $ 91 | |||||||||
Cumulative Number of Claims | claim | 17,974 | |||||||||
Excluding Hardy | 2020 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 389 | $ 398 | ||||||||
IBNR | $ 184 | |||||||||
Cumulative Number of Claims | claim | 13,909 | |||||||||
Excluding Hardy | 2021 | ||||||||||
Short-duration Insurance Contracts, Net Incurred Claim and Claim Adjustment Expenses [Line Items] | ||||||||||
Incurred claims and allocated claim adjustment expense, net | $ 426 | |||||||||
IBNR | $ 297 | |||||||||
Cumulative Number of Claims | claim | 10,401 |
Claim, Claim Adjustment Expe_36
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Hardy - Net Cumulative Paid Claim and Claim Adjustment Expenses) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | $ 19,205 | $ 18,701 | $ 17,885 | $ 17,965 | ||||||
International | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Total net liability for unpaid claim and claim adjustment expenses | 1,940 | 1,822 | ||||||||
Hardy | International | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 1,479 | |||||||||
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | 529 | |||||||||
Net liability for unpaid claim and claim adjustment expenses for accident years prior to 2012 | 3 | |||||||||
Liability for unallocated claim adjustment expenses for accident years presented | 8 | |||||||||
Total net liability for unpaid claim and claim adjustment expenses | 540 | |||||||||
Hardy | International | 2012 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 115 | 112 | 111 | 110 | $ 109 | $ 107 | $ 109 | $ 100 | $ 80 | $ 14 |
Net liability for unpaid claim and allocated claim adjustment expenses for the accident years presented | $ 105 | |||||||||
Hardy | International | 2013 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 141 | 140 | 139 | 135 | 132 | 128 | 122 | 102 | $ 38 | |
Hardy | International | 2014 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 166 | 165 | 163 | 157 | 152 | 142 | 124 | $ 56 | ||
Hardy | International | 2015 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 164 | 166 | 158 | 146 | 130 | 99 | $ 30 | |||
Hardy | International | 2016 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 208 | 196 | 183 | 174 | 146 | $ 64 | ||||
Hardy | International | 2017 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 215 | 207 | 185 | 152 | $ 53 | |||||
Hardy | International | 2018 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 236 | 205 | 176 | $ 55 | ||||||
Hardy | International | 2019 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 142 | 104 | $ 44 | |||||||
Hardy | International | 2020 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | 79 | $ 28 | ||||||||
Hardy | International | 2021 | ||||||||||
Short Duration Contracts Net Cumulative Paid Claim Adjustment Expenses [Line Items] | ||||||||||
Cumulative paid claims and allocated claim adjustment expense, net | $ 13 |
Claim, Claim Adjustment Expe_37
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (International - Hardy - Net Strengthening or Releasing of Prior Accident Year Reserves) (Details) - International - Hardy - USD ($) $ in Millions | 12 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | 72 Months Ended | 84 Months Ended | 96 Months Ended | 108 Months Ended | 120 Months Ended | ||||||||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | |
2012 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ 1 | $ (2) | $ (1) | $ 2 | $ 1 | $ (7) | $ 8 | $ 7 | $ 0 | $ 9 | ||||||||
2013 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (2) | 0 | 1 | 3 | 2 | 1 | (8) | $ 15 | $ 12 | |||||||||
2014 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (3) | (1) | 1 | 1 | (7) | (6) | $ (2) | $ (17) | ||||||||||
2015 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 1 | 2 | (2) | 1 | (2) | $ (10) | $ (10) | |||||||||||
2016 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (6) | 2 | (12) | (11) | $ 18 | $ (9) | ||||||||||||
2017 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 7 | 2 | (12) | $ 10 | $ 7 | |||||||||||||
2018 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | 6 | 4 | $ 31 | $ 41 | ||||||||||||||
2019 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | (5) | $ 4 | $ (1) | |||||||||||||||
2020 | ||||||||||||||||||
Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] | ||||||||||||||||||
Cumulative Number of Claims | $ (10) | $ (10) |
Claim, Claim Adjustment Expe_38
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Historical Claims Duration) (Details) | Dec. 31, 2021 |
Medical Professional Liability | Specialty | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 3.60% |
Year 2 | 18.30% |
Year 3 | 23.70% |
Year 4 | 18.20% |
Year 5 | 12.00% |
Year 6 | 8.30% |
Year 7 | 5.10% |
Year 8 | 2.80% |
Year 9 | 0.70% |
Year 10 | 1.00% |
Other Professional Liability and Management Liability | Specialty | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 6.70% |
Year 2 | 21.90% |
Year 3 | 21.10% |
Year 4 | 16.70% |
Year 5 | 9.90% |
Year 6 | 6.40% |
Year 7 | 4.30% |
Year 8 | 3.50% |
Year 9 | 1.70% |
Year 10 | 0.50% |
Surety | Specialty | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 14.10% |
Year 2 | 48.70% |
Year 3 | 18.90% |
Year 4 | 2.60% |
Year 5 | 1.10% |
Year 6 | 1.30% |
Year 7 | 0.00% |
Year 8 | 0.40% |
Year 9 | (0.80%) |
Year 10 | 0.00% |
Commercial Auto | Commercial | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 26.70% |
Year 2 | 23.20% |
Year 3 | 18.00% |
Year 4 | 13.60% |
Year 5 | 10.10% |
Year 6 | 3.20% |
Year 7 | 1.50% |
Year 8 | 0.40% |
Year 9 | 0.00% |
Year 10 | 0.30% |
General Liability | Commercial | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 4.10% |
Year 2 | 14.10% |
Year 3 | 18.00% |
Year 4 | 19.00% |
Year 5 | 13.50% |
Year 6 | 8.70% |
Year 7 | 5.60% |
Year 8 | 4.10% |
Year 9 | 2.20% |
Year 10 | 0.80% |
Workers' Compensation | Commercial | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 14.70% |
Year 2 | 21.70% |
Year 3 | 13.90% |
Year 4 | 9.50% |
Year 5 | 6.40% |
Year 6 | 2.70% |
Year 7 | 1.10% |
Year 8 | 1.50% |
Year 9 | 0.40% |
Year 10 | 0.50% |
Excluding Hardy | International | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 19.00% |
Year 2 | 23.70% |
Year 3 | 10.80% |
Year 4 | 7.40% |
Year 5 | 6.10% |
Year 6 | 5.70% |
Year 7 | 6.80% |
Year 8 | 2.60% |
Year 9 | 1.60% |
Year 10 | 1.20% |
Hardy | International | |
Short-duration Insurance Contracts, Historical Claims Duration [Line Items] | |
Year 1 | 20.40% |
Year 2 | 36.10% |
Year 3 | 13.40% |
Year 4 | 6.90% |
Year 5 | 4.40% |
Year 6 | 3.90% |
Year 7 | 1.00% |
Year 8 | 0.60% |
Year 9 | 0.70% |
Claim, Claim Adjustment Expe_39
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Impact of Loss Portfolio Transfer on the Consolidated Statement of Operations) (Details) - Asbestos and Environmental Reserves - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Liability for Claims and Claims Adjustment Expense [Line Items] | |||
Net A&EP adverse development before consideration of LPT | $ 143 | $ 125 | $ 150 |
Provision for uncollectible third-party reinsurance on A&EP | (5) | (25) | (25) |
Total additional amounts ceded under LPT | 138 | 100 | 125 |
Retroactive reinsurance benefit recognized | (107) | (94) | (107) |
Pretax impact of deferred retroactive reinsurance | $ 31 | $ 6 | $ 18 |
Claim, Claim Adjustment Expe_40
Claim, Claim Adjustment Expense and Future Policy Benefit Reserves (Life & Group Policyholder Reserves) (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2021 | |
Liability for Claims and Claims Adjustment Expense [Abstract] | ||||
Liability for unpaid claims and claims adjustment expense, long term care policies, period increase (decrease) | $ (40) | $ (37) | $ (56) | |
Liability for unpaid claims and claims adjustment expense structured settlement obligations period increase (decrease) | 2 | 46 | ||
Liability for future policy benefits, gross premium valuation, pretax margin | $ 72 | $ 72 | ||
Premium deficiency and future policy benefit | $ 74 | $ 216 |
Legal Proceedings, Contingenc_2
Legal Proceedings, Contingencies and Guarantees (Narrative) (Details) $ in Billions | Dec. 31, 2021USD ($) |
Guarantee Obligations | |
Legal Proceedings, Commitments and Contingencies, and Guarantees [Line Items] | |
Guarantor obligations, maximum exposure, undiscounted | $ 1.6 |
Reinsurance (Components of Rein
Reinsurance (Components of Reinsurance Receivables) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Reinsurance receivables related to insurance reserves | ||||
Ceded claim and claim adjustment expenses | $ 4,969 | $ 4,005 | $ 3,835 | $ 4,019 |
Ceded future policy benefits | 288 | 263 | ||
Reinsurance receivables related to paid losses | 227 | 210 | ||
Reinsurance receivables | 5,484 | 4,478 | ||
Allowance for uncollectible reinsurance | (21) | (21) | ||
Reinsurance receivables, net of allowance for uncollectible reinsurance | $ 5,463 | $ 4,457 |
Reinsurance (Voluntary Reinsura
Reinsurance (Voluntary Reinsurance) (Details) $ in Millions | Dec. 31, 2021USD ($) |
Effects of Reinsurance [Line Items] | |
Total voluntary reinsurance outstanding balance | $ 4,802 |
A- to A++ | |
Effects of Reinsurance [Line Items] | |
Total voluntary reinsurance outstanding balance | 3,812 |
B- to B++ | |
Effects of Reinsurance [Line Items] | |
Total voluntary reinsurance outstanding balance | 987 |
Insolvent | |
Effects of Reinsurance [Line Items] | |
Total voluntary reinsurance outstanding balance | $ 3 |
Reinsurance (Narrative) (Detail
Reinsurance (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Feb. 05, 2021 | |
Ceded Credit Risk [Line Items] | ||||
Funds held under reinsurance agreements, liability | $ 4,000 | $ 3,300 | $ 690 | |
Largest recoverable from single reinsurer | 5,463 | 4,457 | ||
Reinsurance recoveries reported in insurance claims and policyholders' benefits reported on the Consolidated Statement of Operations | 3,058 | 3,158 | $ 2,733 | |
Subsidiaries of Berkshire Hathaway Group | ||||
Ceded Credit Risk [Line Items] | ||||
Largest recoverable from single reinsurer | 1,800 | |||
Cavello Bay Reinsurance Limited | ||||
Ceded Credit Risk [Line Items] | ||||
Largest recoverable from single reinsurer | 612 | |||
Gateway Rivers Insurance Company | ||||
Ceded Credit Risk [Line Items] | ||||
Largest recoverable from single reinsurer | 425 | |||
Significant Captive Program | ||||
Ceded Credit Risk [Line Items] | ||||
Direct and ceded earned premiums | 3,638 | 3,543 | 3,578 | |
Reinsurance recoveries reported in insurance claims and policyholders' benefits reported on the Consolidated Statement of Operations | $ 2,003 | $ 2,375 | $ 2,080 |
Reinsurance (Components of Earn
Reinsurance (Components of Earned Premiums) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Premiums Earned, Net [Abstract] | |||
Direct | $ 12,997 | $ 12,001 | $ 11,491 |
Assumed | 288 | 288 | 338 |
Ceded | 5,110 | 4,640 | 4,401 |
Net | 8,175 | 7,649 | 7,428 |
Property and casualty | |||
Premiums Earned, Net [Abstract] | |||
Direct | 12,554 | 11,547 | 11,021 |
Assumed | 240 | 238 | 288 |
Ceded | 5,110 | 4,640 | 4,401 |
Net | 7,684 | 7,145 | 6,908 |
Long term care | |||
Premiums Earned, Net [Abstract] | |||
Direct | 443 | 454 | 470 |
Assumed | 48 | 50 | 50 |
Ceded | 0 | 0 | 0 |
Net | $ 491 | $ 504 | $ 520 |
Percentage of assumed premiums earned to net premiums earned | |||
Premiums Earned, Net [Abstract] | |||
Assumed/ Net % | 3.50% | 3.80% | 4.60% |
Percentage of assumed premiums earned to net premiums earned | Property and casualty | |||
Premiums Earned, Net [Abstract] | |||
Assumed/ Net % | 3.10% | 3.30% | 4.20% |
Percentage of assumed premiums earned to net premiums earned | Long term care | |||
Premiums Earned, Net [Abstract] | |||
Assumed/ Net % | 9.80% | 9.90% | 9.60% |
Reinsurance (Components of Writ
Reinsurance (Components of Written Premiums) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Premiums Written, Net [Abstract] | |||
Direct | $ 13,587 | $ 12,612 | $ 11,894 |
Assumed | 303 | 279 | 331 |
Ceded | 5,485 | 4,832 | 4,569 |
Net | 8,405 | 8,059 | 7,656 |
Property and casualty | |||
Premiums Written, Net [Abstract] | |||
Direct | 13,150 | 12,168 | 11,421 |
Assumed | 255 | 229 | 281 |
Ceded | 5,485 | 4,832 | 4,569 |
Net | 7,920 | 7,565 | 7,133 |
Long term care | |||
Premiums Written, Net [Abstract] | |||
Direct | 437 | 444 | 473 |
Assumed | 48 | 50 | 50 |
Ceded | 0 | 0 | 0 |
Net | $ 485 | $ 494 | $ 523 |
Percentage of assumed premiums written to net premiums written | |||
Premiums Written, Net [Abstract] | |||
Assumed/ Net % | 3.60% | 3.50% | 4.30% |
Percentage of assumed premiums written to net premiums written | Property and casualty | |||
Premiums Written, Net [Abstract] | |||
Assumed/ Net % | 3.20% | 3.00% | 3.90% |
Percentage of assumed premiums written to net premiums written | Long term care | |||
Premiums Written, Net [Abstract] | |||
Assumed/ Net % | 9.90% | 10.10% | 9.60% |
Debt (Schedule of debt instrume
Debt (Schedule of debt instruments) (Details) - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
Debt Instrument [Line Items] | ||
Long term debt | $ 2,779,000,000 | $ 2,776,000,000 |
Total | $ 2,779,000,000 | 2,776,000,000 |
3.950%, face amount of $550, due May 15, 2024 | ||
Debt Instrument [Line Items] | ||
Stated interest rate | 3.95% | |
Face amount | $ 550,000,000 | |
Long term debt | $ 549,000,000 | 548,000,000 |
4.500%, face amount of $500, due March 1, 2026 | ||
Debt Instrument [Line Items] | ||
Stated interest rate | 4.50% | |
Face amount | $ 500,000,000 | |
Long term debt | $ 499,000,000 | 499,000,000 |
3.450%, face amount of $500, due August 15, 2027 | ||
Debt Instrument [Line Items] | ||
Stated interest rate | 3.45% | |
Face amount | $ 500,000,000 | |
Long term debt | $ 497,000,000 | 496,000,000 |
3.900%, face amount of $500, due May 1, 2029 | ||
Debt Instrument [Line Items] | ||
Stated interest rate | 3.90% | |
Face amount | $ 500,000,000 | |
Long term debt | $ 496,000,000 | 496,000,000 |
2.050%, face amount of $500, due August 15, 2030 | ||
Debt Instrument [Line Items] | ||
Stated interest rate | 2.05% | |
Face amount | $ 500,000,000 | |
Long term debt | $ 495,000,000 | 495,000,000 |
Debenture of CNAF, 7.250%, face amount of $243, due November 15, 2023 | ||
Debt Instrument [Line Items] | ||
Stated interest rate | 7.25% | |
Face amount | $ 243,000,000 | |
Long term debt | $ 243,000,000 | $ 242,000,000 |
Debt (Narrative) (Details)
Debt (Narrative) (Details) | 12 Months Ended | ||
Dec. 31, 2019USD ($)extensionTerm | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | |
Debt Disclosure [Abstract] | |||
Federal Home Loan Bank stock | $ 5,000,000 | ||
Federal Home Loan Bank, advances, general debt obligations, maximum amount available | 106,000,000 | ||
Federal Home Loan Bank, advances, branch of FHLB Bank, amount of advances | 0 | $ 0 | |
Debt instrument, term | 5 years | ||
Line of credit, current borrowing capacity | $ 250,000,000 | ||
Additional borrowing capacity available | $ 100,000,000 | ||
Number of extension options | extensionTerm | 2 | ||
Extension term | 1 year | ||
Line of credit, minimum net worth required for compliance | 8,700,000,000 | ||
Line of credit, amount outstanding | $ 0 | $ 0 |
Debt (Maturity of debt) (Detail
Debt (Maturity of debt) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Debt Disclosure [Abstract] | ||
2022 | $ 0 | |
2023 | 243 | |
2024 | 550 | |
2025 | 0 | |
2026 | 500 | |
Thereafter | 1,500 | |
Less: discount | (14) | |
Total | $ 2,779 | $ 2,776 |
Benefit Plans (Funded Status) (
Benefit Plans (Funded Status) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Changes in benefit obligation: | |||
Actuarial (gain) loss | $ (84) | $ 205 | |
Pension Benefits | |||
Changes in benefit obligation: | |||
Balance at beginning of period | 2,769 | 2,661 | |
Interest cost | 62 | 80 | $ 100 |
Participants' contributions | 0 | 0 | |
Actuarial (gain) loss | (84) | 205 | |
Benefits paid | (182) | (173) | |
Foreign currency translation and other | (2) | 3 | |
Settlements | (2) | (7) | |
Balance at end of period | 2,561 | 2,769 | 2,661 |
Change in plan assets: | |||
Balance beginning of period | 2,420 | 2,285 | |
Actual return on plan assets | 332 | 295 | |
Company contributions | 10 | 16 | |
Participants' contributions | 0 | 0 | |
Benefits paid | (182) | (173) | |
Foreign currency translation and other | (1) | 4 | |
Settlements | (2) | (7) | |
Balance end of period | 2,577 | 2,420 | 2,285 |
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract] | |||
Funded status | 16 | (349) | |
Amounts recognized on the Consolidated Balance Sheets as of December 31: | |||
Other assets | 77 | 2 | |
Other liabilities | (61) | (351) | |
Net amount recognized | 16 | (349) | |
Amounts recognized in Accumulated other comprehensive income, not yet recognized in net periodic cost (benefit): | |||
Net actuarial (gain) loss | 763 | 1,073 | |
Net amount recognized | 763 | 1,073 | |
Postretirement Benefits | |||
Changes in benefit obligation: | |||
Balance at beginning of period | 7 | 8 | |
Interest cost | 0 | 0 | |
Participants' contributions | 3 | 2 | |
Actuarial (gain) loss | 1 | 2 | |
Benefits paid | (5) | (5) | |
Foreign currency translation and other | 0 | 0 | |
Settlements | 0 | 0 | |
Balance at end of period | 6 | 7 | 8 |
Change in plan assets: | |||
Balance beginning of period | 0 | 0 | |
Actual return on plan assets | 0 | 0 | |
Company contributions | 2 | 3 | |
Participants' contributions | 3 | 2 | |
Benefits paid | (5) | (5) | |
Foreign currency translation and other | 0 | 0 | |
Settlements | 0 | 0 | |
Balance end of period | 0 | 0 | $ 0 |
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract] | |||
Funded status | (6) | (7) | |
Amounts recognized on the Consolidated Balance Sheets as of December 31: | |||
Other assets | 0 | 0 | |
Other liabilities | (6) | (7) | |
Net amount recognized | (6) | (7) | |
Amounts recognized in Accumulated other comprehensive income, not yet recognized in net periodic cost (benefit): | |||
Net actuarial (gain) loss | 1 | 0 | |
Net amount recognized | $ 1 | $ 0 |
Benefit Plans (Narrative) (Deta
Benefit Plans (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Actuarial (gain) loss | $ (84) | $ 205 | |
Defined benefit plan, plan with accumulated benefit obligation in excess of plan assets, accumulated benefit obligation | 61 | ||
Defined benefit plan, plan with accumulated benefit obligation in excess of plan assets, plan assets | $ 0 | ||
Assumptions used in calculating assumed health care cost trend rate | 4.00% | ||
Future capital call commitments for limited partnership investments | $ 160 | ||
Percentage of limited partnerships employing hedge fund strategies focused on fixed income and equity investments | 32.00% | 51.00% | |
Defined contribution plan, maximum annual contributions per employee, percent | 50.00% | ||
Defined contribution plan, employer matching contribution, percent of match | 100.00% | ||
Defined contribution plan, employer matching contribution, percent of employees' gross pay | 6.00% | ||
Company contribution of eligible compensation, depending on age, percent | 5.00% | ||
Defined contribution plan, employers matching contribution, vesting period in years | 5 years | ||
Benefit expense for the Company's savings plan | $ 65 | $ 70 | $ 71 |
Pension Benefits | |||
Defined benefit plan, accumulated benefit obligation | 2,561 | 2,769 | |
Actuarial (gain) loss | $ (84) | $ 205 | |
Percentage of limited partnerships employing hedge fund strategies focused on fixed income and equity investments | 65.00% | 75.00% | |
Limited partnership equity related hedge fund strategy plan assets | 76.00% | ||
Limited partnership hedge fund multi strategy plan assets | 19.00% | ||
Limited partnership hedge fund strategy distressed investments plan assets | 5.00% | ||
Defined benefit plan, expected future employer contributions, next fiscal year | $ 5 | ||
Postretirement Benefits | |||
Actuarial (gain) loss | $ 1 | $ 2 | |
Defined benefit plan, health care cost trend rate assumed for next fiscal year | 4.00% | 4.00% | 4.00% |
Defined benefit plan, expected future employer contributions, next fiscal year | $ 1 | ||
Minimum | |||
Defined benefit plan, plan assets, target allocation, percentage | 40.00% | ||
Maximum | |||
Defined benefit plan, plan assets, target allocation, percentage | 60.00% |
Benefit Plans (Components of Ne
Benefit Plans (Components of Net Periodic Cost (Benefit)) (Details) - Pension Benefits - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Interest cost on projected benefit obligation | $ 62 | $ 80 | $ 100 |
Expected return on plan assets | (154) | (155) | (142) |
Amortization of net actuarial (gain) loss | 46 | 45 | 39 |
Settlement loss | 1 | 3 | 0 |
Total net periodic pension cost (benefit) | $ (45) | $ (27) | $ (3) |
Benefit Plans (Schedule of Non-
Benefit Plans (Schedule of Non-Service Cost (Benefit) Presented in the Consolidated Statement of Operations) (Details) - Pension Benefits - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net periodic defined benefits expense (reversal of expense), excluding service cost component | $ (45) | $ (27) | $ (3) |
Insurance claims and policyholder's benefits | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net periodic defined benefits expense (reversal of expense), excluding service cost component | (13) | (8) | (1) |
Other operating expenses | |||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
Net periodic defined benefits expense (reversal of expense), excluding service cost component | $ (32) | $ (19) | $ (2) |
Benefit Plans (Schedule of Amou
Benefit Plans (Schedule of Amounts Recognized in Other Comprehensive Income) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Retirement Benefits [Abstract] | |||
Amounts arising during the period | $ 262 | $ (67) | $ (112) |
Settlement | 1 | 3 | 0 |
Reclassification adjustment relating to prior service credit | 0 | 0 | 0 |
Reclassification adjustment relating to actuarial loss | 46 | 45 | 39 |
Total increase (decrease) in Other comprehensive income | $ 309 | $ (19) | $ (73) |
Benefit Plans (Actuarial Assump
Benefit Plans (Actuarial Assumptions for Benefit Obligations) (Details) | Dec. 31, 2021 | Dec. 31, 2020 |
Pension Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Discount rate | 2.75% | 2.35% |
Interest crediting rate | 3.00% | 3.00% |
Postretirement Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Discount rate | 2.25% | 1.60% |
Benefit Plans (Actuarial Assu_2
Benefit Plans (Actuarial Assumptions for Net Cost or Benefit) (Details) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Discount rate | 2.35% | 3.15% | 4.25% |
Expected long term rate of return | 6.75% | 7.25% | 7.50% |
Interest crediting rate | 3.00% | 5.00% | 5.00% |
Postretirement Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Discount rate | 1.60% | 2.30% | 3.55% |
Benefit Plans (Fair Value of Pl
Benefit Plans (Fair Value of Plan Assets Measured on a Recurring Basis) (Details) - Pension Benefits - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | $ 2,577 | $ 2,420 | $ 2,285 |
Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 2,577 | 2,420 | |
Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 1,719 | 1,664 | |
Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 777 | 699 | |
Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 934 | 956 | |
Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 8 | 9 | |
Fair Value Measured at Net Asset Value Per Share | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 838 | 756 | |
Fair Value Measured at Net Asset Value Per Share | Fair Value, Recurring | Equity Securities [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 20 | ||
Total fixed maturity securities trading | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 793 | 782 | |
Total fixed maturity securities trading | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Total fixed maturity securities trading | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 785 | 773 | |
Total fixed maturity securities trading | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 8 | 9 | |
Corporate and other bonds | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 653 | 652 | |
Corporate and other bonds | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Corporate and other bonds | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 645 | 643 | |
Corporate and other bonds | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 8 | 9 | |
States, municipalities and political subdivisions | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 30 | 32 | |
States, municipalities and political subdivisions | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
States, municipalities and political subdivisions | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 30 | 32 | |
States, municipalities and political subdivisions | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Asset-backed | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 110 | 98 | |
Asset-backed | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Asset-backed | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 110 | 98 | |
Asset-backed | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Equity securities | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 873 | 803 | |
Equity securities | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 732 | 666 | |
Equity securities | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 141 | 137 | |
Equity securities | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Short term investments | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 45 | 58 | |
Short term investments | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 45 | 20 | |
Short term investments | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 38 | |
Short term investments | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Other assets | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 8 | 8 | |
Other assets | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Other assets | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 8 | 8 | |
Other assets | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Cash | Total | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 13 | |
Cash | Level 1 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 13 | |
Cash | Level 2 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | 0 | 0 | |
Cash | Level 3 | Fair Value, Recurring | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Fair value of plan assets | $ 0 | $ 0 |
Benefit Plans (Estimated Future
Benefit Plans (Estimated Future Minimum Benefit Payments to Participants) (Details) $ in Millions | Dec. 31, 2021USD ($) |
Pension Benefits | |
Defined Benefit Plan Disclosure [Line Items] | |
2022 | $ 182 |
2023 | 179 |
2024 | 177 |
2025 | 175 |
2026 | 173 |
2027-2031 | 798 |
Postretirement Benefits | |
Defined Benefit Plan Disclosure [Line Items] | |
2022 | 1 |
2023 | 1 |
2024 | 1 |
2025 | 0 |
2026 | 0 |
2027-2031 | $ 1 |
Stock-Based Compensation (Narra
Stock-Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares authorized (in shares) | 16,000,000 | ||
Number of shares available for grant (in shares) | 5,600,000 | ||
Measurement period of specific annual performance goals, in years | 1 year | ||
Cliff vesting period following date of grant | 2 years | ||
Allocated share-based compensation expense | $ 32 | $ 37 | $ 34 |
Tax benefit from compensation expense | 6 | 6 | 8 |
Compensation cost not yet recognized | $ 41 | ||
Compensation cost not yet recognized, period for recognition | 1 year 8 months 12 days | ||
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value | $ 36 | $ 35 | $ 31 |
Weighted average grant date fair value of awards granted (in usd per share) | $ 45.82 | $ 34.36 | $ 43.86 |
Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage | 0.00% | ||
Award vesting period | 1 year | ||
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage | 200.00% | ||
Award vesting period | 3 years |
Stock-Based Compensation (Restr
Stock-Based Compensation (Restricted shares, performance-based restricted share units and performance share unit activity) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Number of Awards | |||
Balance as of beginning of period (in shares) | 2,439,141 | ||
Awards granted (in shares) | 1,044,772 | ||
Awards vested (in shares) | (789,495) | ||
Awards forfeited, canceled or expired (in shares) | (355,881) | ||
Performance-based adjustment (in shares) | 37,061 | ||
Balance as of end of period (in shares) | 2,375,598 | 2,439,141 | |
Weighted Average Grant Date Fair Value | |||
Balance as of January 1, 2020 (in dollars per share) | $ 40.56 | ||
Awards granted (in dollars per share) | 45.82 | $ 34.36 | $ 43.86 |
Awards vested (in dollars per share) | 46.13 | ||
Awards forfeited, canceled or expired (in dollars per share) | 40.19 | ||
Performance-based adjustment (in dollars per share) | 43.70 | ||
Balance as of December 31, 2020 (in dollars per share) | $ 41.21 | $ 40.56 |
Other Intangible Assets (Summar
Other Intangible Assets (Summary of Other Intangible Assets) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Schedule of Other Intangible Assets [Abstract] | ||
Finite-lived intangible assets: | $ 18 | $ 18 |
Indefinite-lived intangible assets: | 63 | 64 |
Total other intangible assets | 81 | 82 |
Accumulated Amortization | 14 | 13 |
Syndicate capacity | ||
Schedule of Other Intangible Assets [Abstract] | ||
Indefinite-lived intangible assets: | 47 | 48 |
Agency force | ||
Schedule of Other Intangible Assets [Abstract] | ||
Indefinite-lived intangible assets: | $ 16 | 16 |
Trade name | ||
Schedule of Other Intangible Assets [Abstract] | ||
Economic Useful Life | 8 years | |
Finite-lived intangible assets: | $ 7 | 7 |
Accumulated Amortization | $ 7 | 7 |
Distribution channel | ||
Schedule of Other Intangible Assets [Abstract] | ||
Economic Useful Life | 15 years | |
Finite-lived intangible assets: | $ 11 | 11 |
Accumulated Amortization | $ 7 | $ 6 |
Other Intangible Assets (Narrat
Other Intangible Assets (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Finite-Lived Intangible Assets [Line Items] | |||
2022 | $ 1 | ||
2023 | 1 | ||
2024 | 1 | ||
2025 | 1 | ||
2026 | 1 | ||
Other Intangible Assets | International | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization expense included in other operating expenses | $ 1 | $ 1 | $ 1 |
Leases (Narrative) (Detail)
Leases (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Leases [Abstract] | |||
Lease expense | $ 57 | $ 57 | $ 55 |
Operating lease, cost | 38 | 38 | 37 |
Variable lease, cost | 19 | 19 | 18 |
Operating lease, payments | 44 | 41 | 34 |
Right-of-use asset obtained in exchange for operating lease liability | $ 11 | $ 6 | $ 12 |
Leases (Assets and Liabilities)
Leases (Assets and Liabilities) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Leases [Abstract] | ||
Operating lease ROU assets | $ 175 | $ 199 |
Operating lease liabilities | $ 248 | $ 279 |
Leases (Maturities) (Details)
Leases (Maturities) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Leases [Abstract] | ||
2022 | $ 42 | |
2023 | 37 | |
2024 | 30 | |
2025 | 25 | |
2026 | 22 | |
Thereafter | 141 | |
Total lease payments | 297 | |
Less: Discount | (49) | |
Total operating lease liabilities | $ 248 | $ 279 |
Leases (Lease Term and Discount
Leases (Lease Term and Discount Rate) (Details) | Dec. 31, 2021 | Dec. 31, 2020 |
Leases [Abstract] | ||
Weighted average remaining lease term | 9 years 9 months 18 days | 10 years 3 months 18 days |
Weighted average discount rate | 3.40% | 3.40% |
Stockholders' Equity and Stat_3
Stockholders' Equity and Statutory Accounting Practices (Narrative) (Details) $ in Millions | 12 Months Ended | |
Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | |
Stockholders' Equity and Statutory Accounting Practices [Abstract] | ||
Increase in statutory capital and surplus due to prescribed practice | $ 67 | $ 91 |
Statutory amount available for dividend payment before consideration of statutory dividends paid in the preceding twelve months | 1,201 | |
Dividends paid in the preceding twelve months | $ 880 | |
Capital required for capital adequacy to risk weighted assets | 2.64 | 2.66 |
Stockholders' Equity and Stat_4
Stockholders' Equity and Statutory Accounting Practices (Combined statutory capital and surplus and net income (loss)) (Details) - Combined Continental Casualty Companies - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statutory Accounting Practices [Line Items] | |||
Statutory Capital and Surplus | $ 11,321 | $ 10,708 | |
Statutory Net Income (Loss) | $ 1,253 | $ 800 | $ 1,062 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) by Component (Schedule of Accumulated Other Comprehensive Income (Loss) by Component) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | $ 12,707 | $ 12,215 |
Other comprehensive income (loss) before reclassifications | (444) | 714 |
Amounts reclassified from accumulated other comprehensive income (loss) net of tax | 39 | (38) |
Other comprehensive income (loss) after tax (expense) benefit | (483) | 752 |
Total stockholder's equity at end of period | 12,809 | 12,707 |
Reclassification from AOCI, tax | (10) | 10 |
Tax (expense) benefit on other comprehensive income (loss) | 124 | (185) |
Accumulated other comprehensive income (loss) | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | 803 | 51 |
Total stockholder's equity at end of period | 320 | 803 |
Net unrealized gains (losses) on investments with an allowance for credit losses | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | 0 | 0 |
Other comprehensive income (loss) before reclassifications | (43) | |
Amounts reclassified from accumulated other comprehensive income (loss) net of tax | (43) | |
Other comprehensive income (loss) after tax (expense) benefit | 0 | |
Total stockholder's equity at end of period | 0 | |
Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on investments with an allowance for credit losses | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Reclassification from AOCI, tax | 12 | |
Tax (expense) benefit on other comprehensive income (loss) | 0 | |
Net unrealized gains (losses) on investments | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | 1,745 | 1,025 |
Other comprehensive income (loss) before reclassifications | 763 | |
Amounts reclassified from accumulated other comprehensive income (loss) net of tax | 43 | |
Other comprehensive income (loss) after tax (expense) benefit | 720 | |
Total stockholder's equity at end of period | 1,745 | |
Net unrealized gains (losses) on investments | Net unrealized gains (losses) on investments with an allowance for credit losses | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | 0 | |
Other comprehensive income (loss) before reclassifications | (7) | |
Amounts reclassified from accumulated other comprehensive income (loss) net of tax | (5) | |
Other comprehensive income (loss) after tax (expense) benefit | (2) | |
Total stockholder's equity at end of period | (2) | 0 |
Reclassification from AOCI, tax | 1 | |
Tax (expense) benefit on other comprehensive income (loss) | 1 | |
Net unrealized gains (losses) on investments | Net unrealized gains (losses) on other investments | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | 1,745 | |
Other comprehensive income (loss) before reclassifications | (625) | |
Amounts reclassified from accumulated other comprehensive income (loss) net of tax | 81 | |
Other comprehensive income (loss) after tax (expense) benefit | (706) | |
Total stockholder's equity at end of period | 1,039 | 1,745 |
Reclassification from AOCI, tax | (21) | (12) |
Tax (expense) benefit on other comprehensive income (loss) | 188 | (189) |
Pension and postretirement benefits | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | (848) | (833) |
Other comprehensive income (loss) before reclassifications | 207 | (53) |
Amounts reclassified from accumulated other comprehensive income (loss) net of tax | (37) | (38) |
Other comprehensive income (loss) after tax (expense) benefit | 244 | (15) |
Total stockholder's equity at end of period | (604) | (848) |
Reclassification from AOCI, tax | 10 | 10 |
Tax (expense) benefit on other comprehensive income (loss) | (65) | 4 |
Cumulative foreign currency translation adjustment | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Total stockholder's equity at beginning of period | (94) | (141) |
Other comprehensive income (loss) before reclassifications | (19) | 47 |
Amounts reclassified from accumulated other comprehensive income (loss) net of tax | 0 | 0 |
Other comprehensive income (loss) after tax (expense) benefit | (19) | 47 |
Total stockholder's equity at end of period | (113) | (94) |
Reclassification from AOCI, tax | 0 | 0 |
Tax (expense) benefit on other comprehensive income (loss) | $ 0 | $ 0 |
Business Segments (Narrative) (
Business Segments (Narrative) (Details) - segment | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Segment Reporting Information [Line Items] | |||
Percentage of direct foreign written premiums | 10.00% | 9.00% | 9.00% |
Core Segments - Specialty, Commercial and International | |||
Segment Reporting Information [Line Items] | |||
Number of operating segments | 3 | ||
Non-Core Segments - Life & Group and Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Number of operating segments | 2 |
Business Segments (Income State
Business Segments (Income Statement Information) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Segment Reporting Information [Line Items] | |||
Net written premiums | $ 8,405 | $ 8,059 | $ 7,656 |
Operating revenues | |||
Net earned premiums | 8,175 | 7,649 | 7,428 |
Net investment income | 2,159 | 1,935 | 2,118 |
Non-insurance warranty revenue | 1,430 | 1,252 | 1,161 |
Other revenues | 24 | 26 | 31 |
Total operating revenues | 11,788 | 10,862 | 10,738 |
Claims, Benefits and Expenses | |||
Net incurred claims and benefits | 6,327 | 6,149 | 5,783 |
Policyholders’ dividends | 22 | 21 | 23 |
Amortization of deferred acquisition costs | 1,443 | 1,410 | 1,383 |
Non-insurance warranty expense | 1,328 | 1,159 | 1,082 |
Other insurance related expenses | 1,062 | 1,028 | 1,038 |
Other expenses | 242 | 220 | 235 |
Total claims, benefits and expenses | 10,424 | 9,987 | 9,544 |
Core income (loss) before income tax | 1,364 | 875 | 1,194 |
Income tax (expense) benefit on core income (loss) | (258) | (140) | (215) |
Core income (loss) | 1,106 | 735 | 979 |
Net investment gains (losses) | 120 | (54) | 29 |
Income tax (expense) benefit on net investment gains (losses) | (24) | 9 | (8) |
Net investment gains (losses), after tax | 96 | (45) | 21 |
Net income (loss) | 1,202 | 690 | 1,000 |
Operating Segments | Specialty | |||
Segment Reporting Information [Line Items] | |||
Net written premiums | 3,225 | 3,040 | 2,848 |
Operating revenues | |||
Net earned premiums | 3,076 | 2,883 | 2,773 |
Net investment income | 497 | 449 | 556 |
Non-insurance warranty revenue | 1,430 | 1,252 | 1,161 |
Other revenues | 1 | 1 | 1 |
Total operating revenues | 5,004 | 4,585 | 4,491 |
Claims, Benefits and Expenses | |||
Net incurred claims and benefits | 1,787 | 1,792 | 1,595 |
Policyholders’ dividends | 3 | 3 | 5 |
Amortization of deferred acquisition costs | 643 | 621 | 610 |
Non-insurance warranty expense | 1,328 | 1,159 | 1,082 |
Other insurance related expenses | 296 | 280 | 292 |
Other expenses | 47 | 50 | 48 |
Total claims, benefits and expenses | 4,104 | 3,905 | 3,632 |
Core income (loss) before income tax | 900 | 680 | 859 |
Income tax (expense) benefit on core income (loss) | (196) | (145) | (188) |
Core income (loss) | 704 | 535 | 671 |
Operating Segments | Commercial | |||
Segment Reporting Information [Line Items] | |||
Net written premiums | 3,595 | 3,565 | 3,315 |
Operating revenues | |||
Net earned premiums | 3,552 | 3,323 | 3,162 |
Net investment income | 624 | 513 | 605 |
Non-insurance warranty revenue | 0 | 0 | 0 |
Other revenues | 23 | 25 | 29 |
Total operating revenues | 4,199 | 3,861 | 3,796 |
Claims, Benefits and Expenses | |||
Net incurred claims and benefits | 2,540 | 2,375 | 2,086 |
Policyholders’ dividends | 19 | 18 | 18 |
Amortization of deferred acquisition costs | 594 | 592 | 537 |
Non-insurance warranty expense | 0 | 0 | 0 |
Other insurance related expenses | 511 | 506 | 505 |
Other expenses | 38 | 34 | 32 |
Total claims, benefits and expenses | 3,702 | 3,525 | 3,178 |
Core income (loss) before income tax | 497 | 336 | 618 |
Income tax (expense) benefit on core income (loss) | (103) | (69) | (138) |
Core income (loss) | 394 | 267 | 480 |
Operating Segments | International | |||
Segment Reporting Information [Line Items] | |||
Net written premiums | 1,101 | 961 | 971 |
Operating revenues | |||
Net earned premiums | 1,057 | 940 | 974 |
Net investment income | 57 | 58 | 63 |
Non-insurance warranty revenue | 0 | 0 | 0 |
Other revenues | 0 | 0 | 0 |
Total operating revenues | 1,114 | 998 | 1,037 |
Claims, Benefits and Expenses | |||
Net incurred claims and benefits | 652 | 629 | 624 |
Policyholders’ dividends | 0 | 0 | 0 |
Amortization of deferred acquisition costs | 206 | 197 | 236 |
Non-insurance warranty expense | 0 | 0 | 0 |
Other insurance related expenses | 144 | 136 | 130 |
Other expenses | (2) | (7) | 8 |
Total claims, benefits and expenses | 1,000 | 955 | 998 |
Core income (loss) before income tax | 114 | 43 | 39 |
Income tax (expense) benefit on core income (loss) | (28) | (5) | (9) |
Core income (loss) | 86 | 38 | 30 |
Operating Segments | Life & Group | |||
Segment Reporting Information [Line Items] | |||
Net written premiums | 485 | 494 | 523 |
Operating revenues | |||
Net earned premiums | 491 | 504 | 520 |
Net investment income | 966 | 851 | 820 |
Non-insurance warranty revenue | 0 | 0 | 0 |
Other revenues | 0 | 0 | 0 |
Total operating revenues | 1,457 | 1,355 | 1,340 |
Claims, Benefits and Expenses | |||
Net incurred claims and benefits | 1,239 | 1,286 | 1,416 |
Policyholders’ dividends | 0 | 0 | 0 |
Amortization of deferred acquisition costs | 0 | 0 | 0 |
Non-insurance warranty expense | 0 | 0 | 0 |
Other insurance related expenses | 103 | 109 | 115 |
Other expenses | 10 | 7 | 8 |
Total claims, benefits and expenses | 1,352 | 1,402 | 1,539 |
Core income (loss) before income tax | 105 | (47) | (199) |
Income tax (expense) benefit on core income (loss) | 21 | 56 | 90 |
Core income (loss) | 126 | 9 | (109) |
Operating Segments | Corporate & Other | |||
Segment Reporting Information [Line Items] | |||
Net written premiums | 0 | 0 | 1 |
Operating revenues | |||
Net earned premiums | 0 | 0 | 1 |
Net investment income | 15 | 64 | 74 |
Non-insurance warranty revenue | 0 | 0 | 0 |
Other revenues | 6 | 5 | 6 |
Total operating revenues | 21 | 69 | 81 |
Claims, Benefits and Expenses | |||
Net incurred claims and benefits | 109 | 67 | 62 |
Policyholders’ dividends | 0 | 0 | 0 |
Amortization of deferred acquisition costs | 0 | 0 | 0 |
Non-insurance warranty expense | 0 | 0 | 0 |
Other insurance related expenses | 9 | (2) | (2) |
Other expenses | 155 | 141 | 144 |
Total claims, benefits and expenses | 273 | 206 | 204 |
Core income (loss) before income tax | (252) | (137) | (123) |
Income tax (expense) benefit on core income (loss) | 48 | 23 | 30 |
Core income (loss) | (204) | (114) | (93) |
Eliminations | |||
Segment Reporting Information [Line Items] | |||
Net written premiums | (1) | (1) | (2) |
Operating revenues | |||
Net earned premiums | (1) | (1) | (2) |
Net investment income | 0 | 0 | 0 |
Non-insurance warranty revenue | 0 | 0 | 0 |
Other revenues | (6) | (5) | (5) |
Total operating revenues | (7) | (6) | (7) |
Claims, Benefits and Expenses | |||
Net incurred claims and benefits | 0 | 0 | 0 |
Policyholders’ dividends | 0 | 0 | 0 |
Amortization of deferred acquisition costs | 0 | 0 | 0 |
Non-insurance warranty expense | 0 | 0 | 0 |
Other insurance related expenses | (1) | (1) | (2) |
Other expenses | (6) | (5) | (5) |
Total claims, benefits and expenses | (7) | (6) | (7) |
Core income (loss) before income tax | 0 | 0 | 0 |
Income tax (expense) benefit on core income (loss) | 0 | 0 | 0 |
Core income (loss) | $ 0 | $ 0 | $ 0 |
Business Segments (Balance Shee
Business Segments (Balance Sheet Information) (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Segment Reporting Information [Line Items] | ||
Reinsurance receivables | $ 5,484 | $ 4,478 |
Insurance receivables | 2,974 | 2,640 |
Deferred acquisition costs | 737 | 708 |
Goodwill | 148 | 148 |
Deferred non-insurance warranty acquisition expense | 3,476 | 3,068 |
Insurance reserves | ||
Claim and claim adjustment expenses | 24,174 | 22,706 |
Unearned premiums | 5,761 | 5,119 |
Future policy benefits | 13,236 | 13,318 |
Deferred non-insurance warranty revenue | 4,503 | 4,023 |
Operating Segments | Specialty | ||
Segment Reporting Information [Line Items] | ||
Reinsurance receivables | 1,200 | 886 |
Insurance receivables | 1,136 | 1,052 |
Deferred acquisition costs | 363 | 330 |
Goodwill | 117 | 117 |
Deferred non-insurance warranty acquisition expense | 3,476 | 3,068 |
Insurance reserves | ||
Claim and claim adjustment expenses | 6,433 | 5,748 |
Unearned premiums | 3,001 | 2,635 |
Future policy benefits | 0 | 0 |
Deferred non-insurance warranty revenue | 4,503 | 4,023 |
Operating Segments | Commercial | ||
Segment Reporting Information [Line Items] | ||
Reinsurance receivables | 923 | 848 |
Insurance receivables | 1,488 | 1,254 |
Deferred acquisition costs | 278 | 281 |
Goodwill | 0 | 0 |
Deferred non-insurance warranty acquisition expense | 0 | 0 |
Insurance reserves | ||
Claim and claim adjustment expenses | 8,890 | 8,250 |
Unearned premiums | 2,066 | 1,824 |
Future policy benefits | 0 | 0 |
Deferred non-insurance warranty revenue | 0 | 0 |
Operating Segments | International | ||
Segment Reporting Information [Line Items] | ||
Reinsurance receivables | 381 | 302 |
Insurance receivables | 340 | 328 |
Deferred acquisition costs | 96 | 97 |
Goodwill | 31 | 31 |
Deferred non-insurance warranty acquisition expense | 0 | 0 |
Insurance reserves | ||
Claim and claim adjustment expenses | 2,280 | 2,091 |
Unearned premiums | 585 | 546 |
Future policy benefits | 0 | 0 |
Deferred non-insurance warranty revenue | 0 | 0 |
Operating Segments | Life & Group | ||
Segment Reporting Information [Line Items] | ||
Reinsurance receivables | 401 | 390 |
Insurance receivables | 6 | 4 |
Deferred acquisition costs | 0 | 0 |
Goodwill | 0 | 0 |
Deferred non-insurance warranty acquisition expense | 0 | 0 |
Insurance reserves | ||
Claim and claim adjustment expenses | 3,754 | 3,743 |
Unearned premiums | 109 | 114 |
Future policy benefits | 13,236 | 13,318 |
Deferred non-insurance warranty revenue | 0 | 0 |
Operating Segments | Corporate & Other | ||
Segment Reporting Information [Line Items] | ||
Reinsurance receivables | 2,579 | 2,052 |
Insurance receivables | 4 | 2 |
Deferred acquisition costs | 0 | 0 |
Goodwill | 0 | 0 |
Deferred non-insurance warranty acquisition expense | 0 | 0 |
Insurance reserves | ||
Claim and claim adjustment expenses | 2,817 | 2,874 |
Unearned premiums | 0 | 0 |
Future policy benefits | 0 | 0 |
Deferred non-insurance warranty revenue | 0 | 0 |
Eliminations | ||
Segment Reporting Information [Line Items] | ||
Reinsurance receivables | 0 | 0 |
Insurance receivables | 0 | 0 |
Deferred acquisition costs | 0 | 0 |
Goodwill | 0 | 0 |
Deferred non-insurance warranty acquisition expense | 0 | 0 |
Insurance reserves | ||
Claim and claim adjustment expenses | 0 | 0 |
Unearned premiums | 0 | 0 |
Future policy benefits | 0 | 0 |
Deferred non-insurance warranty revenue | $ 0 | $ 0 |
Business Segments (Revenues by
Business Segments (Revenues by Line of Business) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Total revenues | $ 11,908 | $ 10,808 | $ 10,767 |
Total operating revenues | 11,788 | 10,862 | 10,738 |
Net investment gains (losses) | 120 | (54) | 29 |
Operating Segments | Specialty | |||
Total revenues | 5,004 | 4,585 | 4,491 |
Operating Segments | Commercial | |||
Total revenues | 4,199 | 3,861 | 3,796 |
Operating Segments | International | |||
Total revenues | 1,114 | 998 | 1,037 |
Operating Segments | Life & Group | |||
Total revenues | 1,457 | 1,355 | 1,340 |
Operating Segments | Corporate & Other | |||
Total revenues | 21 | 69 | 81 |
Eliminations | |||
Total revenues | (7) | (6) | (7) |
Management & Professional Liability | Operating Segments | Specialty | |||
Total revenues | 2,776 | 2,577 | 2,572 |
Surety | Operating Segments | Specialty | |||
Total revenues | 604 | 596 | 596 |
Warranty & Alternative Risks | Operating Segments | Specialty | |||
Total revenues | 1,624 | 1,412 | 1,323 |
Middle Market | Operating Segments | Commercial | |||
Total revenues | 1,508 | 1,444 | 1,439 |
Construction | Operating Segments | Commercial | |||
Total revenues | 1,322 | 1,120 | 1,043 |
Small Business | Operating Segments | Commercial | |||
Total revenues | 558 | 482 | 504 |
Other Commercial | Operating Segments | Commercial | |||
Total revenues | 811 | 815 | 810 |
Canada | Operating Segments | International | |||
Total revenues | 344 | 291 | 277 |
Europe | Operating Segments | International | |||
Total revenues | 473 | 389 | 363 |
Hardy | Operating Segments | International | |||
Total revenues | $ 297 | $ 318 | $ 397 |
Related Party Transactions Narr
Related Party Transactions Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Due to related parties | $ 56 | $ 89 | |
Fees and expenses of investment facilities and services | |||
Amounts reimbursed to Loews for services provided to the Company | 47 | 47 | $ 44 |
Due to related parties | 23 | 22 | |
Corporate services and related travel expenses | |||
Amounts reimbursed to Loews for services provided to the Company | 1 | 1 | |
Taxes paid | |||
Due from related parties | 33 | 67 | |
Loews | |||
Amounts earned from Loews for insurance premiums | $ 2 | $ 2 | $ 2 |
Non-Insurance Revenues from C_2
Non-Insurance Revenues from Contracts with Customers (Narrative) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||
Deferred non-insurance warranty revenue | $ 4,503 | $ 4,023 |
Contract with customer, liability, revenue recognized | 1,200 | 1,100 |
Deferred non-insurance warranty acquisition expense | 3,476 | 3,068 |
Amortization of deferred sales commissions | 1,100 | 900 |
Capitalized Commission Costs | ||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||
Deferred non-insurance warranty acquisition expense | 3,500 | 3,100 |
Capitalized Administrator Service Costs | ||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | ||
Deferred non-insurance warranty acquisition expense | $ 47 | $ 37 |
Non-Insurance Revenues from C_3
Non-Insurance Revenues from Contracts with Customers (Performance Obligation) (Details) $ in Billions | Dec. 31, 2021USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Remaining performance obligation, expected timing of satisfaction, period | 12 months |
Remaining performance obligation, amount | $ 1.3 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Remaining performance obligation, expected timing of satisfaction, period | 1 year |
Remaining performance obligation, amount | $ 1 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Remaining performance obligation, expected timing of satisfaction, period | 1 year |
Remaining performance obligation, amount | $ 0.8 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Remaining performance obligation, expected timing of satisfaction, period | |
Remaining performance obligation, amount | $ 1.3 |
Schedule II. Condensed Financ_2
Schedule II. Condensed Financial Information of Registrant (Parent Company) (Schedule of Condensed Financial Information of Registrant, Statements of Operations and Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Revenues | |||
Net investment income | $ 2,159 | $ 1,935 | $ 2,118 |
Net investment gains (losses) | 120 | (54) | 29 |
Total revenues | 11,908 | 10,808 | 10,767 |
Expenses | |||
Interest | 113 | 122 | 131 |
Income tax benefit | (282) | (131) | (223) |
Net income | 1,202 | 690 | 1,000 |
Total comprehensive income | 719 | 1,442 | 1,929 |
Parent Company | |||
Revenues | |||
Net investment income | 0 | 3 | 13 |
Net investment gains (losses) | 0 | (20) | (21) |
Total revenues | 0 | (17) | (8) |
Expenses | |||
Administrative and general | 1 | 1 | 1 |
Interest | 112 | 122 | 131 |
Total expenses | 113 | 123 | 132 |
Loss from operations before income taxes and equity in net income of subsidiaries | (113) | (140) | (140) |
Income tax benefit | 11 | 18 | 21 |
Loss before equity in net income of subsidiaries | (102) | (122) | (119) |
Equity in net income of subsidiaries | 1,304 | 812 | 1,119 |
Net income | 1,202 | 690 | 1,000 |
Equity in other comprehensive (loss) income of subsidiaries | (483) | 752 | 929 |
Total comprehensive income | $ 719 | $ 1,442 | $ 1,929 |
Schedule II. Condensed Financ_3
Schedule II. Condensed Financial Information of Registrant (Parent Company) (Schedule of Condensed Financial Information of Registrant, Balance Sheets) (Details) - USD ($) $ / shares in Units, $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Assets | |||
Cash | $ 536 | $ 419 | |
Other assets | 2,261 | 1,628 | |
Total assets | 66,639 | 64,026 | |
Liabilities | |||
Long term debt | 2,779 | 2,776 | |
Other liabilities | 3,377 | 3,377 | |
Total liabilities | 53,830 | 51,319 | |
Stockholders' Equity | |||
Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 271,363,999 and 271,391,603 shares outstanding) | 683 | 683 | |
Additional paid-in capital | 2,215 | 2,211 | |
Retained earnings | 9,663 | 9,081 | |
Accumulated other comprehensive income | 320 | 803 | |
Treasury stock (1,676,244 and 1,648,640 shares), at cost | (72) | (71) | |
Total stockholders’ equity | 12,809 | 12,707 | $ 12,215 |
Total liabilities and stockholders' equity | $ 66,639 | $ 64,026 | |
Balance Sheet Parenthetical | |||
Common stock, par value (in usd per share) | $ 2.50 | $ 2.50 | |
Common stock, shares authorized (in shares | 500,000,000 | 500,000,000 | |
Common stock, shares issued (in shares) | 273,040,243 | 273,040,243 | |
Common stock, shares outstanding (in shares) | 271,363,999 | 271,391,603 | |
Treasury stock, shares (in shares) | 1,676,244 | 1,648,640 | |
Parent Company | |||
Assets | |||
Investment in subsidiaries | $ 14,937 | $ 14,996 | |
Cash | 1 | 0 | |
Short term investments | 685 | 522 | |
Amounts due from affiliates | 3 | 4 | |
Other assets | 0 | 1 | |
Total assets | 15,626 | 15,523 | |
Liabilities | |||
Long term debt | 2,779 | 2,776 | |
Other liabilities | 38 | 40 | |
Total liabilities | 2,817 | 2,816 | |
Stockholders' Equity | |||
Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 271,363,999 and 271,391,603 shares outstanding) | 683 | 683 | |
Additional paid-in capital | 2,215 | 2,211 | |
Retained earnings | 9,663 | 9,081 | |
Accumulated other comprehensive income | 320 | 803 | |
Treasury stock (1,676,244 and 1,648,640 shares), at cost | (72) | (71) | |
Total stockholders’ equity | 12,809 | 12,707 | |
Total liabilities and stockholders' equity | $ 15,626 | $ 15,523 |
Schedule II. Condensed Financ_4
Schedule II. Condensed Financial Information of Registrant (Parent Company) (Schedule of Condensed Financial Information of Registrant, Statements of Cash Flows) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Cash Flows from Operating Activities | |||
Net income | $ 1,202 | $ 690 | $ 1,000 |
Adjustments to reconcile net income to net cash flows provided by operating activities: | |||
Net investment income | (120) | 54 | (29) |
Other, net | (76) | (145) | (225) |
Net cash flows provided by operating activities | 1,997 | 1,775 | 1,140 |
Cash Flows from Investing Activities | |||
Change in short term investments | (83) | (39) | (535) |
Other, net | 1 | 16 | 15 |
Net cash flows used by investing activities | (1,228) | (705) | (225) |
Cash Flows from Financing Activities | |||
Dividends paid to common stockholders | (621) | (950) | (929) |
Proceeds from the issuance of debt | 0 | 495 | 496 |
Repayment of debt | 0 | (419) | (520) |
Purchase of treasury stock | (18) | (18) | (23) |
Other, net | (9) | (10) | (12) |
Net cash flows used by financing activities | (648) | (902) | (988) |
Net change in cash | 117 | 177 | (68) |
Cash, beginning of year | 419 | 242 | 310 |
Cash, end of period | 536 | 419 | 242 |
Parent Company | |||
Cash Flows from Operating Activities | |||
Net income | 1,202 | 690 | 1,000 |
Adjustments to reconcile net income to net cash flows provided by operating activities: | |||
Equity in net income of subsidiaries | (1,304) | (812) | (1,119) |
Dividends received from subsidiaries | 880 | 975 | 1,065 |
Net investment income | 0 | 20 | 21 |
Other, net | 33 | 26 | 13 |
Net cash flows provided by operating activities | 811 | 899 | 980 |
Cash Flows from Investing Activities | |||
Change in short term investments | (163) | 2 | 10 |
Capital contributions to subsidiaries | 0 | (1) | (2) |
Other, net | 0 | 0 | 0 |
Net cash flows used by investing activities | (163) | 1 | 8 |
Cash Flows from Financing Activities | |||
Dividends paid to common stockholders | (621) | (950) | (929) |
Proceeds from the issuance of debt | 0 | 495 | 496 |
Repayment of debt | 0 | (419) | (520) |
Purchase of treasury stock | (18) | (18) | (23) |
Other, net | (8) | (9) | (12) |
Net cash flows used by financing activities | (647) | (901) | (988) |
Net change in cash | 1 | (1) | 0 |
Cash, beginning of year | 0 | 1 | 1 |
Cash, end of period | $ 1 | $ 0 | $ 1 |
Schedule II. Condensed Financ_5
Schedule II. Condensed Financial Information of Registrant (Parent Company) (Narrative) (Details) | Dec. 31, 2021 |
CNAF Consolidated | Loews | |
Condensed Financial Statements, Captions [Line Items] | |
Noncontrolling interest, ownership percentage by parent | 89.60% |
Schedule V. Valuation and Qua_2
Schedule V. Valuation and Qualifying Accounts (Schedule of valuation and qualifying accounts) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Mortgage loan receivables | |||
Movement in valuation allowances and reserves [Roll Forward] | |||
Balance Beginning of Period | $ 26 | $ 7 | |
Charged to Costs and Expenses | 0 | 0 | |
Charged to Other Accounts | (10) | 19 | |
Deductions | 0 | 0 | |
Balance at End of Period | 16 | 26 | $ 7 |
Insurance and reinsurance receivables | |||
Movement in valuation allowances and reserves [Roll Forward] | |||
Balance Beginning of Period | 54 | 57 | 71 |
Charged to Costs and Expenses | 4 | 4 | (6) |
Charged to Other Accounts | 0 | 0 | 0 |
Deductions | (8) | (7) | (8) |
Balance at End of Period | 50 | 54 | 57 |
Fixed maturity securities | |||
Movement in valuation allowances and reserves [Roll Forward] | |||
Balance Beginning of Period | 40 | 6 | |
Charged to Costs and Expenses | 0 | 0 | |
Charged to Other Accounts | 30 | 92 | |
Deductions | (52) | (58) | |
Balance at End of Period | $ 18 | $ 40 | $ 6 |
Schedule VI. Supplemental Inf_2
Schedule VI. Supplemental Information Concerning Property and Casualty Insurance Operations (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Incurred claim and claim adjustment expenses related to current year | $ 5,970 | $ 5,793 | $ 5,356 |
Incurred claim and claim adjustment expenses related to prior years | (104) | (119) | (127) |
Consolidated Property and Casualty Insurance Entity | |||
Deferred acquisition costs | 737 | 708 | |
Reserves for unpaid claim and claim adjustment expenses | 24,174 | 22,706 | |
Discount deducted from claim and claim adjustment expense reserves above (based on interest rates ranging from 3.5% to 6.4%) | 1,146 | 1,209 | |
Unearned premiums | 5,761 | 5,119 | |
Net written premiums | 8,405 | 8,059 | 7,656 |
Net earned premiums | 8,175 | 7,649 | 7,428 |
Net investment income | 2,111 | 1,896 | 2,063 |
Incurred claim and claim adjustment expenses related to current year | 5,793 | 5,356 | |
Incurred claim and claim adjustment expenses related to prior years | (119) | (127) | |
Amortization of deferred acquisition costs | $ 1,443 | 1,410 | 1,383 |
Paid claim and claim adjustment expenses | $ 5,164 | $ 5,576 | |
Consolidated Property and Casualty Insurance Entity | Minimum | |||
Supplemental Information Parenthetical | |||
SEC Schedule, 12-18, supplemental information, property-casualty insurance underwriters, interest rate at which discount computed | 3.50% | 3.50% | |
Consolidated Property and Casualty Insurance Entity | Maximum | |||
Supplemental Information Parenthetical | |||
SEC Schedule, 12-18, supplemental information, property-casualty insurance underwriters, interest rate at which discount computed | 6.40% | 6.40% |